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ABSTRACT 
Synthetic organic chemistry played a crucial role in the construction of molecules through 
the formation and dissociation of covalent bonds. However, the laborious synthetic procedures as 
well as the low yield after multiple steps have restricted the pursuit of complicated giant molecules 
with high efficiency. Being complementary to organic synthesis, self-assembly provided an 
alternative route to achieving the giant architectures using weak non-covalent interactions in high 
efficiency, which is in analog to natural systems such as DNA, peptide, and protein. Among the 
various interactions, coordination has shown unique advantages in terms of directionality, 
reversibility and strength. Serving as a bottom-up approach, coordination-driven self-assembly has 
been well flourished in the past few decades and is ready to face more challenges in constructing 
complicated 2D and 3D architectures with increasing complexity. 
Pyridine is one of the most important ligands that have been extensively applied in the self-
assembly of metallo-supramolecules. i.e., the coordination with square-planner metal centers to 
generate 2D and 3D architectures. Inspired by the beauty of Star of David, we have designed and 
synthesized 2D and 3D star-shaped metallo-supramolecules with Star of David figures via the self-
assembly of tetratopic pryidinyl ligand with 180° diplatinum(II) motif and Pd(II), respectively. 
Compared with other strategies such as template-directed synthesis and stepwise self-assembly, 
this design allows the formation of 2D and 3D structures in one step with nearly quantitative yield. 
The structures were characterized via both one-dimensional (1H, 13C, 31P) and two-dimensional 
(COSY, NOESY, DOSY) NMR techniques, as well as electrospray ionization-mass spectrometry 
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(ESI-MS) and ion mobility-mass spectrometry (IM-MS), AFM, TEM as well as X-ray 
crystallography. Moreover, the stabilities of the 2D and 3D structures were measured and 
compared using gradient tandem-mass spectrometry (gMS2). The high stability of 3D Star of 
David was correlated to its high density of coordination sites (DOCS).   
Being a derivative of pyridine, terpyridine as a tridentate ligand has also been widely 
applied in the coordination with transition metal ions to construct metallo-macrocycles and 
metallo-cages. Challenges still remain, however, within the construction of giant architectures in 
terms of high efficiency and complexity from simple building blocks. Inspired by the features of 
DNA and protein, which both have specific sequence, we designed a series of linear building 
blocks with specific sequences through the coordination between terpyridine ligands and Ru(II). 
Different generations of polycyclic supramolecules (C1 to C5) with increasing complexity are 
obtained through the self-assembly with Cd(II), Fe(II) or Zn(II). The assembled structures are 
characterized via multi-dimensional mass spectrometry analysis as well as multi-dimensional and 
multi-nuclear NMR (1H, COSY, NOESY, 19F) analysis. Moreover, the largest two cycles C4 and 
C5 hierarchically assemble into ordered nanoscale structures on a graphite based on their 
precisely-controlled shapes and sizes with high shape-persistence. 
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CHAPTER 1. INTRODUCTION 
1.1. Pyridine-Based Coordination-Driven Self-Assembly 
 Synthetic chemistry has been well developed for almost 200 years. Up to now, more than 
9 million organic molecules have been discovered1, which could be constructed via the formation 
and dissociation of covalent bonds between atoms in a controlled and precise manner. However, 
getting down to the fundamentals, one can easily find that most of the natural systems, such as 
DNA double helix, α-helixs, and β-sheets of peptides and proteins, are mainly induced by weak 
non-covalent interactions such as hydrogen bonding and π-π interactions. Driven by the curiosity 
and desire to finally understand as well as mimic these natural systems, chemists started to pay 
attention to these non-covalent interactions and thus have midwifed a new area of research, named 
Suparmolecular Chemistry. Being different from traditional synthetic chemistry, this field mainly 
focuses on developing structures and systems based on non-covalent interactions such as π-π, 
hydrogen bonding, electrostatic interactions, as well as van der Waals.  
The pioneering work  of supramolecular chemistry can be traced back to 1964, when 
Pedersen2 first explored crown ether. Shortly afterwards Lehn3 and Cram4 also did similar 
researches and investigated the host-guest interactions with Na+ and K+. Since then, chemists 
started to realize that a building block with well-defined size and geometry could assemble into 
large 2D and 3D architectures based on these non-covalent interactions. The self-assembly of 
discrete architectures requires the following conditions, including: 1) pre-organized rigid precursor 
with specific geometries, e.g., size, angle, dimensionalities; 2) good directionality installed in each 
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building block for further interaction; 3) reversible interactions for self-corrections. For a very long 
time, chemists have been struggling in looking for interactions which have good control over 
geometry as well as the directionality. Being different from the other interactions, coordination as 
a unique but powerful tool has shown its advantages in the construction of 2D and 3D architectures 
based on the reversible metal-ligand interactions. Such a method provided a “bottom-up” approach 
to precisely control the geometry of final assemblies based on directional metal-ligand interactions. 
Up to now, this field has witnessed a rapid growth with a wide variety of 2D, and 3D architectures 
reported by Clever5, Fujita6, Lehn7, Leigh8, Mirkin9, Mukherjee10, Newkome11, Nitschke,12 
Raymond13, Reek, Stang14, Sauvage15, Schmittel16, Shionoya17, Severin18, Stoddart19,  Ward20, and 
others.21  . Among all the works that have been reported, pyridine usually played an important role 
in the binding with different metals. In this chapter, we will mainly discuss the mono-pyridine 
based self-assemblies of 2D and 3D architectures. In chapter 1.2 we will discuss the terpyridine-
based self-assemblies for 2D metallocycles. 
Pyridine was first discovered by Scottish chemist Thomas Anderson in 1849. It is the 
simplest six-membered aromatic heterocycle in analog to benzene. Owning to the electron 
withdrawing ability of nitrogen atom, the electrons on the six-membered ring are unevenly 
distributed, and thus leading to a weaker resonance stabilization (117 kJ/mol) as compared to 
benzene (150 kJ/mol)22. Despite the fact that all the six atoms are sp2 hybridized, the lone pair 
electron on nitrogen is not involved in the π system. Instead, it remains in the same plane with the 
skeleton and is pointing to the outside, thus can serve as Lewis base to interact with Lewis acids. 
Thanks to this special character, pyridine can form metal-ligand complexes with a variety of metal 
ions. Also, the π-electron as well as the π* anti-bonding orbitals can form π-back bonding with the 
d orbitals on the metal ions (Figure 1), leading to good stabilities. On the other hand, however, 
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pyridine is regarded as a moderate ligand based on the crystal field theory (CFT)23. All the above 
characteristics made pyridine a perfect candidate in the construction of supramolecules in terms of 
good stability and reversibility, directionality as well as structural rigidity. In section 1.1.1, we 
mainly discuss the pyridine-based supramolecular self-assemblies of 2D metallo-supramolecules. 
In section 1.1.2, we cover the pyridine-based supramolecular self-assemblies of 3D architectures.  
 
Figure 1.1. σ-bonding and π-back bonding of pyridine with transition metals.  
1.1.1. Bis-pyridine-Based Coordination-Driven Self-Assembly in the Construction of 2D 
Architectures 
Although pyridine is beneficial for the construction of metallo-supramolecules, it was not 
an easy job during the initial trials for self-assemblies with metal. The first discrete structure, i.e., 
a molecular square was not reported until 1990 by Fujita and co-workers. Using a 180o 4,4-
bipyridine to self-assemble with cis-end capped Pd(II) ([enPd(NO3)2]), a molecular square could 
be formed in quantitative yield (Figure 1.2)24. It was indeed a pioneering work since no one ever 
used this kind of strategy to synthesize molecules. Moreover, the selection of Pd(II) was not a 
straightforward process. After screening a series of transition metals, Pd(II) was finally proved to 
be the most effective one 6c. They have also tried Pt(II), but the result came out that the coordination 
was not finished even after four days’ heating in water. 
π
π*
π-back bonding
σ-bonding
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Figure 1.2. Self-assembly of molecular square by Fujita (Reproduced with permission from 
reference 24) 
Similarly, Stang and co-workers also reported the self-assembly of a supramolecular square 
(Figure 1.3)25, in which both end-capped Pd(II) and Pt(II) were used. Compared with Fujita’s 
system, organic solvent was used to facilitate the self-assembly process, and Pt(II) has been proven 
successful. In both works, the self-assembly was realized using 90° metal acceptors with 180° 
pyridinyl donors in 1:1 ratio.  
 
Figure 1.3. Self-assembly of molecular square by Stang (Adopted permission from reference 25) 
Following the success of molecular square, Stang group continued in-depth researches for 
the self-assembly of 2D metallo-cycles during the following two decades. They have designed a 
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series of metal acceptors (Figure 1.4a) and pyridinyl donors (Figure 1.4b) with different shapes 
and angles. They found that the supramolecular ring structures could be constructed by 
combination of ligand donors and metal acceptors with different angle in different ratio. For 
example, a molecular square could also be obtained by the self-assembly of 180° metal acceptor 
and 90° ligand donor in 4:4 ratio, or 90° metal acceptor and 90° ligand acceptor in 2:2 ratio26. By 
changing the 90° metal acceptor into 60° angle and then self-assembling with 180° ligand donor, 
a molecular triangle could be achieved with ligand/metal in 3:3 ratio27. Keeping the ligand donor 
at 180° but enlarging the angle of metal acceptor to 120°, a molecular hexagon could be obtained 
with metal to ligand 6:6 ratio28. Similarly, the hexagon could also be achieved using 120° acceptor 
and 120° donor in a [3+3] manner29. And a combination of 60° donor and 120° acceptor in 2:2 
ratio would give a rhomboid. These strategies were later summarized by Stang et. al. as 
“combination of ditopic building blocks with predetermined angles” and thus generated a 
molecular library 30(Figure 1.4c). The same concept was also summarized as “directional-bonding 
approach” by Mirkin et. al31. 
 
Figure 1.4. Representative metal acceptors (a); pyridinyl donors (b) and combination of ditopic 
building blocks with predetermined angles (c). (Adapted with permission from reference 30) 
a
b
c
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However, it should be noted that the self-assembly result also relies on the rigidity of 
ligand/metal backbone. For instance, the molecular square could go through thermodynamic 
exchange to form the supramolecular triangle32 (Figure 1.5a), and a molecular rhomboid could 
also be transformed into molecular hexagon by increasing the concentration33 (Figure 1.5b). 
Moreover, the molecular hexagon sometimes can also suffer from the “hexagon-pentagon 
equalibrium”34 (Figure 1.5c) Among all of the transformations, there is always competition 
between kinetics and thermodynamics. 
 
Figure 1.5. Equilibrium between (a) molecular triangle and square. (b) molecular rhomboid and 
hexagon. (c) molecular hexagon and pentagon. 
Based on the success of these 2D metallo-supramolecular rings, numerous  work has been 
reported about the properties and applications by introducing functional groups on the 
macrocycles35a, 14d, 35b, 14e, 35c, which have enriched the library of the family of 2D metallo-
supramolecules. 
 
 
M
M
M
M
M
(a)
(b)
(c)
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1.1.2. Pyridine-Based Coordination-Driven Self-Assembly in the Construction of 3D 
Architectures 
Polyhedrons widely exist in nature. For instance, the capsids of most viruses are of 
icosahedron or dodecahedron shape. With the goal of mimicking the complexity of nature, 
chemists have been dreaming to create 3D polyhedrons using chemical methods. In this section, 
we mainly summarize the development of 3D self-assemblies using pyridine as the organic donor. 
 
Figure 1.6. Self-assembly of [2]catenane and concentration dependent experiment. (Reproduced 
with permission from reference 36) 
The first discovery of pyridine-based 3D self-assembly was closely related to the discovery 
of 2D metallo-macrocycle. During the study of a [2+2] self-assembled rhomboid, Fujita and co-
workers found that the self-assembly process was concentration dependent. At lower concentration, 
they mainly obtained molecular rhomboid; while at higher concentration, the system tended to 
form a interlocked [2]catenane (Figure 1.6), which was the first complicated structure reported 
other than macrocycles36.  
After the success of catenane, Fujita group started to investigate the self-assembly of cages. 
Since two-armed ligand donor with end-capped metal always resulted in the formation of a 2D 
H2O Concentration A (%) B (%)
1 mM <1 >99
2 mM 11 89
5 mM 38 62
10 mM 59 41
20 mM 75 25
50 mM 91 9
A B
 8 
 
metallocycle or catenane, increasing the number of arms would change the dimensionality of the 
final assemblies from 2D to 3D. By using a three-armed pyridinyl ligand with the self-assembly 
of end-capped Pd(II), a supramolecular cage could thus be achieved. The benzyl group resulted in 
the formation of a cavity in the center, and it should be noted that the self-assembly process must 
be in the presence of guest molecules. According to the screening, bulky guest molecules usually 
led to higher yield (Figure 1.7)37. 
 
Figure 1.7. Self-assembly of a molecular cage with the assistance of guest molecules (Adapted 
with permission from reference 37). 
One year after that work, Fujita group reported the self-assembly of a molecular pseudo 
octahedron based on the self-assembly between end-capped Pd(II) donor and three-armed 
pyridinyl ligand38 (Figure 1.8). In this case, the three-armed pyridinyl groups were in triangle shape, 
assembling with a 1,3,5-triazine in the center being electron deficient. This is the first 
supramolecular adamantoid ever reported, and was also regarded as a pseudo octahedron molecule 
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Such kind of M6L4 cage have thus been continuously used and reported in the following two 
decades39.  
 
Figure 1.8. Self-assembly of molecular octahedron by Fujita et al. (Adapt with permission from 
reference 41) 
The success of pseudo octahedron advanced their design with assembling large 3D 
assemblies through a combination of multitopic ligand with end-capped metal acceptors. By 
increasing the coordination sites in on each ligand, for instance, a four-armed ligand with D2h 
symmetry could self-assemble into a M8L4 cage in parallel or anti-parallel ways40 (Figure 1.9); 
while a hexadentate ligand can self-assemble with end-capped Pd(II) to give M18L6 cage. 
Interestingly, increasing the number of building blocks resulted in a decrease of the cavity: 
comparing with the previous two self-assemblies,  the cavity of this M18L6 cage is too small to 
encapsulate any organic molecules41 (Figure 1.10). A series of work using muti-dentate ligand 
with the self-assembly with end-capped Pd(II) was also reported during the same period42. 
6 + 4
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Figure 1.9. Self-assembly of M8L4 in parallel or anti-parallel ways (Adapted with permission 
from reference 41). 
 
Figure 1.10. Self-assembly of M18L6 trigonal-bipyramidal structure (Adapted with permission 
from reference 41) 
18 + 66
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It is noteworthy that in 1999, Stang group also reported a self-assembly of octahedral 
structure via the self-assembly between tridentate triangular acceptor/donor with 120° 
donor/acceptor43 (Figure 1.11). Being different from Fujita’s strategy in increasing coronation sites, 
this work realized the expansion of structure by increasing the angle from 90° to 120°. Such an 
approach proved that the molecular structure could be tuned by changing the angle of 
donor/acceptor but keeping the same coordination sites. This study not only gave a successful 
example for the self-assembly of molecular octahedron, but also provided an alternative strategy 
compared with Fujita’s tetrahedron study. It is worth mentioning that Stang group also reported a 
series of 3D cages by increasing the number of arms44. But afterwards his group mainly focused 
on 2D architectures and some 3D architectures with simple geometry. Below we mainly centered 
on Fujita’s system in terms of constructing 3D architectures. 
 
Figure 1.11. Self-assembly of molecular cuboctahedron by Stang (Adapted with permission from 
reference 43) 
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Before the year 2000, the majority of the reported examples of pyridine-based 3D 
architectures was using end-capped Pd(II)/Pt(II) or pre-synthesized metal acceptor with a specific 
angle. However, naked Pd(II)/Pt(II) as metal acceptors were rarely reported. In 1998, Atwood 
group first reported a M2L4 cage using octahedron Cu(II) with the coordination of four bidentate 
pyridinyl ligands, leaving two H2O molecules coordinated at the top and bottom45. In this case, the 
coordination between pyridine and metal were still square planner. One can easily speculate that, 
Pd(II) and Pt(II) should also be able to applied directly to form the [M(py)4]2+ linkage since they 
have the inherent square planner coordination in nature. And in the same year, McMorran and 
Steel first reported the self-assembly of Pd2L4 assembly. However, at that time, the coordination 
of Pd(II) with pyridine was still not well studied that they used [PdI2(py)2] as the metal and added 
AgOTf to remove the halide46. This might inspire others, especially Fujita group to further 
investigate the self-assembly using naked Pd(II) and Pt(II). In 2001, Fujita et al. reported the 
 
Figure 1.12. Self-assembly of M2L4 structure (Adapted with permission from Reference 47) 
self-assembly of a bidentate pyridinyl ligand with Pd(NO3)2 to form the M2L4 stucture47 (Figure 
1.12). Instead of using end-capped Pd(II), all the four coordination sites on each Pd(II) participated 
in the coordination with pyridine, leading to the formation of a convergent architecture. Although 
the structure is simple and small, it is still a pioneering work demonstrating the self-assembly of 
 13 
 
pyridine systems with naked metal ions directly. Several years later Clever et al. have developed 
interlocked Pd4L8 systems based on these M2L4 assemblies48, 5a.  
With the success of M2L4, Fujita group further investigated the self-assembly using 
bidentate pyridinyl ligand with naked Pd(II). According to previous experiences, expansion the 
angle between the two pyridines should lead to larger structures. Following this idea, the Fujita et 
al. reported a self-assembly of cuboctahedron based on the self-assembly of 120° bidentate ligand 
and Pd(II)6b (Figure 1.13). Although Omar Yaghi already first reported molecular cuboctahedron 
based on the coordination between carboxylic acid and Cu(II) cluster in 200149, Fujita’s 
cuboctahedron is still an epoch-making work in the field of supramolecular chemistry, since a 
metallo-supramolecular Archimedean solid could be easily obtained by heating two components 
in organic solvent at atmospheric pressure without further purification. And cuboctahedron was 
later proven to be the most extensively studied polyhedron within Fujita’s system50.  
 
Figure 1.13. Structure of the self-assembled cuboctahedron. (Reproduced with permission from 
reference 50). 
Besides cuboctahedron, the Fujita group continued to change the angle of ligand to 
construct different assemblies. For example, decrease the angle from 120° to 90° would give a 
smaller M6L12 assembly51 (Figure 1.14). The structure was a molecular cube but could also be 
viewed as an octahedron when taking all the metal junction as vertices. It should be noted that the 
+ Pd(II)
2a, 2b, 2c
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molecular octahedron structure could also be obtained by using a tridentate ligand with the self-
assembly of Pd(II)52. In this case all the ligands served as the faces instead of edges. Such a strategy 
has also been applied in the formation of octahedrons by others53. 
 
Figure 1.14. Self-assembly of a molecular cube (Adapted with permission from reference 49) 
By increasing the angle from 120° to 149°, the self-assembly was expanded from M12L24 
to M24L48 (Figure 1.15)6d. Comparing with the previous cuboctahedron, the rhombicuboctahedron 
is much more complicated with the number of building blocks being doubled. However, such a 
huge difference just came from a little change on the ligand by switching the center furan into a 
thiophen, which led to a slight difference on the angle. Such kind of phenomenon was described 
as “emergent effect” by the authors. Moreover, the authors also tested the self-assembly process 
by mixing two different ligands with different angles at different ratio. And the result turned out 
that the self-assembly process is exclusive depending on the average angle of the ligand, which 
further illustrated the “emergent effect”. 
 
Figure 1.15. Self-assembly of M24L48 (Adapted with permission from reference 6d) 
+ Pd(NO3)2
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Based on Platonic and Archimedean solids, the Fujita group have predicted the possible 
structures of such kind of MnL2n self-assemblies (Figure 1.17). And in 2016, the supramolecular 
icosidodecahedron was successfully achieved6e. The M30L60 was closely related to the M24L48 
system and it is a kinetic-controlled product. During the first hour, all that have been observed was 
the M24L48 rhombicuboctahedron. After further heating for 12h, a mixture of M30L60 and M24L48 
was obtained (Figure 1.16a). Based on the previous experiences, such system might also suffer 
from “emergent effect”. As a result, in order to get pure M30L60 assemblies, Fujita et. al. made 
modifications on the ligand. And finally, the ligand with eight methyl group substituted on the 
benzene ring was proven to be successful (Figure 1.16b).  
 
Figure 1.16. (a). Kinetic control for the formation of M24L48 and M30L60. (b). Self-assembly of 
pure M30L60 using a modified ligand. 
 
Figure 1.17. Prediction of self-assembly of MnL2n system on Platonic and Archimedean solids 
(Adapted with permission from reference 6f) 
+ Pd(II) M24L48
70 
1h 12h
70 M24L48
M30L60
+
+ Pd(II)
12h
70 
M30L60
(a)
(b)
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In the same year, the Fujita group even reported the M48L96 assembly6f, which is a 
Goldenberg polyhedron being different from the originally predicted Platonic or Archimedean 
system (Figure 1.17). It should be noted that the formation of such a Goldenberg polyhedron is a 
thermodynamic transformation process from M30L60. 
The success of MnL2n system, especially the M12L24 cuboctahedron, have advanced the 
further study in pursuing complex structures and seeking novel applications. For instance, Fujita 
and co-workers have reported a sphere-in-sphere system by connecting a larger and a smaller 120° 
ligands using alkyl chain54. The corresponding self-assembly with Pd(II) resulted in the formation 
of an M24L24 sphere-in sphere molecular system (Figure 1.18a). The same author have also 
published another stellated cuboctahedron M18L24, in which six extra cavities were created on the  
 
Figure 1.18. Examples of self-assembly of cage-in-cage structures. (Adapted with permission 
from Reference 52, 53, 54, and 55). 
outside55 (Figure 1.18b). Similarly, Partha and co-workers have reported a self-assembly of a cage-
in-cage using a tripyrimidine donor56. It is interesting that half of the nitrogen atoms on the outer 
layer did not participate in the coordination process (Figure 1.18c). Li et. al. has also reported a 
Pd(II)
(a) (b)
(c)
+ Pd(II)
(d)
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sphere-in-sphere structure based on the four-armed pyridinyl ligand21i (Figure 1.18d). And the 
functionalization, including template synthesis, molecular encapsulation, catalysis, polymerization, 
etc. have also been investigated by Fujita57, Reek58, Lusby59 and others60. 
To summarize, pyridine has been widely applied in the construction of 2D and 3D 
architectures via the coordination with end-capped/functionalized or naked square planner metal 
acceptors, viz, Pd(II), Pt(II). By changing the geometry, e.g., angle, size, and dimensionality of the 
building blocks, one can easily control the final assemblies from small structures (triangle, square, 
rhomboid, cube, etc.) to large architectures (hexagon, cuboctahedron, icosidodecahedron, etc.). 
However, the increase of size also brought about the challenges of structural characterizations. 
Conventional characterizations such as NMR, ESI-MS, and TEM only gave partial or even obscure 
information. Single crystal crystallography is able to unambiguously characterize these 3D 
structures. However, due to the increasing structural complexity as well as lability of the crystals, 
all of the characterizations has to be performed on synchrotron in order to obtain acceptable 
resolution for refinement. On the other hand, growing single crystals of these cages is time 
consuming and challenging process, which might take up to several months for large ones6e. Also, 
with structure becomes larger, the resolution becomes lower, due to the protein-like structure as 
well as the huge void spaces filled with disordered solvent molecules61.  
1.2 Terpyridine-Based Coordination-Driven Self-Assembly in the Construction of 2D 
Metallo-Supramolecules 
2,2,6,6-terpyridine (tpy) as a tridentate ligand has been discovered for almost one century. 
It emerged as a powerful moiety in coordination with a wide array of transition metal ions to form 
the <tpy-M-tpy> connectivity, in which the metal centers are usually distorted octahedron 
coordination62. The complexation is usually strong due to the d-π* back-bonding. Nevertheless, 
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the binding strength could also be tuned based on the metal being coordinated. For example, a 
strong coordination which is almost kinetically irreversible is formed when metals such as Ru(II), 
Os(II) are employed. When using metal ions such as Zn(II), Cd(II), the coordination is reversible 
but thermodynamically stable. During the past few decades, tpy coordination has been utilized in 
the fields of sensing63, photovoltaics64, optoelectronics65 as well as biological fields66. Also, 
another important field is the construction of metallo-supramolecular architectures. In this section, 
we mainly summarize the works on discrete architectures during the past twenty years. Section 
1.2.1 is centered on the self-assemblies using pure organic terpyridinyl ligands, and section 1.2.2 
focuses on the self-assembly using metal-organic ligands with <tpy-Ru-tpy> connectivity through 
stepwise synthesis. 
1.2.1. Self-Assembly Using Pure Organic Tpy-Based Multitopic Ligands 
 
Figure 1.19. Self-assembly of supramolecular grids (Reproduced with permission from reference 
66, 67 and 68). 
M(II)
5c, 4x4
M=Pb(II)
5b, 3x2 or 2x3
M=Co(II), Zn(II) or Fe(II)
5a, 2x2
M=Co(II) Zn(II), Fe(II), Mn(II), 
Ni(II), Cu(II), Cd(II), Pb(II)
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The pioneering work of tpy coordination to form discrete architectures was initiated by 
Lehn and co-workers in the construction of [m×n] metallo-supramolecular grids (Figure 1.19). The 
linear multi-terpyridinyl ligand could self-assemble with most first and second row transition 
metals to form the 2×267, 2×368 and 4×467a, 69 grids in almost quantitative yield. The 3×3 grid was 
challenging to be obtained using regular transition metals, possibly due to the pinching of the 
binding subunit on coordination of transition-metal ions which caused ligand banding70. It is 
noteworthy that Ru(II) and Os(II) could also be applied in the construction of molecular grids, but 
post separation is needed due to the poor reversibility of <tpy-Ru-tpy>/<tpy-Os-tpy> connectivity. 
During the same period with Lehn’s supramolecular girds, the first metallo-supramolecular 
macrocycle based on tpy was reported by Newkome and co-workers11a. However, since the authors 
chose ruthenium (Ru(II)) as the metal, considerable effort on separation has to be applied, and thus 
this work is more like using a stepwise synthesis approach rather than self-assembly. Three years 
later in 2002, Newkome group synthesized a metallo-macrocycle with the same shape, but with 
FeCl2 as the metal source for one-pot self-assembly followed by separation with 87% yield11b 
(Figure 1.20). A similar strategy in the synthesis of metallo-triangle was also reported in 200511d.  
Shortly afterwards Newkome and co-workers also reported a self-assembly of 
supramolecular pentamer based on bis-terpyridine carbazo ligand11c. Besides Ru(II) and Fe(II), 
Zn(II) was also applied in the self-assembly (Figure 1.21). Despite the low yield (35%), it still 
demonstrated the first self-assembly of bis-terpyridine ligand with Zn(II) to generate macrocycles. 
The next year, the same group further published the self-assembly of hexagon using 
triphenylamine (TPA) based bistpy ligand with Zn(II)11e, and the similar hexagon structure has 
been explored afterwards in terms of properties11f, 11g, 11j, 11l and applications11i, 11k 
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Figure 1.20. Synthesis and self-assembly of metallo-supramolecular hexagon. (Reproduced with 
permission from Reference 11b) 
 
Figure 1.21. Self-assembly of supramolecular pentamer (Reproduced with permission from 
reference 11c) 
Despite numerous reports, the self-assembly based on 120° angle bistpy ligand with metal 
ions did not always produce the desired hexagon product71. In order to get a pure product, Wang 
et. al. from the Newkome group reported a three-component self-assembly using a three-armed 
terpyridinyl ligand together with a six-armed ligand, and the self-assembly was accomplished 
using Cd(II) as the metal ions72 (Figure 1.22). This is the first tpy-based multi-component self-
assembly with formation of a single product. The six-armed ligand in the center might serve as a 
template, which blocked the formation of other species other than hexamer on the outer layer. 
FeCl2N-ethylmorpholin
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Based on this strategy, Newkome group reported another multi-component self-assembly with two 
equivalent of three-armed ligand stacking together to form the six-armed template in the center73. 
 
Figure 1.22. Three-component self-assembly of a spoke-wheel structure. (Reproduced with 
permission from reference 72). 
 
Figure 1.23. Self-assembly of molecular rhomboid and the self-sorting of 60° “V” ligands. 
(Adapted with permission from reference 74). 
Another example of multi-component self-assembly was reported in 2012 by Lu et. al. 
from Newkome group74. They proposed that a molecular rhomboid could theoretically be 
constructed through the self-assembly using two 60° “V” ligands and two 120° bistpy ligands with 
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metal ions. However, further experiment revealed that only a small amount of rhomboid could be 
self-assembled, and the major product was a molecular triangle due to the self-sorting of three 60° 
“V” ligands with three metal ions. With an alternative design, the pure rhomboid could only be 
obtained when using a tris-terpyridinyl ligand to replace the 120° bis-terpyridinyl ligand. The extra 
two terpyridines would form a “bridge” across the structure, which forced the 60° “V” ligand to 
participate in end-capping (Figure 1.23).  
This result revealed that large structures may not be obtained by simply mixing several 
components with metal ions together since self-assembly always tends to form smaller 
architectures in order to reach maximum entropy. In order to solve this problem, Chan et al. 
developed a bulky tpy system by introducing 2,6-dimethoxypheny groups onto the 3,3’’positions 
of tpy75 (Figure 1.24). In this system, the substituted terpyridines could not coordinate with 
themselves due to the steric hinderance. Instead, they can only coordinate with regular 
unsubstituted terpyridines to form a complementary pair. Moreover, the modified tpy was proven  
 
Figure 1.24. Coordination of substituted tpy with regular tpy to form the 1:1 complex 
to have better affinity binding with metal. Following this idea, The Chan group first used this 
system to construct enlarged molecular ditrigons. The modified tpy were designed on the 180° 
ligand. Only the desired product was observed during the self-assembly (Figure 1.25a). Also, this 
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modified tpy could be applied to construct the 60° “V” ligand, which also avoided self-sorting 
efficiently76 (Figure 1.25b).  
 
Figure 1.25. Self-assembly of ditrigons (a) and uulti-component self-assembly of a stellated 
metallo-supramolecule (Adapted with permission from Reference 75 and 76). 
Besides multi-component self-assemblies, the Li group have developed the self-assembly 
of multi-layered architectures using multi-layered ligands. The inner layer(s) and the outer layer 
were connected via rigid connection. This design efficiently avoided the formation of multi-entities 
during the self-assembly, due to the increase of rigidity of the whole molecule.  Using this strategy, 
two hexagon wreathes were first assembled in 201421g (Figure 1.26a, b). The two supramolecules 
have exactly the same inner layer like the previous reported ones11a, but in this case only the 
hexagonal structure was obtained, which proved the feasibility of this design principle. Later in 
201621m and 201877, Li and coworkers also developed a concentric hexagon system by using 
ligands with two, three and four layers. Each of them can self-assemble into the desired concentric 
hexagons or named as “Kandinsky circles” (Figure 1.26d, e, f). Very recently, a one-pot synthesis 
and self-assembly of 2D hexagonal metallo-supramolecules was reported78. In that report, Li et al. 
combined reversible coordination and irreversible condensation reaction in one pot to construct a 
(a) (b)
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two-layered hexagonal circle. A six-armed ligand or two three-armed ligands could also be fixed 
in the center when introducing another tpy building block on the ligand. This strategy has pushed 
multi-component synthesis and self-assembly into a new level of complexity.  
 
Figure 1.26. Li group’s self-assembly of hexagonal wreath (a, b); supramolecular fractal (c) and 
Kandinsky circles (d-f). (Reproduced with permission from reference 21g, 77). 
 
Figure 1.27. Concentration-dependent transformation between trimer and tetramer. (Adapted 
with permission from Reference 79) 
a b c
d
f
e
=Zn =Cd
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Similarly, Chan and co-workers have reported self-assembly using multi-layered ligand to 
construct “satellate supramolecular spiderweb”79, 76. Being different from Li’s rigid multitopic 
building blocks, Chan’s design relied on flexible chain connecting different layers, and a “V” 
ligand stayed in the center to connect two outer-layered arms. Due to the flexibility, concentration-
dependent behavior was observed during the self-assembly (Figure 1.27). 
1.2.2. Self-Assembly Using Metal-Organic Terpyridine Ligands Based on Stepwise Synthesis 
In the previous section, the self-assembly of supramolecular macrocycles using multi-topic 
terpyridinyl ligand has been summarized. However, the multi-component self-assemblies usually 
have problems of low selectivity as well as self-sorting during coordination. The best solution to 
solve this problem is to pre-connect the building blocks as expected.  As has been previously 
mentioned, the tpy<Ru>tpy connection is strong and almost irreversible. This nature provided a 
possibility to serve as linker which connect the different components. In this section we will mainly 
summarize the work in this field. 
The very early work for stepwise synthesis actually came from Newkome’s synthesis of 
hexameric metallo-supramolecular macrocycle11a (Figure 1.17). This work proved that <tpy-Ru-
tpy> could be synthesized in a step-wise manner and the product was able to be separated via 
chromatography. Such method yielded extraordinarily brilliant results in 2006, when Newkome 
published Sirpinski Gasket11h. In that work, step-wise strategy was first used in the synthesis of 
metallo-ligand, which has a six-membered ring backbone with two free terpyridines in 120°degree. 
Further self-assembly with Fe(II) resulted in the final hexameric structure (Figure 1.28). It should 
be noted that in that work, Newkome and coworkers used ultra-high vacuum-low temperature-
scanning tunneling spectroscopy (UHV-LT-STM) to directly visualize the molecules as the major 
evidence for the formation of the hexamers. 
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Figure 1.28. Self-assembly of Sirpinski Gasket. (Reproduced with permission from reference 11a). 
 
Figure 1.29. Dimerization based on <tpy-Ru-tpy> connectivity (a) and direct end-capping based 
on Ru(III) coordination followed by reduction (b). 
This strategy could be briefly summarized as dimerization based on <tpy-Ru-tpy> 
connectivity and direct end-capping based on the Ru(III) coordination followed by reduction 
(Figure 1.29). The metallo-ligand can either self-assemble with each other or go through multi-
component self-assemblies to generate larger assemblies. For example, Newkome and workers 
constructed the Dondorff rings80 through the self-assembly of a Ru(II) connected dimer of two “V” 
Cl Cl
(a)
(b)
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ligand, and the same ligand could self-assemble into supramolecular bowtie and butterfly11o 
through multi-component self-assemblies with other “X” or “K” ligands (Figure 1.30). Using the 
same precursor to coordinate with another “X” ligand could give a triangular ligand which could 
further self-assemble into a supramolecular metallo-triangulane81.  
 
Figure 1.30. Self-assembly of supramolecular bowtie, butterfly and Dondorff ring. (Reproduced 
with permission from reference 80,11o). 
However, using ruthenium-based coordination to build metallo-ligand has the following 
two major problems: 1) the unavoidable self-sorting during the self-assembly using multiple types 
of building blocks; 2) low selectivity caused by multiple type of free tpy group on each ligand. In 
order to solve this problem, a further step-wise method have been developed based on the Suzuki 
coupling reaction on. Briefly, the metal-organic ligand could be constructed by preparing Ru(II)-
organic precursor with a halogen atom, followed by Suzuki coupling reaction with bronic 
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acid/bronic ester motif to give the final ligand (Figure 1.31). Using this method, one can easily 
avoid self-sorting or coordination to the undesired position.  
 
Figure 1.31. Suzuki coupling reaction on ruthenium precursors to synthesize the final metal-
organic ligand. 
For instance, Wang and coworkers have constructed a supramolecular pentagram and 
hexagram based on the linkage with “V” and “X” ligands82. To avoid self-sorting, “V” and “X” 
was initially connected through stepwise synthesis. In their initial design, such a ligand was 
initially designed to self-assemble into a supramolecular Star of David. However, the result came  
 
Figure 1.32. (a). Ligand “V+X” and the subsequent self-assembly toward supramolecular 
pentagon. (b). Ligand “V+2X” and the self-assembly. (Adapted with permission from reference 
82) 
Br
B(OH)2
B(OH)2
(a) (b)
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out that a pentagon was obtained, possibly due to the lack of rigidity of ligand backbone (Figure 
1.32a). In order to get a Star of David, they redesigned the ligand in which one “V” was connected 
with two “X”, which avoided the formation of odd-numbered rings. Subsequent self-assembly with 
an extra three equivalents of “V” ligands could produce the desired Star of David architecture. 
However, this is not a perfect example of multi-component self-assembly since the “V” ligands 
still inevitably suffer from self-sorting so that a mixture of triangle and Star of David was obtained. 
In order to get pure Star of David, Fe(II) was employed and  the final hexamer was isolated via 
column chromatography  (Figure 1.32b). 
 
Figure 1.33. Self-assembly of supramolecular snowflakes with different sizes. (Adapted with 
permission from reference 83b) 
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The multi-component self-assembly using <tpy-Ru-tpy> motif prepared through Suzuki 
coupling reaction was also reported by Li et. al. for the self-assembly of supramolecular 
snowflakes83. The metal-organic ligand was synthesized by connecting “V” ligand and “Y” ligand 
with Ru(II), followed by self-assembly with a six-armed “*” ligand and Zn(II). Similar to 
Newkome’s spoke-wheel72-73, the six-armed ligand is critical as a template in the formation of a 
snowflake. Self-assembly without the six-armed ligand would result in a tetrameric nanocage84. 
Keeping the size of “V” and “*”, the size of supramolecular snowflake could be tuned by changing 
the length of the arms on the “Y” ligand (Figure 1.33). And the snowflakes with different size 
could go through dynamic ligand exchange at a certain degree to form hybrid snowflakes83b.  
Another example was reported by Wang and coworkers in the construction of a giant 
supramolecule using a dimerized three-armed ligand with the self-assembly with “K” ligand85. 
(Figure 1.34). In this case, dimerization of the three-armed ligand was realized through 
coordination between 1,5-dibromo-substituted tpy motif first, leaving four bromines for Suzuki 
coupling reaction to generate the other four tpy arms. Subsequent multi-component self-assembly 
with “K” ligand generated the hollow giant metallo-supramolecular architecture.  
Similar to this work, the same group also constructed Sírpinski triangle, in which six-fold 
Suzuki reaction was performed in one step in order to connect one “V” ligand with two “K” 
ligands86. 
One of the most challenging example involving stepwise synthesis using <tpy-Ru-tpy> 
connectivity was reported by Wang et al. in 201687. That work involved multiple steps of Ru(III) 
coordination and reduction, as well as Suzuki coupling reactions, as was shown in figure 1.35. The 
ligand is reminiscent of the “Hexagon Wreath” by Li et al.21g but using <tpy-Ru-tpy> as the  
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Figure 1.34. Stepwise synthesis of ligand and self-assembly of hollow supramolecular nut. 
(Reproduced with permission from reference 85). 
connection. The size of the ligand has been substantially enlarged to assemble a honeycomb 
architecture with a diameter of 13nm, among one of the largest 2D metallo-supramolecules. 
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Figure 1.35. Synthesis and self-assembly of supramolecular honeycomb (Adapted with 
permission from reference 87). 
In summary, stepwise synthesis using <tpy-Ru-tpy> connectivity served as a powerful tool 
in the construction of multitopic terpyridinyl ligand. Such a strategy not only helped build large 
ligand with the desired shape and angle, but also avoided self-sorting and undesired assemblies 
efficiently. The ruthenium-based coordination could build the linkage directly, while Suzuki 
coupling reaction is uniquely powerful when dealing with ligands with lower symmetry. The 
metal-organic ligand could be designed to either undergo direct self-assembly with metal ions; or 
multi-component self-assemblies with other building blocks to achieve higher complexity. 
However, current methods in the construction of metal-organic ligand still suffer from drawbacks. 
When multiple reactive sites are present, Suzuki coupling reaction suffer from low selectivity so 
that the boronic acid/boronic ester motif always have to be the same and in excess amount in order 
to guarantee complete reaction on all sites.  Such characteristic restricted the design architectures 
with higher level of complexity.  
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CHAPTER 2. SELF-ASSEMBLY OF 2D AND 3D STAR OF DAVID 
2.1. Background 
In section 1.1, we have introduced pyridine-based self-assemblies of 2D and 3D 
architectures. The significance of 2D metallocycles and 3D metallo-cages have always motivated 
chemists for greater challenges. Inspired by the success of Stang and Fujita, our group have 
reported a 2D ring-in-ring and 3D sphere-in-sphere system in 20151 (Figure 2.1).  
 
Figure 2.1. Self-assembly of ring-in-ring and sphere-in-sphere architecture. (Adapted with 
permission from reference 1). 
This work has successfully combined the construction of 2D and 3D architectures using 
one ligand, and the 3D structure has been proven to be more stable than the 2D structure by 
gradient tandem mass spectrometry. Moreover, we have also proposed the concept of “Density of 
Coordination Sites (DOCS)” to interpret stability of 2D and 3D metallo-supramolecules. The 
success has stimulated us seeking more complicated 2D and 3D architectures which could be 
interpreted using a similar method, until the Star of David came into our view. 
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The Star of David, a hexagram or the compound of two equilateral triangles recognized as 
the symbol of Jewry, has been extensively explored across science, mathematics, engineering, 
technology, business, history and art. It is still challenging, however, to express this geometry 
using chemistry due to the structural complexity. Previously, several groups have already involved 
the Star of David architecture. For instance, Lehn and co-workers have initiated the self-assembly 
of pentameric and hexameric circular helicate using tris(bipyridine) ligand and Fe(II)2. The 
chlorine ions could serve as template for the formation of pentagons. But when sulfate served as 
the counterion, a hexameric structure was obtained and could be viewed as a proto-type of Star of 
David with six open corner vertices (Figure 2.2).  
 
Figure 2.2. Lehn’s self-assembly of metallo-supramolecular hexagram and pentagram. 
(Reproduced with permission from reference 2). 
On the basis of this hexameric circular helicate scaffold, Leigh and coworkers successfully 
synthesized a Star of David catenane by post-assembly ring-closing olefin metathesis of the 
adjacent terminal bipyridine residues3 (Figure 2.3) 
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Figure 2.3. Leigh’s Star of David catenane (Adapted with permission from reference 3). 
 
Figure 2.4. Star of David shape 2D metallo-supramolecules based on terpyridine. (Reproduced 
with permission from reference 4 and 5). 
The endeavors for the construction of similar structures also appeared in the field of 
terpyridine-based supramolecular chemistry by Newkome and co-workers4. In this study, a 
Sierpiński hexagonal gasket with Star of David feature was achieved via the self-assembly of 
metal-organic ligand and Fe(II) in a step-wise manner. Similarly, a central hollow Star of David 
=Ru(II)
=Fe(II)
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was assembled by a step-wise strategy using terpyridine ligand prepared by Suzuki cross-coupling 
reaction on the complex5.  
Besides supramolecular chemistry, Star of David has also been reported as a repeat unit 
within the infinite structure of metal-organic frameworks (MOFs)6 and covalent organic 
frameworks (COFs)7, or inorganic cluster complexes8 in the field of materials science.  
Up to date, it is still challenging for direct self-assembly of discrete supramolecular Star of 
David rather than using template-directed synthesis or step-wise self-assembly. Herein, we 
attempted to employ multitopic pyridyl ligand and 180° diplatinum(II) motif to assemble 2D Star 
of David without using template or metal-organic ligand prepared by tedious synthesis. More 
interestingly, such ligand could also assemble with Pd(II) ions to form a giant and discrete ‘3D’ 
version of Star of David, in which every cross-section is a 2D Star of David. With structural 
analysis of Star of David, we reasoned that a tetratopic ligand could assemble with metal 
components to form a dual-rim supramolecular structure. After a careful design and detailed 
molecular dynamics simulation, ligand LA and LB was selected in the study to assemble with a 
180° diplatinum(II) motif to construct 2D and 3D Star of David (Figure 2.5).  
 
Figure 2.5. Chemical structure for ligand LA, LB and the self-assemblies for 2D and 3D Star of 
David. 
 
6  × + A1 (LA)
B1 (LB)
Pd2+
LA: R1=R2=H
LB: R1=CH3, R2=OC4H9
A2 (LA)
B2 (LB)
24 × +12 × 24 ×
or
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2.2. Experimental Section 
All reagents were purchased from Alfa Aesar, Sigma-Aldrich, Matrix Scientific and were 
used without further purification. Column chromatography was conducted using basic Al2O3 
(Brockman I, activity, 58 Å) or SiO2 (VWR, 40-60 µm, 60 Å) and the separated products were 
visualized by UV light. The 180° acceptor was prepared according to reported methods[1] and 
showed identical spectroscopic properties to those reported. 
1H NMR, 13C NMR, 31P NMR, 2D COSY NMR, 2D NOESY NMR spectra data were 
recorded on a 400 MHz and 500 MHz Bruker Avance NMR and Varian inova-600 MHz NMR 
spectrometer in CDCl3 and DMSO-d6. Variant-temperature NMR was recorded on Varian inova-
600 MHz NMR spectrometer and the temperature was calibrated using ethylene glycol. 31P NMR 
resonances are referenced to a sample 85% H3PO4 (δ 0.0 ppm). All chemical shifts were given in 
ppm. 
Electrospray ionization mass spectra (ESI-MS) and traveling wave ion mobility (TWIM-
MS) were recorded with a Waters Synapt G2 tandem mass spectrometer, using solutions of 0.01 
mg sample in 1 mL of CHCl3/CH3OH (1:3, v/v) for ligands or 0.5 mg sample in 1 mL of 
DMSO/Acetone/MeOH (1:3:1, v/v) for complexes.  
The TWIM-MS experiments were performed under the following conditions: ESI capillary 
voltage, 3 kV; sample cone voltage, 30 V; extraction cone voltage, 3.5 V;  source temperature 100 
ºC; desolvation temperature, 100 ºC; cone gas flow, 10 L/h; desolvation gas flow, 700 L/h (N2);  
source gas control, 0 mL/min; trap gas control, 2 mL/min; helium cell gas control, 100 mL/min; 
ion mobility (IM) cell gas control, 30 mL/min;  sample flow rate, 5 μL/min;  IM traveling wave 
height, 25 V; and IM traveling wave velocity, 1000 m/s. Q was set in rf-only mode to transmit all 
ions produced by ESI into the triwave region for the acquisition of TWIM-MS data. 
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Gradient tandem mass spectrometry were performed under the following conditions: 17+ 
charged ions of complexes were isolated by quadrupole for the following collision induced 
dissociation (CID), in which collision energy was gradually increased by changing the voltage of 
trap cell depended on different complexes. 
The calibration procedure of Scrivens et. al.9 was used to convert the drift time scale of the 
TWIM-MS experiments to a collision cross-section (CCS) scale. The calibration curve was 
constructed by plotting the corrected CCSs of the molecular ions of myoglobin against the 
corrected drift times of the corresponding molecular ions measured in TWIM-MS experiments at 
the same traveling wave velocity, traveling wave height and ion mobility gas flow settings viz., 
1000 m/s, 25 V, and 30 mL/min, respectively. The database for CCSs of myoglobin was obtained 
from Clemmer group webpage 
(https://indiana.edu/~clemmer/Research/Cross%20Section%20Databas/cs_database.php). 
Energy minimization of the macrocycles was conducted with Materials Studio version 4.2, 
using the Anneal and Geometry Optimization tasks in the Forcite module (Accelrys Software, Inc.). 
All counterions are omitted. An initially energy-minimized structure was subjected to multiple 
annealing cycles with initial and mid-cycle temperatures of 50 K and 1500 K, respectively, twenty 
heating ramps per cycle, one thousand dynamic steps per ramp, and one femtosecond per dynamic 
step. A constant volume/constant energy (NVE) ensemble was used and the geometry was 
optimized after each cycle. Geometry optimization used a universal force field with atom-based 
summation and cubic spline truncation for both the electrostatic and Van der Waals parameters. 
40 - 100 energy-minimized structures were used for the calculation of theoretical collision cross-
sections using MOBCAL programs.  
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For TEM characterization, the sample was dissolved in DMSO at a concentration of 10-6 
M. The solution was drop casted on to a carbon-coated Cu grid and the extra solution was absorbed 
by filter paper to avoid aggregation. The grid was then washed with one drop of acetone to remove 
resulting DMSO. The TEM images of the drop casted samples were taken with a FEI Morgagni 
transmission electron microscope.  
AFM was carried out with an Agilent 5500 AFM system (Agilent, Chandler, AZ). The 
sample was diluted to a concentration of 10-6 M using acetone, then dropped on freshly cleaved 
mica surface and dried in the air. Silicon cantilevers tip with spring constant of around 0.1N/m 
was used for the experiments. The images were obtained in air using Agilent magnetic AC (MAC) 
mode AFM, and image was analyzed using WSxM software. 
2.2.1. Synthesis of Ligands LA and LB 
  
Figure 2.6. Synthesis of ligand LA 
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Figure 2.7. Synthesis of ligand LB 
 
Compound 1: Periodic acid (12.3 g, 54.0 mmol) was successively added into 150 mL of 
concentrated sulfuric acid. To the colorless solution was added KI (26.9 g, 162.3 mmol), and the 
mixture was cooled to 0 °C. 1,3-Dibromobenzene (25.1 g, 106.1 mmol) was quickly added, and 
the reaction mixture was allowed to stir for 30 min. The entire reaction was poured into ice and 
the solid was collected via filtration. The crude product was recrystallized in toluene to give 
compound 1 as a white crystalline solid (25.8 g, 51.3% yield). 1H NMR (400 MHz, CDCl3, 300 K, 
ppm): δ 8.21 (s, 1H, ph-H1), 7.84 (s, 1H, ph-H2). 13C NMR (100 MHz, CDCl3, 300 K, ppm): δ 
149.46, 135.33, 130.42, 100.42. 
 
Compound 2: To a Schlenk flask containing compound 1 (690 mg, 1.4 mmol), 
PdCl2(PPh3)2 (49.0 mg, 0.07 mmol) and CuI (13.0 mg, 0.07 mmol) were added. After the removal 
of air and back-filled with nitrogen, 100 mL of triethylamine and trimethylsilylacetylene (0.5 mL, 
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3.5 mmol) was added, and the suspension was stirred at room temperature for 2 hours. After 
evaporating the solvent under vacuum, the residue was purified via flash column chromatography 
(hexane) to get compound 2 as a pale yellow oil (560 mg, 93% yield). 1H NMR (400 MHz, CDCl3, 
300K,ppm): δ 7.81 (s, 1H, ph-H2), 7.61 (s, 1H, ph-H1), 0.28 (s, 18H, H3). 13C NMR (100 MHz, 
CDCl3, 300K, ppm): δ 137.4, 135.6, 125.6, 124.5, 14 101.4, 101.3, -0.3. 
 
Compound 3: To a Schlenk flask containing compound 2 (570 mg, 1.33 mmol), Pd(PPh3)4 
(152.3 mg, 0.09 mmol), CuI (20.3 mg, 0.06 mmol) and 4-Ethynylpyridine hydrochloride (555 mg, 
3.97 mmol) was added. After the removal of air and back-filled with nitrogen, 30 mL of 
triethylamine and 30 mL of THF was added. The suspension was then stirred at 70 °C for 24 hours. 
After evaporating the solvent under vacuum, the residue was purified via column chromatography 
(chloroform/methanol = 100/1, v/v) to get compound 3 as a yellow solid (408.2 mg, 65% yield). 
1H NMR (400 MHz, CDCl3, 300 K, ppm): δ 8.64 (dd, J = 4.5, 1.6 Hz, 4H, py-H4), 7.72 (d, J = 0.5 
Hz, 1H, ph-H1), 7.70 (d, J = 0.5 Hz, 1H, ph-H2). 7.41 (dd, J = 4.5, 1.6 Hz, 4H, py-H3), 0.28 (s, 
18H, H5).13C NMR (100 MHz, CDCl3, 300 K, ppm): δ 149.7, 136.2, 135.8, 131.1, 126.41, 125.56, 
124.51, 102.4, 101.6, 92.3, 91.5, -0.2. ESI-TOF (m/z): Calcd. for ([C30H28N2Si2+H]+) 473.18, 
Found 473.18. 
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Compound 4: Potassium carbonate (1.65 g, 12 mmol) was added to a solution of compound 
3 (0.94 g, 2.0 mmol) in 50 mL methanol. The mixture was stirred at room temperature for 3h. After 
that, 50 mL of water was added, and the suspension was extracted with CHCl3. The combined 
organic layer was washed with brine, dried over anhydrous Na2SO4, and then concentrated in vacuo, 
the crude product was purified by column chromatography on silica gel (chloroform/methanol = 
100/1, v/v) to afford the product as a yellow solid (0.56 g, 85.4%). 1H NMR (500 MHz, CDCl3, 
300K, ppm): δ 8.64 (dd, J = 4.4, 1.6 Hz, 4H, py-H4), 7.77 (s, 1H, ph-H1), 7.70 (m, 1H, ph-H2), 
7.41 (dd, J = 4.4, 1.6 Hz, 4H, py-H3), 3.51 (s, 2H, H5). 13C NMR (125 MHz, CDCl3, 300 K, ppm): 
δ 150.00, 136.87, 135.54, 130.88, 125.76, 125.58, 125.55, 92.83, 90.84, 84.29, 80.69. ESI-TOF 
(m/z): Calcd. for ([C24H12N2+H]+) 329.11, Found 329.12.  
 
 
Compound 5: To a Schlenk flask containing 3-ethynylpyridine (515 mg, 5.0 mmol) and 
1,4-diiodobenzene (4.95 g, 15.0 mmol), Pd(PPh3)4 (260 mg, 0.2 mmol) and CuI (36 mg, 0.17 mmol) 
was added. After the removal of air and back-filled with nitrogen, 60 mL of diisopropylamine and 
40 mL of THF was added. The suspension was then stirred at 70 °C for 12 hours. After evaporating 
the solvent under vacuum, the residue was purified via column chromatography 
(chloroform/hexane = 4/1, v/v) to get compound 4 as a pale yellow solid (0.69 g, 40% yield). 1H 
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NMR (400 MHz, CDCl3, 300 K, ppm): δ 8.77 (s, 1H, py-H1), 8.57 (d, J = 3.8 Hz, 1H, py-H4), 7.81 
(dt, J = 7.9, 1.8 Hz, 1H, py-H2), 7.75 – 7.68 (m, 2H, ph-H5), 7.32 – 7.29 (m, 1H, py-H3), 7.29 – 
7.25 (m, 2H, ph-H6). 13C NMR (100MHz, CDCl3, 300 K, ppm): δ 152.3, 149.8, 139.6, 138.1, 133.7, 
123.1, 122.6, 121.2, 95.8, 92.4, 87.9. ESI-TOF (m/z): Calcd. for ([C13H8NI+H]+) 305.98, Found 
305.97.  
 
Ligand LA: To a Schlenk flask containing compound 4 (254.2 mg, 0.83 mmol) and 
compound 5 (140.4 mg, 0.29 mmol), Pd(PPh3)4 (23.5 mg, 0.029 mmol) and CuI (4.4 mg, 0.020 
mmol) were added. After the removal of air and back-filled with nitrogen, 20 mL of triethylamine 
and 20 mL of THF was added. The reaction mixture was then stirred at 70 °C for 48 hours. After 
cooling down to room temperature, the mixture was extracted with CHCl3, and the organic layer 
was washed with water and brine, respectively and dried over anhydrous sodium sulfate. After 
evaporating the solvent under vacuum, the residue was purified via column chromatography on 
silica gel (chloroform/methanol = 100/2, v/v) to give ligand LA as a yellow solid (89 mg, 45% 
yield). 1H NMR (500 MHz, CDCl3, 300 K, ppm): δ 8.79 (d, J = 1.4 Hz, 2H, Py-H10), 8.66 (dd, J = 
4.5, 1.5 Hz, 4H, Py-H1), 8.58 (dd, J = 4.9, 1.6 Hz, 2H, Py-H7), 7.84 (td, J = 3.8, 1.9 Hz, 2H, Py-
H9), 7.83 (s, 1H, Ph- H3), 7.82 (s, 1H, Ph- H4), 7.56 (m, 8H, Ph-H5, 6), 7.45 (d, J = 4.5, 1.5 Hz, 4H, 
Py-H2), 7.32 (dd, J = 7.9, 4.9 Hz, 2H, Py-H8). 13C NMR (125 MHz, CDCl3, 300 K, ppm): δ 152.1, 
149.4, 148.8, 138.6, 135.6, 135.2, 131.9, 131.7, 126.6, 125.6, 124.3, 123.4, 123.2, 122.7, 120.1, 
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99.9, 96.2, 92.6, 92.1, 91.9, 88.8, 88.4. ESI-TOF (m/z): Calcd. for ([C50H26N4+H]+) 683.22. Found 
683.23.  
 
Compound 6: To a 100 mL Schlenk flask, 3-bromo-5-methylpyridine (1.03 g, 6 mmol), 
Pd(PPh3)4 (346.5mg, 0.3 mmol), CuI (45.65 mg, 0.24 mmol) was added. After the removal of air 
and back-filled with nitrogen, 30 mL THF and 18 mL NEt3 were added into the reaction. The 
mixture was stirred at 75 °C for 30 min, and trimethylsilylacetylene (2.55 mL, 18 mmol) was 
added. After stirring under 75 °C for another 12h, the solution was cooled down to room 
temperature, and the mixture was extracted with CHCl3. The combined organic layer was washed 
with brine, dried over anhydrous Na2SO4, and then concentrated in vacuo. The crude product was 
purified by column chromatography on silica gel (dichloromethane/ethanol = 100/0.5, v/v) to 
afford the product as a yellow liquid (1.03g, 90.8%). 1H NMR (500 MHz, CDCl3, 300 K, ppm): δ 
8.53 (s, 1H, py-H3), 8.39 (s, 1H, py-H1), 7.57 (s, 1H, py-H2), 2.31 (s, 3H, H4), 0.25 (s, 9H, H5). 13C 
NMR (126 MHz, CDCl3, 300 K, ppm): δ 149.85, 149.40, 139.43, 101.82, 98.00, 18.31, -0.03. ESI-
TOF (m/z): Calcd. for ([C11H15NSi+H]+) 190.11, Found: 190.10.  
 
Compound 7: Potassium carbonate (2.07g, 15 mmol) was added to a solution of compound 
6 (0.95g, 5mmol) in 50 ml methanol. The mixture was stirred at room temperature for 2h and then 
extracted with CHCl3. The combined organic layer was washed with brine, dried over anhydrous 
Na2SO4, and then concentrated in vacuo. The crude product was purified by column 
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chromatography on silica gel (dichloromethane/ethanol = 100/0.5, v/v) to afford the product as a 
yellow liquid (0.55g, 94.0% yield). 1H NMR (400 MHz, CDCl3, 300 K, ppm): δ 8.52 (d, J = 1.7 
Hz, 1H, py-H3), 8.39 (d, J = 1.6 Hz, 1H, py-H1), 7.58 (ddd, J = 2.8, 1.6, 0.8 Hz, 1H, py-H2), 3.18 
(s, 1H, H5), 2.32 (s, 3H, H4). 13C NMR (125 MHz, CDCl3, 300 K, ppm): δ 150.09, 149.92, 139.63, 
132.78, 118.86, 80.66, 80.35, 18.30. ESI-TOF (m/z): Calcd. for ([C8H7N+H]+) 118.07, Found: 
118.09. 
 
Compound 8: Hydroquinone (3.30 g, 30 mmol), K2CO3 (24.8 g 180 mmol) and 1-
Bromobutane (12.33 g, 90 mmol) were combined in a 250 mL round bottom flask. 100 mL of 
DMF was added, and the mixture was stirred at 88 °C for 8h under N2. The reaction was allowed 
to cool down to room temperature. After that, 300 mL of water was added, and the mixture was 
extracted with CH2Cl2, and the combined organic layer was washed with brine and dried over 
anhydrous Na2SO4. After evaporating the solvent in vacuum, the crude product was purified by 
column chromatography on silica gel (dichloromethane/hexane = 1/4, v/v) to afford the product as 
a pale yellow liquid (5.3 g, 79.5 %).1H NMR (500 MHz, CDCl3, 300 K, ppm): δ 6.82 (s, 4H, py-
H1), 3.91 (t, J = 6.6 Hz, 4H, H2), 1.77 – 1.71 (m, 4H, H3), 1.52 – 1.43 (m, 4H, H4), 0.97 (t, J = 7.4 
Hz, 6H, H5). 13C NMR (125 MHz, CDCl3, 300 K, ppm): δ 153.18, 115.36, 68.32, 31.45, 19.25, 
13.87. 
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Compound 9: Compound 8 (6.66g, 30 mmol) was dissolved in 70 mL CHCl3. The solution 
was putted into ice-water bath 30min, then Br2 (11.85g, 75mmol) in 30 mL CHCl3 was slowly 
added. After that, the ice bath was removed and the solution was stirred at room temperature 8h. 
The mixture was then extracted with 5% NaOH solution, and the combined organic phase was 
dried with anhydrous Na2SO4. The crude product was purified by column chromatography on silica 
gel (dichloromethane/hexane = 1/3, v/v) to afford the product as a yellow liquid (8.65g, 75.9% 
yield). 1H NMR (500 MHz, CDCl3, 300 K, ppm): δ 7.09 (s, 2H, py-H1), 3.95 (t, J = 6.5 Hz, 4H, 
H2), 1.83 – 1.75 (m, 4H, H3), 1.57 – 1.47 (m, 4H, H4), 0.98 (t, J = 7.4 Hz, 6H, H5). 13C NMR (125 
MHz, CDCl3, 300 K, ppm): δ 150.21, 118.59, 111.26, 70.13, 31.34, 19.35, 13.97.  
 
Compound 10: A 100 mL Schlenk flash was charged with compound 7 (585 mg, 5 mmol), 
compound 9 (5.67g, 15 mmol), Pd(PPh3)4 (288.75 mg, 0.25 mmol), CuI (38 mg, 0.20 mmol). After 
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the removal of air and back-filled with nitrogen, 30 mL THF and 18 mL NEt3 were added into the 
reaction. The mixture was stirred at 75 °C for 12h. After cooling down to room temperature, the 
suspension was extracted with CHCl3. The combined organic layer was washed with brine, dried 
over anhydrous Na2SO4, and then concentrated in vacuum. The crude product was purified by 
column chromatography on silica gel (dichloromethane/ ethanol = 100/1, v/v) as eluent to afford 
the product as a yellow solid (1.42g, 68.4%).1H NMR (500 MHz, CDCl3, 300 K, ppm): δ 8.55 (d, 
J = 81.9 Hz, 2H, Py-H5,4 ), 7.62 (s, 1H, Py-H3), 7.11 (s, 1H, Ph-H1), 7.01 (s, 1H, Ph-H2), 4.00 (td, 
J = 6.4, 4.6 Hz, 4H, H6), 2.35 (s, 3H, H10), 1.85 – 1.77 (m, 4H, H7), 1.54 (dddd, J = 16.7, 14.7, 
10.5, 6.5 Hz, 4H, H8), 0.99 (td, J = 7.4, 4.1 Hz, 6H, H9). 13C NMR (100 MHz, CDCl3, 300 K, ppm): 
δ 154.31, 149.51, 138.82, 134.67, 129.78, 128.66, 127.76, 118.02, 117.56, 113.99, 111.93, 90.58, 
88.51, 69.87, 69.56, 31.28, 19.24, 18.27, 13.86, 13.84. ESI-TOF (m/z): Calcd. for 
([C22H26NO2Br+H]+) 416.12, Found 416.11. 
 
Ligand LB: A 100 mL Schlenk flash was charged with compound 9 (250 mg, 0.76 mmol), 
compound 5 (949 mg, 2.29 mmol), Pd(PPh3)4 (88 mg, 0.076 mmol), CuI (11.61 mg, 0.061 mmol). 
After the removal of air and back-filled with nitrogen, 20 mL THF and 12 mL NEt3 were added 
into the reaction. The mixture was stirred at 75 oC for 48 h. After cooling to room temperature, the 
mixture was extracted with CHCl3. The combined organic layer was washed with brine, dried over 
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anhydrous Na2SO4, and then concentrated in vacuo. The crude product was purified by column 
chromatography on silica gel (chloroform/methanol = 100/1.5, v/v) to afford the product as a 
yellow solid (482 mg, 63.4%). 1H NMR (500 MHz, CDCl3, 300 K, ppm): δ 8.60 (m, 6H, Py-H1,7), 
8.39 (s, 2H, Py-H9), 7.81 (s, 1H, Ph-H3), 7.77 (s, 1H, Ph-H4), 7.63 (s, 2H, Py-H8), 7.42 (d, J = 5.7 
Hz, 4H, Py-H2), 7.05 (s, 2H, Ph-H5), 7.00 (s, 2H, Ph-H6), 4.02 (t, J = 6.6 Hz, 4H, H-OCH2-), 3.91 (t, 
J = 6.4 Hz, 4H, H-OCH2- ), 2.36 (s, 6H, H10), 1.84 – 1.73 (m, 8H, H-CH2-), 1.57 – 1.46 (m, 8H, H-
CH
2
-), 0.96 (dt, J = 27.3, 7.4 Hz, 12H, H-CH3). 13C NMR (125 MHz, CDCl3, 300 K, ppm): δ 153.80, 
153.75, 149.79, 149.34, 149.26, 138.79, 135.39, 135.02, 131.06, 126.94, 125.57, 123.99, 117.21, 
116.97, 114.42, 113.66, 93.22, 92.44, 92.26, 92.04, 91.72, 88.70, 69.54, 69.23, 31.29, 31.18, 19.26, 
19.16, 18.25, 13.85, 13.83. ESI-TOF: Calcd. for ([C68H62N4O4+H]+)  999.48, Found: 999.48. 
2.2.2. Synthesis of Supramolecules A1, B1, A2, B2 
 
2D Star of David A1 with OTf – as counterion: Ligand LA (2.0 mg, 2.9 μmol) and 180o 
acceptor (OTF- as counterion) (7.24 mg, 5.8 μmol) were weighted and dissolved in 2.0 mL DMSO, 
and the mixture was heated at 80 °C for 5 h then cooled to room temperature. Excessive amount 
of diethyl ether was added, and a precipitate was formed. The solid was collected by centrifugation 
and then washed with diethyl ether, dried in vacuo to give a dark gray solid (8.2 mg, 90% yield). 
1H NMR (500 MHz, DMSO-d6, 300 K, ppm): δ 8.92 (m, 8H, Py-H1, Py-H7, Py-H10), 8.31 (m, 4H, 
Py-H9, Ph-H3, Ph-H4), 8.19 (m, 2H, Ph-H8), 7.89 (m, 10H, Py-H2, Ph-H5, Ph-H6), 7.01 (m, 8H, Ph-
A1
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H11, Ph-H12), 1.35 (m, 48H, H-CH2-), 1.12 (m, 72H, H-CH3). ESI MS (m/z)：2556.6 [M-7OTf¯]7+ 
(calcd m/z: 2556.6), 2218.4 [M-8OTf¯]8+ (calcd m/z: 2218.4), 1955.4 [M-9OTf¯]9+ (calcd m/z: 
1955.4), 1745.0 [M-10OTf¯]10+ (calcd m/z: 1745.0), 1572.8 [M-11OTf¯]11+ (calcd m/z: 1572.8), 
1429.3 [M-12OTf¯]12+ (calcd m/z: 1429.3), 1307.8 [M-13OTf¯]13+ (calcd m/z: 1307.8), 1203.8 [M-
14OTf¯]14+ (calcd m/z: 1203.8), 1113.6 [M-15OTf¯]15+ (calcd m/z: 1113.6), 1034.7 [M-16OTf¯]16+ 
(calcd m/z: 1034.7), 965.0 [M-17OTf¯]17+ (calcd m/z: 965.0). 847.8 [M-18OTf¯]18+ (calcd m/z: 
847.8).  
2D Star of David A1 with NO3¯ as counterion: Ligand LA (2.0 mg, 2.9 μmol) and 180o 
acceptor (NO3¯ as counterion) (6.0 mg, 5.8 μmol) were weighted and dissolved in 0.6 mL DMSO-
d6 and then heated at 80 °C for 5 h. The resulted product was directly subjected for NMR. 1H NMR 
(500 MHz, DMSO-d6, 300 K, ppm): δ 8.93 (m, 8H, Py-H1, Py-H7, Py-H10), 8.35 (m, 4H, Py-H9, 
Ph-H3, Ph-H4), 8.21 (m, 2H, Ph-H8), 7.88 (m, 10H, Py-H2, Ph-H5, Ph-H6), 7.05 (m, 8H, Ph-H11, 
Ph-H12), 1.38 (m, 48H, H-CH2-), 1.10 (m, 72H, H-CH3). 13C NMR (125 MHz, DMSO-d6, 300 K, ppm): 
δ 153.0, 152.0, 139.1, 137.5, 136.5, 133.8, 132.6, 130.5, 129.3, 124.3, 122.8, 121.5, 110.2, 31.1, 
23.4, 12.4, 7.8 ppm. 31P NMR (202.5 MHz, DMSO-d6, 300K) δ 13.07 (s, JPt-P =2717.5 Hz). 
Diffusion Coefficient (500 MHz, DMSO-d6, 300K): 1.58×10-10 m2s-1 (log D = -9.80). However, 
we were unable to get satisfactory ESI-MS using NO3¯ as counterion. 
 
3D Star of David A2 with BF4- as counterions: Ligand LA (3.0 mg, 4.4 μmol) and 
A2
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Pd(CH3CN)4(BF4)2 (1.95 mg, 4.4 μmol) were weighted and dissolved in 1 mL DMSO, and the 
mixture was heated at 80 °C for 5 h then cooled to room temperature. Excessive amount of diethyl 
ether was added, and a precipitate was formed. The precipitate was collected by centrifugation and 
then washed with diethyl ether, dried in vacuo to give a dark gray solid. (4.7 mg, 96% yield). ESI-
MS (m/z): 1453.0 [M-15BF4¯]15+ (calcd m/z: 1453.1), 1357.3 [M-16BF4¯]16+ (calcd m/z: 1357.3), 
1272.4 [M-17BF4¯]17+ (calcd m/z: 1272.4), 1196.9 [M-18 BF4¯]18+ (calcd m/z: 1196.9), 1129.3 [M-
19BF4¯]19+ (calcd m/z: 1129.3), 1068.5 [M-20BF4¯]20+ (calcd m/z: 1068.5), 1013.5 [M-21BF4¯]21+ 
(calcd m/z: 1013.5), 963.5 [M-22BF4¯]22+ (calcd m/z: 963.5), 917.8 [M-23BF4¯]23+ (calcd m/z: 
917.8), 876.0 [M-24BF4¯]24+ (calcd m/z: 876.0), 837.4 [M-25BF4¯]25+ (calcd m/z: 837.4). However, 
A2 did not give good NMR spectrum because of the poor solubility. 
 
 
2D Star of David B1 with OTf ¯ as counterion: Ligand LB (2.0 mg, 2.0 μmol) and 180° 
acceptor (OTf¯ as counterion) (5.0 mg, 4.0 μmol) were weighted and dissolved in 0.6 mL of 
DMSO. The mixture was heated at 80 °C for 5 h, and then cooled to room temperature. Excessive 
amount of diethyl ether was added, and a precipitate was formed. The precipitate was collected by 
centrifugation and then washed with diethyl ether, dried in vacuo to give a dark gray solid (5.8 mg, 
85% yield). The resulted product was directly used for mass spectrometry. 1H NMR (500 MHz, 
DMSO-d6, 300 K, ppm): δ 8.93 (m, 4H, Py-H1), 8.70 (m, 2H, Py-H7), 8.54 (m, 2H, Ph-H9), 8.31 
B1
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(m, 2H, Ph-H3,4), 8.14 (m, 2H, Ph-H8), 7.88 (m, 4H, Py-H2), 7.41 (m, 4H, Ph-H5,6), 7.03 (m, 4H, 
Ph-H11,12), 8.44 (m, 8H, H-OCH2-), 2.47 (m, 6H, H10), 1.37 (m, 64H, H-CH2-), 1.09 (m, 84H, H-CH3). 
ESI-MS (m/z)：2455.7 [M-8OTf¯]8+ (calcd m/z: 2455.7), 2166.3 [M-9OTf¯]9+ (calcd m/z: 2166.3), 
1934.8 [M-10OTf¯]10+ (calcd m/z: 2166.3), 1745.4 [M-11OTf¯]11+ (calcd m/z: 1745.4), 1587.43 
[M-12OTf¯]12+ (calcd m/z: 1587.43), 1453.9 [M-13OTf¯]13+ (calcd m/z: 1453.9), 1339.4 [M-
14OTf¯]14+ (calcd m/z: 1339.4), 1240.2 [M-15OTf¯]15+ (calcd m/z: 1240.2), 1153.3 [M-16OTf¯]16+ 
(calcd m/z: 1153.3), 1076.7 [M-17OTf¯]17+ (calcd m/z: 1076.7), 1008.6 [M-18OTf¯]18+ (calcd m/z: 
1008.6).  
2D Star of David B1 with NO3¯ as counterion: Ligand LB (4.0 mg, 4.0 μmol) and 180° 
acceptor (8.51 mg, 8.0 μmol) were weighted and dissolved in 0.6 mL DMSO-d6, then heated at 
80 °C for 5 h. The resulted product was directly subjected for NMR. 1H NMR (500 MHz, DMSO-
d6, 300 K, ppm): δ 8.96 (m, 4H, Py-H1), 8.72 (s, 2H, Py-H7), 8.53 (s, 2H, Ph-H9), 8.33 (s, 2H, Ph-
H3,4), 8.14 (s, 2H, Ph-H8), 7.88 (m, 4H, Py-H2), 7.41 (m, 4H, Ph-H5,6), 7.03 (m, 4H, Ph-H11,12), 
8.44 (m, 8H, H-OCH2-), 2.47 (m, 6H, H10), 1.37 (m, 64H, H-CH2-), 1.09 (m, 84H, H-CH3-). 13C NMR 
(150 MHz, DMSO-d6, 300 K, ppm): δ 185.9, 182.5, 157.5, 154.2, 152.8, 149.4, 138.7, 136.6, 129.5, 
124.7, 122.8, 118.1, 113.9, 94.4, 69.7, 69.0, 31.2, 19.3, 18.2, 14.2, 12.5, 8.4, 7.8, 7.2, 6.6. 31P NMR 
(202.5 MHz, DMSO-d6, 300K) δ 13.03 (s, JPt-P =2725.6 Hz). Diffusion Coefficient (500 MHz, 
DMSO-d6, 300K): 1.17×10-10 m2s-1 (log D = -9.93). However, B1 did not show good ESI-MS using 
NO3- as the counterion. 
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3D Star of David B2 with NO3¯ as counterion: Ligand LB (4mg, 4.0 μmol) and Pd(NO3)2 
(0.92 mg, 4.0 μmol) were weighted and dissolved in 0.6 mL DMSO-d6, then heated at 80 °C for 
5h. The result product was directly subjected for NMR. 1H NMR (500 MHz, DMSO-d6, 300 K, 
ppm): δ 9.42 (m, 4H, Py-H1,7), 9.19 (s, 2H, Py-H9), 8.17 (s, 1H, Ph-H3), 8.02 (s, 2H, Ph-H8), 7.76 
(m, 5H, Ph-H4, Py- H2), 7.21 (m, 4H, Ph-H5,6), 4.00 (m, 8H, H-OCH2-), 2.40 (m, 6H, H10), 1.74 (m, 
4H, H-CH2-), 1.36 (m, 8H, H-CH2-), 1.16 (m, 4H, H-CH2-), 0.70 (m, 12H, H-CH3). 13C NMR (150 MHz, 
DMSO-d6, 300 K, ppm): δ 157.2, 156.9, 155.1, 154.2, 153.6, 152.2, 151.9, 150.7, 130.9, 129.5, 
128.9, 128.6, 117.8, 116.9, 69.4, 30.8, 18.9, 18.7, 13.7. Diffusion Coefficient (500 MHz, DMSO-
d6, 300 K): 1.15×10-10 m2s-1 (log D = -9.94). However, we were unable to obtain satisfactory mass 
spectrometry data with NO3¯ as counterion. 
3D Star of David B2 with BF4¯ as counterion: Ligand LB (3.0 mg, 3.0 μmol) and 
Pd(CH3CN)4(BF4)2 (1.3 mg, 3.0 μmol) were weighted and dissolved in 1mL DMSO, the mixture 
was heated at 80 °C for 5h, then cooled to room temperature. Excessive amount of diethyl ether 
was added, and a precipitate was formed. The precipitate was collected by centrifugation, washed 
with diethyl ether and dried in vacuo to give a brown solid (3.68 mg, 85% yield). 1H NMR (500 
MHz, DMSO-d6, 300 K, ppm): δ 9.42 (m, 4H, Py-H1,7), 9.19 (s, 2H, Py-H9), 8.17 (s, 1H, Ph-H3), 
8.02 (s, 2H, Ph-H8), 7.76 (m, 5H, Ph-H4, Py- H2), 7.21 (m, 4H, Ph-H5,6), 4.00 (m, 8H, H-OCH2-), 
2.40 (m, 6H, H10), 1.74 (m, 4H, H-CH2-), 1.36 (m, 8H, H-CH2-), 1.16 (m, 4H, H-CH2-), 0.70 (m, 12H, 
B2
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H-CH3). ESI-MS (m/z): 1832.0 [M-16BF4¯]16+ (calcd m/z: 1832.0), 1719.1 [M-17BF4¯]17+ (calcd 
m/z: 1719.1), 1618.8 [M-18BF4¯]18+ (calcd m/z: 1618.8), 1529.1 [M-19BF4¯]19+ (calcd m/z: 
1529.1), 1448.3 [M-20BF4¯]20+ (calcd m/z: 1448.3), 1375.2 [M-21BF4¯]21+ (calcd m/z: 1375.2), 
1308.7 [M-22BF4¯]22+ (calcd m/z: 1308.7), 1248.0 [M-23 BF4¯]23+ (calcd m/z: 1248.0), 1192.4 [M-
24BF4¯]24+ (calcd m/z: 1192.4), 1141.3 [M-25BF4¯]25+ (calcd m/z: 1141.3). 
2.3. Results and Discussion 
Ligand LA was first employeed to assemble with a 180° diplatinum(II) motif to construct 
2D Star of David by mixing with 180° diplatinium component at 1:2 ratio in DMSO-d6 at 80 °C 
for 5 hours. The resulting solution was directly used for NMR characterization without further 
purification. 1H NMR of complex exhibited broad signals due to the slow tumbling rate10, 
suggesting the formation of large assemblies (Figure 2.8). Both α-H and β-H on the pyridines 
presented a low field shift, which indicates that the electron density on the pyridine rings decreased 
because of the coordination between Pt and ligand11. Further identification of the peaks was based 
on 2D NOESY experiment (Figures S20 and S21). It is noteworthy that the correlation between 
pyridines and PEt3 was observed. However, only one broad peak at 13.2 ppm was observed on 31P 
NMR spectrum of the 2D Star of David. This may be attributed to the considerable broadening 
effect as well as the similar chemical environment of inner and outer rims of 2D Star of David. 
Because of the back-donation from Pt(II), the decrease in coupling of flanking 195Pt satellites (ca. 
ΔJ = −168 Hz) was detected as previous study11. 2D diffusion-ordered NMR spectroscopy (DOSY) 
displayed a single band at log D = -9.80, corresponding to a discrete supramolecular architecture. 
All the evidence from NMR suggested that a single supramolecular complex with highly 
symmetric geometry was formed during self-assembly. 
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Figure 2.8. (a) 1H NMR spectra of A1 (500 MHz, CDCl3, 300K),A1 (500 MHz, DMSO-d6, 300 
K) and 180° diplatinum (II) acceptor (500 MHz, CDCl3, 300 K). (b) 31P NMR (202.5 MHz, 
DMSO-d6, 300 K) spectra of A1 and 180° diplatinum (II) acceptor (500 MHz, CDCl3, 300 K). (c) 
2D DOSY (500 MHz, DMSO-d6, 300 K) spectrum of A1. 
In the following mass spectrometry characterization, electrospray ionization mass 
spectrometry (ESI-MS) was first applied to measure the molecular weight and composition of this 
complex. As shown in Figure 2.9, a series of peaks with continuous charges were obtained at m/z 
2555(7+), 2218(8+), 1955(9+), 1745(10+), 1573(11+), 1429(12+), 1308(13+), 1204(14+), 
1114(15+) due to the loss of different numbers of triflate counterion, agreeing well with expected 
molecular composition [(C50H26N4)6(C30H64P4Pt2)12(CF3SO3-)24] with theoretical molecular 
weight 18,928 Da. Isotope pattern for each charge state could be clearly observed, which matched 
theoretical modeling. (Appendix A). It is worthy to note that the ESI-MS spectrum showed 
negligible fragments compared with prior Pt(II) macrocycles with single rim12  because of the 
enhanced stability derived from the interaction between tetratopic pyridyl ligand and Pt(II) motif. 
In addition, ion mobility-mass spectrometry (IM-MS)13 showed a series of charge states with 
narrow drift time distribution ranging from 8+ to 12+, excluding the formation of any isomers or 
oligomers. 
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Figure 2.9. (a) ESI-MS of 2D Star of David A1 and the experimental and theoretical isotope 
pattern for charge state 9+. (b) 2D ESI-IM-MS plot (m/z vs drift time) of A1. The charge states 
of intact assemblies are marked. 
 
Figure 2.10. (a) ESI-MS of 3D Star of David A2 (b) 2D ESI-IM-MS plot (m/z vs drift time) of 
A2. The charge states of intact assemblies are marked. 
The success of 2D Star of David motivated us to explore other attributes of this tetratopic 
ligand LA within the realm of possibility. In the light of previous study and molecular dynamics 
simulation,14a, 1, 14b we should be able to assemble a 3D supramolecular cage using Pd(II) ions to 
replace 180° diplatinium motif in the self-assembly with LA. This giant 3D architecture was named 
as 3D Star of David A2 as it contains four 2D of Star of David as cross section (see modeling video 
in supporting information). In the self-assembly, LA was mixed with equimolar amount of 
Pd(CH3CN)4(BF4)2 in DMSO and was heated under 80 °C for direct mass spectrometry 
characterization. Both ESI-MS and IM-MS (Figure 2.10) showed strong evidence for the 
formation of 3D Star of David with molecular composition [(C50H26N4)24Pd24 (BF4-)48] and 
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molecular weight up to 23,091 Da. Isotope patterns, however, were not observed possibly due to 
the inclusion of unknown number of solvent molecules. 
Unfortunately, no satisfactory 1H NMR data were obtained possibly due to the poor 
solubility of 3D Star of David. Based on the same design principle, LB was prepared by 
introducing four alkyne chains into the outer rim of 3D Star of David to increase the solubility for 
NMR characterization. Also, a methyl group was introduced on the top pyridine for further 
simplification of the 1H-NMR spectra. As depicted in Figure 2.11a, ligand LB showed two sets of 
peaks at 8.83 ppm and 8.49 ppm, which can be attributed to three α-H of the pyridines. 
 
Figure 2.11. (a) 1H NMR spectra of LB (500 MHz, CDCl3, 300K), B2 (500 MHz, DMSO-d6, 300 
K (b) 2D DOSY (500 MHz, DMSO-d6, 300 K) spectrum of B2. 
The -OCH2 group on the alkyloxy chains showed two sets of signals because of the different 
chemical environment. Self-assembly of 3D Star of David B2 was also applied by combining LB 
and Pd(NO3)2 in equimolar amount in DMSO-d6 at 80 °C for 5 hours and the solution was directly 
used for NMR characterization without further purification. Because of the coordination between 
Pd(II) and pyridine, both the α-H and β-H on pyridine displayed low-field shift. The -OCH2- group 
on the alkyloxy chains also showed two sets of signals, indicating the formation of single structure 
(Figure 2.11a). All the peak interpretations were accompanied by 2D NOESY spectrum (Appendix 
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A). 2D DOSY experiment gave one set of signals at log D = -9.94, which also suggested the 
formation of a discrete structure (Figure 2.11b).  
 
Figure 2.12. (a) ESI-MS of 3D Star of David B2 (b) 2D ESI-IM-MS plot (m/z vs drift time) of 
B2. The charge states of intact assemblies are marked. 
Likewise, multidimensional mass spectrometry was utilized to further characterize our 3D 
Star of David B2. ESI-MS gave a set of peaks with continuous charges ranging from 1827.4 (16+) 
to 1140.2 (25+). After deconvolution, the measured molecular weight of 3D Star of David B2 was 
30,681 Da. IM-MS showed one dominant series of bands for each charge state with narrow drift 
time, which unambiguously excluded the formation of any isomers or oligomers (Figure 2.12). 
It should be noted that LB was also applied in the synthesis of 2D Star of David B1. As expected, 
the 1H NMR of complex exhibited broad signals, and the α-H and β-H on the pyridines presented 
a low field shift (Figure 2.13a). Similar to A1, one broad peak at 13.02 ppm was observed on 31P 
NMR spectrum of B1, and also satellite peaks with JPt-P = 2725.6 Hz was observed (Figure 2.11b). 
2D diffusion-ordered NMR spectroscopy (DOSY) displayed a single band at log D = -9.93 (Figure 
2.13c), possibly due to the alkyl chains which slightly increased the hydrodynamic radius. ESI-
MS and TWIM-MS also showed strong evidence for the formation of single product, with a series 
of peaks with continuous charge states and isotope patterns being observed (Figure 2.14) 
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Figure 2.13. (a). 1H NMR spectra of A1 (500 MHz, CDCl3, 300K),A1 (500 MHz, DMSO-d6, 
300 K) and 180° diplatinum (II) acceptor (500 MHz, CDCl3, 300 K). (b) 31P NMR (202.5 MHz, 
DMSO-d6, 300 K) spectra of A1 and 180° diplatinum (II) acceptor (500 MHz, CDCl3, 300 K). 
(c) 2D DOSY (500 MHz, DMSO-d6, 300 K) spectrum of A1. 
 
Figure 2.14. (a) ESI-MS of 2D Star of David B1 and the experimental and theoretical isotope 
pattern for charge state 11+. (b) 2D ESI-IM-MS plot (m/z vs drift time) of B1. The charge states 
of intact assemblies are marked. 
In order to assess the stability of the 2D and 3DStar of David supramolecular structures, 
gradient tandem mass spectrometry (gMS2)15 was applied by isolating the 17+ charged ion via 
quadrupole, followed by collision induced dissociation (CID) based on changing the voltage of the 
trap cell (Figure 2.15). In the spectra of gMS2, 2D Star of David A1 was completely dissociated at 
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8V, which was converted to a center-of-mass collision energy of 0.02 eV. Being similar to A1, 2D 
Star of David B1 was also completely dissociated at 8V, corresponding to a same center-of-mass 
collision energy of 0.02 eV. In the case 3D Star of David. The 17+ charged ion (m/z = 1272.4 for 
A2, m/z = 1714.1 for B2) did not fully dissociate until the voltage reached 34V, corresponding to 
the same center of mass collision energy of 0.05 eV, which is significantly higher than that of 2D 
Star of David A1 and B1, i.e., 0.02 eV.  
 
Figure 2.15. Gradient tandem-mass spectrometry (gMS2) of (a) 2D Star of David A1 at m/z 
965.0(17+); (b) 3D Star of David A2 at m/z 1272.4(17+); (c) 2D Star of David B1 at m/z 
1076.7(17+); (d) 3D Star of David B2 at m/z 1714.1(17+) with different collision energy. 
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Moreover, we have also performed molecular modelling in Material studio to get energy-
minimized structure, as well as calculate the theoretical collision cross-sections (CCS) using 
MOBCAL16. As can be seen from Figures 2.16-2.19, all the four structures, A1, A2, B1, B2 
showed relatively centralized trend on the plot of collision cross-section (CCS) vs. relative energy, 
and the theoretical TM collision cross-sections were calculated as 2591 Å2, 3337.5 Å2, 2850 Å2, 
and 3710 Å2 for A1, A2, B1, B2, respectively. Using the formula we proposed, the density of 
coordination sites (DOCS)1 for each molecular were then calculated as, 0.0093 sites/Å2, 0.0287 
sites/Å2, 0.0084 sites/Å2, and 0.0259 sites/Å2, respectively. Comparing with the center-of mass 
collision energy, the enhanced stability of 3D Star of David was consistent with its high DOCS.  
 
Figure 2.16. (a). Plot of collision cross-section (CCS) vs. relative energy for 40 candidate 
structures of 2D Star of David A1 generated by annealing simulations. CCSs were calculated by 
the TM method using the MOBCAL program. The average TM cross section area is 2591 Å2. 
(b). Energy minimized structures of A1 from molecular modeling. 
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Figure 2.17. (a). Plot of collision cross-section (CCS) vs. relative energy for 50 candidate 
structures of 3D Star of David A2 generated by annealing simulations. CCSs were calculated by 
the TM method using the MOBCAL program. The average TM cross section area is 3337.5 Å2. 
(b), (c), (d), (e) Energy minimized structures of A2 from molecular modeling. 
 
Figure 2.18. (a). Plot of collision cross-section (CCS) vs. relative energy for 76 candidate 
structures of 2D Star of David B1 generated by annealing simulations. CCSs were calculated by 
the TM method using the MOBCAL program. The average TM cross section area is 2850 Å2. (b), 
(c) Energy minimized structures of B1 from molecular modeling. Note that the alkyl chains are 
omitted for clarity in the molecular modeling. 
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Figure 2.19.(a) Plot of collision cross-section (CCS) vs. relative energy for 100 candidate 
structures of 3D Star of David B2 generated by annealing simulations. CCSs were calculated by 
the TM method using the MOBCAL program. The average TM cross section area is 3710 Å2. (b), 
(c), (d), (e) Energy minimized structures of B2 from molecular modeling. Note that the alkyl chains 
are omitted for clarity in the molecular modeling. 
Moreover, the giant size and high molecular weight along with multiple heavy metals ions 
of 2D and 3D Star of David facilitated further characterization by transmittance electron 
microscope (TEM) and atomic force microscope (AFM). The TEM image of 2D Star of David B1 
showed uniform ring structure with high contrast because of the 24 Pt(II) ions with high electron 
density in the rims. Similarly, 3D Star of David B2 displayed dark dots with comparable size as 
molecular modeling (Figure. 2.20). AFM was performed by dropping very dilute solution to 
freshly cleaved mica surface. After collecting the data for 71 dots, the average height exhibited 
two different values, i.e., 4.85 nm and 6.22 nm, respectively, owning to the different standing 
orientation of 3D Star of David on the mica surface (Figure 2.21). Note that the measured width 
of the molecule was much larger than the height measured by AFM and molecular modeling 
because of inevitable tip broadening effect17. 
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Figure 2.20.TEM images of (a) 2D Star of David B1 and (b) 3D Star of David B2.   
 
Figure 2.21.(a), (b) AFM image for 3D Star of David B2. (c), (d) Height of 3D Star of David B2 
measured by AFM. (e), (f) Aggregation of 3D Star of David B2 and height measurement by AFM. 
(g), (h) 3D AFM image for individual 3D Star of David B2 and statistical height distribution based 
on 71 individual dots on AFM. 
Shortly after the paper was published, we finally got the single crystal for 3D Star of David 
A2, which unambiguously confirmed the structure as M24L24 architecture (Figure 2.20). The center 
of the structure was observed as a cuboctahedron with a large cavity, while the outer rims formed 
a pyramid-like cage with void spaces in each of them. Being different from most of the cages that 
have been previously published, this cage contains a total of 13 cavities, one in the center and the 
(c) (d)
100nm100nm
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other twelve surrounded on the outer layer. The different cavities might provide opportunities for 
molecular encapsulation and catalysis. 
 
Figure 2.22. Crystal structure of the 3D Star of David A2. 
In summary, instead of using template-directed synthesis or step-wise self-assembly, we 
were able to construct 2D Star of David through direct self-assembly of tetratopic ligand with Pt(II) 
motif in nearly quantitative yield. Using Pd(II) to replace Pt(II) component, a 3D Star of David 
was assembled with four 2D Star of David as cross-section, which was observed with remarkable 
stability due to its high DOCS. The success of this study will motivate us to construct more 
sophisticated metallo-supramolecules with increasing stability and complexity, which will also 
advance the functionality and broaden the application of these supramolecular architectures with 
precisely controlled shapes and sizes. The future study will be focused on the following two 
directions (i) functionalization of 2D Star of David for hierarchical self-assembly of 
supramolecular materials; (ii) development of supramolecular containers with multiple distinct 
microdomains for catalysis based on 3D Star of David.  
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CHAPTER 3. SELF-ASSEMBLY OF POLYCYCLIC SUPRAMOLECULES USING 
LINEAR METAL-ORGANIC LIGANDS 
3.1. Background 
In chapter 1, we have mainly discussed several different kinds of coordination-driven self-
assemblies. Taking a glance at the numerous works, one can easily find that the design and self-
assembly were heavily concentrated on geometrical parameters (e.g., the size1, angularity2, and 
dimensionality of ligand) and influence of temperature3, solvent4, and counterions5. However, in 
biological systems, the shapes, complexity and functions of DNA- and protein-based assemblies 
are encoded by the defined sequences of nucleotides and amino acids6. The recent success of DNA 
nanostructure7, e.g., DNA origami assembled by specific sequence of DNA chains8, further 
inspired us to revisit the coordination-driven self-assembly. We envisioned that linear building 
blocks with specific sequence could facilitate the self-assembly of metallo-supramolecules with 
increasing complexity.  
Thanks to the diversity of coordination-driven self-assembly, we herein report a series of 
linear building blocks with specific sequence through bridging terpyridine ligands using Ru(II) 
coordination with high stability. In the following self-assembly, Zn(II), Fe(II) and Cd(II) metal 
ions with weak coordination but high reversibility are used to assemble discrete 2D fractal 
architectures9 ranging from generation 1 (C1) to generation 5 (C5), from 3,360 Da to 38,066 Da 
with precisely-controlled structures and increasing complexity (Figure 3.1). Moreover, such 
metallo-supramolecules with precisely-controlled shapes and sizes can serve as promising building 
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blocks to further assemble into ordered nanoscale structures on a solid surface, given that surface 
self-assembly has attracted considerable attention in materials science10.  
 
Figure 3.1.Design of linear metal-organic ligands L1-L5 and corresponding supramolecules C1-
C5. C1: violet = Fe; C2: cardinal = Ru, blue = Zn; C3-1 & C3-2: cardinal = Ru, blue = Zn; C4: 
cardinal = Ru, blue = Zn; C5: cardinal = Ru, yellow = Cd. 
3.2. Experimental Section 
All reagents were purchased from Sigma-Aldrich, Matrix Scientific, Alfa Aesar or Ark 
Pharm and were used without further purification. Column chromatography was conducted using 
neutral Al2O3 (Brockman II, activity, 58 Å) or SiO2 (VWR, 40-60 µm, 60 Å) and the separated 
products were identified by UV light or detected by ESI-TOF-MS. NMR spectra data were 
recorded on Varian inova 400 MHz, Varian inova 500 MHz, Varian inova 600 MHz, Varian dd 
600 MHz, Bruker Avance 400 MHz as well as Bruker Avance 500 MHz NMR spectrometers in 
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CDCl3, CD3CN, CD3OD or DMSO-d6 with TMS as reference. Some of the Ru(II) complexes were 
run using a mixed solvent of CDCl3 with 10% CD3OD. F19 NMR spectra were recorded on a 
Varian inova-400 MHz spectrometer using trifluoromethanesulfonic acid (δ -78.50 ppm) or PF6‾ 
(δ -71.11 ppm)11 as the standard. All chemical shifts were given in ppm. ESI-TOF-MS and TWIM-
MS were recorded on a Waters Synapt G2 mass spectrometer, using solutions of 0.01 mg sample 
in 1 mL of CHCl3/CH3OH (1:3, v/v) for ligands or 0.5 mg sample in 1 mL of MeCN/MeOH (3:1, 
v/v) for supramolecules.  
The TWIM-MS experiments were performed under the following conditions: ESI capillary 
voltage, 3 kV; sample cone voltage, 30 V; extraction cone voltage, 3.5 V; source temperature 100 
ºC; desolvation temperature, 100 ºC; cone gas flow, 10 L per hour; desolvation gas flow, 700 L 
per hour (N2); source gas control, 0 mL per minute; trap gas control, 2 mL per minute; helium cell 
gas control, 100 mL per minute; ion mobility (IM) cell gas control, 30 mL per minute; sample flow 
rate, 5 μL per minute; IM traveling wave height, 25 V; and IM traveling wave velocity, 1000 m 
per second. Q was set in rf-only mode to transmit all ions produced by ESI into the triwave region 
for the acquisition of TWIM-MS data.  
The calibration procedure of Scrivens et. al12 was used to convert the drift time scale of the 
TWIM-MS experiments to a collision cross-section (CCS) scale. The calibration curve was 
constructed by plotting the corrected CCSs of the molecular ions of myoglobin against the 
corrected drift times of the corresponding molecular ions measured in TWIM-MS experiments at 
the same traveling wave velocity, traveling wave height and ion mobility gas flow settings viz., 
1000 m/s, 25 V, and 30 mL/min, respectively.  
Energy minimization of the macrocycles was conducted with Materials Studio version 4.2, 
using the Anneal and Geometry Optimization tasks in the Forcite module (Accelrys Software, Inc.). 
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All counterions were omitted. An initially energy-minimized structure was subjected to 80 - 100 
annealing cycles with initial and mid-cycle temperatures of 300 and 1500 K, respectively, twenty 
heating ramps per cycle, one thousand dynamic steps per ramp, and one femtosecond per dynamic 
step. A constant volume/constant energy (NVE) ensemble was used and the geometry was 
optimized after each cycle. Geometry optimization used a universal force field with atom-based 
summation and cubic spline truncation for both the electrostatic and Van der Waals parameters. 
75-80 energy-minimized structures were used for the calculation of theoretical collision cross-
sections using MOBCAL program13.  
For TEM characterization, the sample was drop-casted on to a lacey carbon coated Cu grid 
(300 mesh, purchased from Ted Pella Inc.) or carbon-coated Cu grid (400 mesh, purchased from 
SPI supplies), and the extra solution was absorbed by filter paper to avoid aggregation. The TEM 
images of the drop casted samples were taken with a FEI Morgagni transmission electron 
microscope,  
AFM imaging was carried out with a Digital Instrument Nanoscope Dimension 3000 
system. The sample was diluted to a concentration of 10-6 M using acetonitrile, then dropped on 
freshly cleaved mica surface and dried in the air. Silicon cantilevers tip with spring constant of 
around 0.1N/m was used for the experiments.  
The sample was dissolved in DMF at a concentration of 5.0 mg/mL. Sample Solution (5 
uL) was dropped on HOPG surface. After 30 seconds, surface was washed slightly with water for 
three times and acetone for once, then dried at room temperature in air. The STM images were 
taken with a PicoPlus SPM system with a PicoScan 3000 Controller. The 3D STM images were 
processed using a free Scanning Probe Microscope (SPM) image analysis software 
(Gwyddion 2.4). 
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3.2.1. Synthesis of Intermediates and Ligands L1-L5 
 
Figure 3.2. Synthesis of Ligand L1 
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Figure 3.3. Synthesis of Intermediates 4-14 
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Figure 3.4. Synthesis of Ligand L2 
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Figure 3.5. Synthesis of Ligand L3’ 
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Figure 3.6. Synthesis of Ligands L3 & L4 
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Figure 3.7. Synthesis of Ligand L5 
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Compound 1 To a solution of 2-hydroxyl-5-bromo benzaldehyde (5.0 g, 25.0 mmol) and 
1-bromohexane (4.5 g, 27.5 mmol) in 80 mL of DMF, K2CO3 (6.9 g, 50.0 mmol) was added. The 
mixture was heated at 110 °C overnight and then cooled down to room temperature. After 
removing the solvent under reduced pressure, the crude product was purified by column 
chromatography on silica gel (hexane/DCM = 100/5) to give compound 1 as a pale yellow oil (6.2 
g, 88% yield). 1H NMR (400 MHz, CDCl3, 300K) δ 10.45 (s, 1H, H-CHO ), 7.91 (d, J = 2.8 Hz, 1H, 
Hc ), 7.60 (ddd, J = 8.9, 2.4, 0.2 Hz, 1H, Ha), 6.89 (d, J = 8.9 Hz, 1H, Hb), 4.10 (t, J = 6.4 Hz, 2H, 
Hd ), 1.98 – 1.75 (m, 2H, He), 1.56 – 1.45 (m, 2H, Hf ), 1.42 – 1.33 (m, 4H, Hg &Hh), 0.92 (t, J = 
6.3 Hz, 3H, Hi). 13C NMR (100 MHz, CDCl3, 300K) δ 188.38, 160.42, 138.22, 130.77, 126.16, 
114.58, 113.20, 69.00, 31.45, 28.93, 25.65, 22.53, 13.96.  
 
Compound2. To a solution of NaOH (3.2 g, 80 mmol) in 70 mL EtOH, 2-(hexyloxy)-5-
bromo benzaldehyde (4.26 g, 15.0 mmol) and 2-acetylpyridine (4.0 g, 33.0 mmol) was added. 
After stirring at 25 ºC for 10 h, aqueous NH3·H2O (50 mL) was added and the mixture was refluxed 
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for 20 h. After cooling down to room temperature, the solvent was removed under reduced pressure, 
and the aqueous phase was extracted using DCM and the organic layer was washed with water for 
three times and dried over anhydrous Na2SO4. After removing the solvent under reduced pressure, 
the residue was purified by column chromatography on silica gel with DCM as eluent to afford 
compound 2 as white solid (5.2 g, 71% yield). 1H NMR (400 MHz, CDCl3, 300K) δ 8.70 (ddd, J 
= 4.8, 1.8, 0.9 Hz, 2H, tpy-H6,6’’), 8.68 – 8.65 (m, 2H, tpy-H3,3’’), 8.66 (s, 2H, tpy-H3’,5’), 7.86 (td, 
J = 7.7, 1.8 Hz, 2H, tpy-H4,4’’), 7.68 (d, J = 2.5 Hz, 1H, Hc), 7.44 (dd, J = 8.8, 2.5 Hz, 1H, Hb), 
7.37 – 7.28 (m, 2H, tpy-H5,5’’), 6.86 (d, J = 8.8 Hz, 1H, Ha), 3.97 (t, J = 6.2 Hz, 2H, Hd), 1.69 (dt, 
J = 14.4, 6.3 Hz, 2H, H-e), 1.44 – 1.29 (m, 2H, Hf), 1.21 – 1.03 (m, 4H, Hg &Hh), 0.72 (t, J = 7.1 
Hz, 3H, Hi). 13C NMR (101 MHz, CDCl3, 300K) δ 156.42, 155.64, 155.33, 149.20, 147.16, 136.89, 
133.08, 132.55, 130.46, 123.77, 121.78, 121.34, 114.12, 112.99, 68.99, 31.61, 29.17, 25.85, 22.45, 
14.02. ESI-TOF (m/z): Calcd. [C27H26BrN3O+H]+ for 488.13, found 488.13. 
 
 
Compound 3 Compound 2 (1.0 g, 2.0 mmol), Pd(PPh3)4 (111.5 mg, 0.1 mmol) and CuI 
(15.3 mg, 0.08 mmol) were mixed in a 100 mL Schlenk flask. After degassing and backfill with 
nitrogen for three times, 30 mL of THF and 30 mL of Et3N were added under nitrogen atmosphere. 
After the addition of TMSA (400 µL, 2.8 mmol), the mixture was stirred at 60 °C for 16h. After 
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cooling down to room temperature, 100 mL of water was added. The mixture was extracted with 
chloroform, and the organic layer was dried over anhydrous Na2SO4 and filtered through celite. 
After the evaporation of solvent under vacuum, 30 mL of chloroform and 30 mL of methanol was 
added, followed by the addition of K2CO3 (1.38 g, 10 mmol) in one portion. The suspension was 
then stirred at room temperature for 2h, and another 100 mL of water was added. With the 
extraction using chloroform, the organic layer was dried over anhydrous Na2SO4 and the solvent 
was evaporated under vacuum. The crude product was purified via column chromatography on 
silica gel (CHCl3/MeOH = 100/1) to give compound 3 as a pale yellow solid (653 mg, 87% yield). 
1H NMR (400 MHz, CDCl3, 300K) δ 8.71 – 8.68 (m, 2H, , tpy-H6,6’’), 8.68 (s, 2H, tpy-H3’,5), 8.66 
(dt, J = 8.0, 1.1 Hz, 2H, tpy-H3,3’’), 7.85 (ddd, J = 8.0, 7.5, 1.8 Hz, 2H, tpy-H4,4’’), 7.73 (d, J = 2.1 
Hz, 1H, Hc), 7.50 (dd, J = 8.5, 2.2 Hz, 1H, Hb), 7.31 (ddd, J = 7.5, 4.8, 1.2 Hz, 2H, tpy-H5,5’’), 6.93 
(d, J = 8.6 Hz, 1H, Ha), 4.01 (t, J = 6.2 Hz, 2H, Hd), 3.03 (s, 1H, Hd), 1.71 (ddt, J = 9.3, 7.9, 6.2 
Hz, 2H, He), 1.50 – 1.32 (m, 2H, Hf), 1.27 – 1.00 (m, 4H, Hg &Hh), 0.72 (t, J = 7.2 Hz, 3H, Hi). 
13C NMR (101 MHz, CDCl3, 300K) δ 156.87, 156.51, 155.31, 149.20, 147.52, 136.81, 134.46, 
133.97, 128.53, 123.70, 121.85, 121.29, 114.39, 112.17, 83.50, 76.34, 68.76, 31.61, 29.15, 25.86, 
22.45, 14.01. ESI-TOF (m/z): Calcd. [C29H27N3O+H]+ for 434.22, found 434.21. 
 
Ligand L1 Compound 2 (400 mg, 0.82 mmol) and compound 3 (499 mg, 0.98 mmol) were 
mixed in a 100 mL Schlenk flask, Pd(PPh3)4 (47.3 mg, 0.041 mmol) and CuI (6.2 mg, 0.033 mmol) 
were added. After degassing and backfill with nitrogen for three times, 30 mL of THF and 30 mL 
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of Et3N were added under nitrogen atmosphere. After the addition of TBAF (0.98 mL, 0.98 mmol, 
1 mol/L in THF), the mixture was stirred at 70 °C for 16h. After that the reaction was cooled down 
to room temperature and 100 mL of water was added. The mixture was extracted with chloroform, 
and the organic layer was collected, dried over anhydrous sodium sulfate and the solvent was 
evaporated under vacuum. The crude product was purified via column chromatography on silica 
gel (CHCl3/MeOH = 100/2) to give L1 as a white solid (374 mg, 52.3% yield). 1H NMR (500 
MHz, CDCl3, 300K) δ 8.75 (s, 2H, tpy-H3’,5’), 8.73 (d, J = 4.3 Hz, 2H, tpy-H6,6’’), 8.69 (d, J = 7.9 
Hz, 2H, tpy-H3,3’’), 7.88 (t, J = 7.4 Hz, 2H tpy-H4,4’’), 7.81 (d, J = 1.1 Hz, 1H, Ha), 7.57 (d, J = 8.4 
Hz, 1H, Hc), 7.39 – 7.31 (m, 2H, tpy-H5,5’’), 7.00 (d, J = 8.6 Hz, 1H, Hb), 4.06 (t, J = 6.1 Hz, 2H, 
Hd), 1.81 – 1.68 (m, 2H, He), 1.46 – 1.38 (m, 2H, Hf), 1.25 – 1.05 (m, 4H, Hg &Hh), 0.76 (t, J = 
7.0 Hz, 3H, Hi). 13C NMR (126 MHz, CDCl3, 300K) δ 156.47, 156.27, 155.16, 149.11, 147.71, 
136.76, 133.78, 133.21, 128.48, 123.58, 121.90, 121.23, 115.83, 112.22, 88.25, 68.65, 31.55, 29.12, 
25.81, 22.38, 13.95. ESI-TOF (m/z): Calcd. [C56H52N6O2+H]+ for 841.42, found 841.43. 
 
Compound 4 To To a solution of NaOH (3.2 g, 80 mmol) in 70 ml EtOH, 4-bromo-2-
fluorobenzaldehyde (3.03 g, 15.0 mmol) and 2-acetylpyridine (4.0 g, 33.0 mmol) was added. After 
stirring at 25 ºC for 10 h, aqueous NH3·H2O (50 mL) was added and the mixture was refluxed for 
20 h. After cooling down to room temperature, the yellow precipitate was collected via vacuum 
filtration and washed with ethanol. The crude product was recrystallized using CHCl3/EtOH to 
give compound 4 as a white solid (3.2 g, 53% yield). 1H NMR (400 MHz, CDCl3, 300K) δ 8.75 
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(ddd, J = 4.8, 1.8, 0.9 Hz, 2H, tpy-H6,6’’), 8.69 (dt, J = 8.0, 1.0 Hz, 2H, tpy-H3,3’’), 8.66 (d, J = 1.5 
Hz, 2H, tpy-H3’,5’), 7.92 (td, J = 7.8, 1.8 Hz, 2H, tpy-H4,4’’), 7.84 (dd, J = 6.7, 2.5 Hz, 1H, Ha), 7.52 
(ddd, J = 8.7, 4.3, 2.5 Hz, 1H, Hb), 7.39 (ddd, J = 7.5, 4.8, 1.2 Hz, 2H, tpy-H5,5’’), 7.11 (dd, J = 
10.0, 8.7 Hz, 1H, Hc). 13C NMR (101 MHz, CDCl3, 300K) δ 160.23, 157.74, 155.85, 149.18, 
144.14, 136.86, 133.23, 133.14, 128.94, 128.80, 123.95, 121.31, 120.71, 120.69, 118.20, 117.96, 
117.04. 19F NMR (376 MHz, CDCl3, 300K) δ -118.45. ESI-TOF (m/z): Calcd. [C21H13BrN3F+H]+ 
for 406.04, found 406.05. 
 
Compound 5 Compound 4 (810 mg, 2.0 mmol), Pd(PPh3)4 (111.5 mg, 0.1 mmol) and CuI 
(15.3 mg, 0.08 mmol) were mixed in a 100 mL Schlenk flask. After degassing and backfill with 
nitrogen for three times, 30 mL of THF and 30 mL of Et3N were added under nitrogen atmosphere. 
After the addition of TMSA (400 µL, 2.8 mmol), the mixture was stirred at 60 °C for 16h. After 
cooling down to room temperature, 100 mL of water was added. The mixture was extracted with 
chloroform, and the organic layer was collected, dried over anhydrous sodium sulfate and the 
solvent was evaporated under vacuum. The crude product was purified via column 
chromatography on silica gel (CHCl3/MeOH = 100/1) to give 3 as a pale yellow solid (600.1 mg, 
71% yield). 1H NMR (400 MHz, CDCl3, 300K) δ 8.72 (dt, J = 3.9, 0.9 Hz, 2H, tpy-H6,6’’), 8.66 (d, 
J = 8.0 Hz, 2H, tpy-H3,3’’), 8.64 (s, 2H, tpy-H3’,5’), 7.95 – 7.85 (m, 2H, tpy-H4,4’’), 7.82 (dd, J = 7.3, 
2.2 Hz, 1H, Ha), 7.50 (ddd, J = 8.5, 4.7, 2.1 Hz, 1H, Hb), 7.34 (ddd, J = 7.4, 4.8, 1.3 Hz, 2H, tpy-
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H5,5’’), 7.14 (dd, J = 10.3, 8.5 Hz, 1H, Hc), 0.26 (s, 9H, H-TMS). 13C NMR (101 MHz, CDCl3, 300K) 
δ 161.10, 158.57, 156.07, 155.90, 149.28, 144.79, 136.98, 134.49, 134.46, 134.19, 134.11, 127.31, 
127.17, 124.02, 121.45, 120.96, 120.93, 120.12, 120.08, 116.74, 116.50, 103.63, 94.82, 0.05. 19F 
NMR (376 MHz, CDCl3, 300K) δ -115.34. ESI-TOF (m/z): Calcd. [C26H22FN3Si+H]+ for 424.16, 
found 424.16. 
 
Compound 6 Compound 5 (600.1 mg, 1.42 mmol) was dissolved in 30 mL chloroform, 
and 30 mL of methanol was added. After the addition of K2CO3 (588 mg, 4.26 mmol), the mixture 
was stirred at room temperature for 3 hours followed by the addition of 100 mL water. The mixture 
was extracted with chloroform, and the organic layer was collected, dried over anhydrous sodium 
sulfate and the solvent was evaporated under vacuum. The crude product was purified via flash 
column chromatography on silica gel (CHCl3/MeOH = 100/1) to give 6 as a white solid (424 mg, 
85% yield). 1H NMR (400 MHz, CDCl3, 300K) δ 8.72 (ddd, J = 4.8, 1.8, 0.9 Hz, 2H, tpy-H6,6’’), 
8.68 (t, J = 1.1 Hz, 2H, tpy-H3,3’’), 8.66 (s, 2H, tpy-H3’,5’), 7.93 – 7.85 (m, 2H, tpy-H4,4’’), 7.84 (dd, 
J = 5.1 Hz, 2.2 Hz , 1H, Ha), 7.53 (ddd, J = 8.5, 4.7, 2.2 Hz, 1H, Hb), 7.35 (ddd, J = 7.5, 4.8, 1.2 
Hz, 2H, tpy-H5,5’’), 7.17 (dd, J = 10.2, 8.5 Hz, 1H, Hc), 3.10 (s, 1H, Hd). 13C NMR (101 MHz, 
CDCl3, 300K) δ 161.17, 158.64, 155.92, 155.82, 149.17, 144.52, 136.85, 134.53, 134.23, 134.14, 
127.33, 127.20, 123.90, 121.30, 120.81, 118.86, 116.74, 116.51, 82.20, 77.58. 19F NMR (376 MHz, 
CDCl3, 300K) δ -113.76. ESI-TOF (m/z): Calcd. [C23H14FN3+H]+ for 352.13, found 352.13. 
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Compound 7 To a flask containing compound 4 (2.0 g, 4.9 mmol), RuCl3.xH2O (2.03 g, 
9.8 mmol) was added. With the addition of 100 mL chloroform and 100 mL methanol, the brown 
slurry was stirred under reflux for 24h. Afterwards the solvent was removed under vacuum, and 
the residue was washed with methanol for three times. The solid was collected via filtration and 
dried under vacuum to give compound 7 as a brown solid (2.8g, 83.6% yield). Due to the extremely 
poor solubility, compound 7 was directly used for the following steps without further 
characterization. 
 
Compound 8 To a flask containing compound 5 (251 mg, 0.6 mmol) and compound 7 (330 
mg, 0.54 mmol), 80 mL chloroform and 80 mL methanol was added. After the addition of N-
ethylmorphline (500 uL), the mixture was stirred under reflux for 36h when it became a dark red 
solution. After cooling down to room temperature, the solvent was evaporated under vacuum, and 
the crude product was purified via column chromatography on aluminum oxide (DCM/MeOH = 
100/1) to give compound 8 as a dark red solid (306.2 mg, 63% yield). 1H NMR (500 MHz, CDCl3, 
300K) δ 9.03 (s, 2H, tpyB-H3’,5’), 8.93 (s, 2H, tpyA-H3’,5’), 8.74 (d, J = 8.1 Hz, 2H, tpyB-H3,3’’), 8.64 
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(d, J = 8.1 Hz, 2H, tpyA-H3,3’’), 8.55 (dd, J = 6.9, 1.9 Hz, 1H, Hd), 8.27 (dd, J = 7.4, 1.8 Hz, 1H, 
Ha), 7.96 (m, 4H, tpyB-H4,4’’ & tpyA-H6,6’’), 7.73 – 7.63 (m, 2H, Hb & He), 7.55 (t, J = 5.4 Hz, 4H, 
tpyA-H4,4’’ & tpyB-H6,6’’), 7.34 – 7.28 (m, 6H, tpyA-H5,5’’, tpyB-H5,5’’, Hc & Hf), 0.28 (s, 9H, H-TMS). 
13C NMR (126 MHz, CDCl3) δ 161.53, 159.13, 153.11, 151.97, 151.77, 149.92, 148.15, 146.80, 
146.67, 145.13, 142.63, 140.40, 139.89, 139.15, 137.56, 137.47, 136.42, 135.07, 133.96, 132.45, 
132.20, 130.47, 129.11, 127.39, 126.51, 125.81, 124.96, 124.06, 123.24, 117.89, 94.04, 90.17, 
3.50. 19F NMR (376 MHz, CDCl3, 300K) δ -115.10, -119.26. ESI-TOF (m/z): Calcd. 
[C47H35BrCl2F2N6RuSi-2Cl]2+ for 465.05, found 465.05. 
 
Compound 9 Compound 8 (240 mg, 0.24 mmol), compound 6 (110 mg, 0.312 mmol), 
Pd(PPh3)4 (13.9 mg, 0.012 mmol) and CuI (2.3 mg, 0.012 mmol) were mixed in a 100 mL Schlenk 
flask. After degassing and backfill with nitrogen for three times, 15 mL of DMF, 15 mL of DME 
and 15 mL of Et3N were added under nitrogen atmosphere. The mixture was then stirred at 80 °C 
for 16h. After cooling down to room temperature, the solvent was evaporated under vacuum. The 
crude product was purified via column chromatography on aluminum oxide (CHCl3/MeOH = 
100/1) to give 9 as a dark red solid (247 mg, 81% yield). 1H NMR (500 MHz, CDCl3, 300K) δ 
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9.03 (s, 2H, tpyB-H3’,5’), 8.93 (s, 2H, tpyA-H3’,5’), 8.74 (d, J = 8.1 Hz, 2H, tpyB-H3,3’’), 8.64 (d, J = 
8.1 Hz, 2H, tpyA-H3,3’’), 8.55 (dd, J = 6.9, 1.9 Hz, 1H, He), 8.27 (dd, J = 7.4, 1.8 Hz, 1H, Hb), 7.96 
(t, J = 7.5 Hz, 4H, tpyB-H4,4’’ & tpyA-H6,6’’), 7.73 – 7.63 (m, 2H, Hc & Hf), 7.55 (t, J = 5.4 Hz, 4H, 
tpyA-H4,4’’ & tpyB-H6,6’’), 7.34 – 7.28 (m, 6H, tpyA-H5,5’’, tpyB-H5,5’’, Ha & Hd), 0.28 (s, 9H, H-TMS). 
13C NMR (126 MHz, CDCl3, 300K) δ 160.77, 160.64, 160.57, 158.74, 158.62, 158.55, 157.75, 
157.62, 157.57, 155.92, 155.88, 155.03, 154.95, 154.93, 152.63, 152.54, 149.23, 144.68, 142.79, 
138.38, 136.99, 135.03, 134.80, 134.74, 134.38, 134.25, 133.72, 128.37, 127.21, 125.38, 125.10, 
124.88, 124.04, 123.94, 121.88, 121.43, 121.18, 120.90, 120.02, 119.67, 118.16, 117.24, 117.12, 
116.93, 116.85, 116.74, 102.89, 96.07, 89.42, 88.03, -0.05. 19F NMR (376 MHz, CDCl3) δ -114.15, 
-114.96, -115.06.ESI-TOF Calcd. [C70H48Cl2F3N9RuSi-2Cl]2+ for 600.64, found 600.64. 
 
Compound 10. Compound 10 was synthesized exactly according to literature report14. To 
an aqueous solution of NaOH (25%, 50 mL) containing p-bromophenol (17.3 g, 0.1 mol) and 
methanol (25 mL) was added formaldehyde (38%, 90 mL) and the mixture was stirred for 12 days 
at room temperature. Then, a mixture of water (50 mL) and acetic acid (15 mL) was added. The 
reaction mixture was stirred for 8 h at room temperature to give a yellow precipitate, which was 
collected via filtration. The precipitate was then dissolved in 10% aqueous NaOH, followed by 
acidify with 2 M HCl until pH = 1. The crystals formed was collected via filtration and washed 
with water, dried to give a pale yellow solid (10.9 g, 47% yield).  
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Compound 11 Compound 11 was synthesized exactly according to literature report15. A 
mixture of 4-bromo-2,6-bis(hydroxymethyl)phenol (6.0 g, 25.9 mmol), 1-bromohexane (5.1 g, 
31.1 mmol), K2CO3 (7.2 g, 52.0 mmol) and methyl ethyl ketone (200 mL) was refluxed under N2 
for 24 h. The mixture was cooled to room temperature, filtrated and dried under vacuum at 60 °C 
for 6 hours. The white residue was dissolved using 200 mL of DCM, after which PCC (11.8 g, 75 
mmol) and celite (20 g) was added. The mixture was stirred at room temperature for 5h with TLC 
analysis until disappearance of the material. After that the mixture was directly poured onto silica 
gel column with DCM as eluent to afford compound 11 as a white solid (6.98 g, 86% yield). 1H 
NMR (400 MHz, CDCl3, 300K) δ 10.36 (s, 2H, H-CHO), 8.20 (s, 2H, Ha), 4.14 (t, J = 6.4 Hz, 2H, 
Hb), 1.95-1.87 (m, 2H, Hc), 1.56 – 1.45 (m, 2H, Hd), 1.40 – 1.35 (m, 4H, He & Hf), 0.97 – 0.89 (t, 
J = 6.4 Hz, 3H, Hg). 13C NMR (100 MHz, CDCl3, 300K) δ 187.13, 139.03, 137.24, 131.76, 118.29, 
81.04, 31.48, 29.85, 25.45, 22.49, 13.94.  
 
Compound 12 Compound 12 was synthesized exactly according to literature report16. To a 
solution of NaOH powder (6.24 g, 156.0 mmol) in EtOH (350 mL), 5-bromo-2-
 113 
 
(hexyloxy)benzene-1,3-dialdehyde (4.0 g, 13.0 mmol) and 2-acetylpyridine (7.5 g, 62 mmol) were 
added. After stirring at room temperature for 20 h, aqueous NH3•H2O (150 mL) was added and the 
mixture was refluxed for 40 h. Upon cooling to room temperature, the precipitate was filtered and 
washed with cold ethanol, dried and recrystallized using CHCl3/EtOH to give 6 as a white solid 
(4.8 g, 51% yield). 1H NMR (400 MHz, CDCl3, 300K) δ 8.80 (s, 4H, tpy-H 3',5'), 8.77 (ddd, J = 
4.8, 1.8, 0.9 Hz, 4H, tpy-H 6, 6’’), 8.70 (dt, J = 8.0, 1.0 Hz, 4H, tpy-H 3,3’’), 7.91 (td, J = 7.7, 1.8 Hz, 
4H, tpy-H 4,4’’), 7.80 (s, 2H, Ha ), 7.38 (ddd, J = 7.5, 4.8, 1.2 Hz, 4H, tpy-H 5,5’’), 3.37 (t, J = 6.4 
Hz, 2H, Hb), 1.24 – 1.17 (dd, J = 9.1, 6.2 Hz, 2H, Hc), 0.92 (s, 2H, Hd), 0.83 – 0.66 (m, 4H, He & 
Hf), 0.55 – 0.41 (t, J = 6.8 Hz, 3H, Hg). 13C NMR (100 MHz, CDCl3, 300K) δ 156.10, 155.58, 
153.98, 149.20, 147.08, 136.80, 135.89, 133.66, 123.82, 121.45, 121.25, 117.05, 74.33, 31.29, 
29.70, 25.39, 22.11, 13.77. ESI-TOF (m/z): Calcd. [C42H35BrN6O+H]+ for 719.21, found 719.21. 
 
Compound 13 Compound 12 (810 mg, 2.0 mmol), Pd(PPh3)4 (111.5 mg, 0.1 mmol) and 
CuI (15.3 mg, 0.08 mmol) were mixed in a 100 mL Schlenk flask. After degassing and backfill 
with nitrogen for three times, 40 mL of THF and 30 mL of Et3N were added under nitrogen 
atmosphere. After the addition of TMSA (400 µL, 2.8 mmol), the mixture was stirred at 60 °C for 
16h. After cooling down to room temperature, 100 mL of water was added. The mixture was 
extracted with chloroform, and the organic layer was collected, dried over anhydrous sodium 
sulfate and the solvent was evaporated under vacuum. The crude product was purified via column 
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chromatography on silica gel (CHCl3/MeOH = 100/1) to give 3 as a white solid (785 mg, 94.7% 
yield). 1H NMR (500 MHz, CDCl3) δ 8.78 (s, 4H, tpy-H 3',5'), 8.77 – 8.72 (m, 4H, tpy-H 6, 6’’), 8.68 
(d, J = 7.9 Hz, 4H, tpy-H 3,3’’), 7.88 (td, J = 7.7, 1.8 Hz, 4H, tpy-H 4,4’’), 7.78 (s, 2H, Ha ), 7.35 (ddd, 
J = 7.4, 4.8, 1.1 Hz, 4H, tpy-H 5,5’’), 3.35 (t, J = 6.0 Hz, 2H, Hb), 1.17 (m, 2H, Hc), 0.91 (m, 2H, 
Hd), 0.77 – 0.67 (m, 4H, He & Hf), 0.48 (t, J = 6.8 Hz, 3H, Hg), 0.34 – 0.21 (s, 9H, H-TMS). 13C 
NMR (101 MHz, CDCl3) δ 156.23, 155.10, 149.23, 147.70, 136.84, 134.80, 123.83, 121.61, 
121.30, 119.59, 104.09, 94.84, 74.41, 31.36, 29.79, 25.46, 22.17, 13.83, 0.07. ESI-TOF (m/z): 
Calcd. [C47H44SiN6O+H]+ for 737.34, found 737.34. 
 
Compound 14 Compound 12 (588 mg, 0.82 mmol) and compound 13 (719 mg, 0.98 mmol) 
were mixed in a 100 mL Schlenk flask, Pd(PPh3)4 (47.3 mg, 0.041 mmol) and CuI (6.2 mg, 0.033 
mmol) were added. After degassing and backfill with nitrogen for three times, 30 mL of THF and 
30 mL of Et3N were added under nitrogen atmosphere. After the addition of TBAF (0.98 mL, 0.98 
mmol, 1 mol/L in THF), the mixture was stirred at 70 °C for 16h. After that the reaction was cooled 
down to room temperature and 100 mL of water was added. The mixture was extracted with 
chloroform, and the organic layer was collected, dried over anhydrous sodium sulfate and the 
solvent was evaporated under vacuum. The crude product was purified via column 
chromatography on silica gel (CHCl3/MeOH = 100/2) to give compound 14 as a white solid (659 
mg, 61.7% yield). 1H NMR (400 MHz, CDCl3, 300K) δ 8.84 (s, 8H, tpy-H3’,5’), 8.74 (ddd, J = 4.8, 
1.8, 0.9 Hz, 8H, tpy-H6,6’’), 8.68 (dt, J = 8.0, 1.0 Hz, 8H, tpy-H3,3’’), 7.89 (s, 4H, Ha), 7.89 – 7.83 
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(m, 8H, tpy-H 4,4’’), 7.33 (ddd, J = 7.5, 4.8, 1.2 Hz, 8H, tpy-H 5,5’’), 3.41 (t, J = 6.1 Hz, 4H, Hb), 
1.28 – 1.15 (m, 4H, Hc), 0.93 (m, 4H, Hd), 0.82 – 0.63 (m, 8H, He & Hf), 0.49 (t, J = 6.7 Hz, 6H, 
Hg). 13C NMR (101 MHz, CDCl3, 300K) δ 156.37, 156.36, 155.64, 155.08, 149.31, 147.81, 136.83, 
134.48, 134.41, 132.23, 132.13, 132.04, 132.01, 128.65, 128.53, 123.79, 121.79, 121.33, 119.61, 
89.11, 74.52, 31.42, 29.86, 25.52, 22.23, 13.88. ESI-TOF (m/z): Calcd. [C76H70N12O2+H]+ for 
1303.58, found 1303.57. 
 
Compound 15-trans To a flask containing compound 14 (300 mg, 0.23 mmol) and 
compound 7 (281 mg, 0.46 mmol), 80 mL chloroform and 80 mL methanol was added. After the 
addition of N-ethylmorphline (500 uL), the mixture was stirred under reflux for 36h when it 
became a dark red solution. After cooling down to room temperature, the solvent was evaporated 
under vacuum, and the crude product was purified via column chromatography on aluminum oxide 
(DCM/MeOH = 100/1.5) to give compound 15 as a dark red solid (410 mg, 56.7% yield). 1H NMR 
(500 MHz, CDCl3, 300K) δ 9.43 (s, 4H, tpyA-H3’,5’), 9.05 (s, 4H, tpyB-H3’,5’), 8.97 (d, J = 8.1 Hz, 
4H, tpyC-H6,6’’), 8.90 (s, 4H, tpyC-H3’,5’), 8.77 (m, 12H, tpyA-H3,3’’, tpyB-H3,3’’ & tpyC-H3,3’’), 
8.50 (dd, J = 6.8, 2.0 Hz, 2H, Hc), 7.97 (m, 14H, tpyA-H4,4’’, tpyB-H4,4’’, tpyC-H4,4’’& Hb), 7.65 
(ddd, J = 8.4, 4.0, 2.4 Hz, 2H, Hd), 7.54 (d, J = 5.4 Hz, 4H, tpyA-H6,6’’), 7.44 – 7.36 (m, 8H, tpyA-
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H5,5’’, tpyC-H5,5’’), 7.32 (d, J = 5.3 Hz, 4H, tpyB-H6,6’’), 7.22 – 7.26  (m, 6H, tpyB-H5,5’’, He), 3.64 
(t, J = 5.9 Hz, 4H, Hf), 1.41 – 1.31 (m, 4H, Hg), 1.13 – 1.03 (m, 4H, Hi), 0.89 – 0.73 (m, 8H, Hi & 
Hj), 0.46 (t, J = 7.2 Hz, 6H, Hk). 13C NMR (151 MHz, CDCl3, 300K) δ 159.79, 158.12, 158.09, 
157.91, 157.83, 157.57, 155.82, 155.72, 155.32, 155.25, 155.23, 154.97, 154.84, 154.76, 154.65, 
152.58, 151.55, 151.42, 151.18, 151.06, 151.03, 147.15, 145.65, 142.62, 142.50, 138.72, 138.66, 
138.53, 138.46, 134.67, 134.62, 131.73, 131.65, 131.62, 128.39, 128.16, 127.99, 127.90, 127.82, 
125.62, 124.42, 124.28, 124.11, 123.73, 121.03, 120.81, 118.72, 118.48, 118.42, 118.23, 118.07, 
89.61, 67.24, 31.22, 30.06, 25.81, 15.58, 13.37. 19F NMR (376 MHz, CDCl3, 300K) δ -118.95. 
ESI-TOF (m/z): Calcd. [C128H96Br2Cl4F2N18O2-4Cl]4+ for 579.11, found 579.12. Note: Isomers 
does form during the reaction. Flash column chromatography on aluminum oxide (DCM/MeOH 
= 100/2) gave a mixture of cis and trans isomers. 1H NMR indicated that the trans- compound is 
the major product. By slowly adjusting the gradient from DCM/MeOH = 100/1 to DCM/MeOH = 
100/1.5 we were able to isolate compound 15 as trans compound. (Supplementary Figure 3, 103). 
Due to the small amount, we were unable to isolate 15-cis.  
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Ligand L2 Compound 15 (80 mg, 0.032 mmol) and compound 9 (103.5 mg, 0.081 mmol) 
were mixed in a 100 mL Schlenk flask, Pd(PPh3)4 (3.8 mg, 0.0032 mmol) and CuI (0.46 mg, 0.0024 
mmol) were added. After degassing and backfill with nitrogen for three times, 15 mL of DMF, 10 
mL of DME and 30 mL of Et3N were added under nitrogen atmosphere. After the addition of 
TBAF (81 uL, 0.081 mmol, 1 mol/L in THF), the mixture was stirred at 80 °C for 16h. After that 
the reaction was cooled down to room temperature and the solvent was evaporated under vacuum. 
The crude product was purified via column chromatography on aluminum oxide (CHCl3/MeOH = 
100/2) to give L2 as a dark red solid (58.9 mg, 39% yield). 1H NMR (400 MHz, CDCl3 with 10% 
CD3OD, 300K) δ 9.30 (s, 4H, , tpyA-H3’,5’), 9.17 (s, 4H, tpyB-H3’,5’), 9.14 (s, 4H, tpyC-H3’,5’), 8.95 
(s, 4H, tpyD-H3’,5’), 8.84 (m , 12H, tpyA-H3,3’’, tpyB-H3,3’’, tpyC-H3,3’’), 8.81 (s, 8H, tpyE-H3’,5’ & 
tpyF-H3’,5’ ), 8.74 (d, J = 7.3 Hz, 4H, Hc, Hh ), 8.71 – 8.51 (m, 32H, tpyE-H3’,5’, tpyE-H3,3’’, tpyE-
H6,6’’, tpyD-H3,3’’, tpyC-H3,3’’, tpyF-H3,3’’, tpyF-H6,6’’, Ha, Hb), 8.27 (d, J = 7.2 Hz, 2H, Hi), 8.06 – 
7.81 (m, 26H, , tpyA,B,C,D,E,F-H4,4’’, Hn), 7.80 – 7.65 (m, 18H, tpyB,C,D-H6,6’’, He, Hf, Hj), 7.63 
– 7.58 (m, 6H, tpyA-H6,6’’, Hi ), 7.47 – 7.15 (m, 32H, tpyA,B,C,D,E,F-H5,5’’, Hd,g,k,m), 3.57 (s, 4H, 
Ho), 1.50 – 1.20 (m, 4H, Hp), 1.15– 0.93 (m, 4H, Hq), 0.91 – 0.49 (m, 8H, Hr,s), 0.35 (t, J = 7.1 Hz, 
6H, Ht). 13C NMR (126 MHz, CDCl3 with 10% CD3OD, 300K) δ 160.88, 158.85, 157.64, 155.87, 
155.20, 155.18, 154.88, 154.88, 152.12, 151.91, 151.49, 149.11, 147.18, 147.12, 145.74, 144.77, 
143.19, 138.73, 137.26, 135.63, 134.84, 134.35, 133.96, 131.87, 128.24, 127.91, 125.50, 125.23, 
125.23, 124.81, 124.17, 124.17, 123.69, 123.68, 123.60, 121.70, 121.31, 120.92, 119.67, 117.15, 
89.58, 88.95, 87.82, 75.24, 31.30, 29.70, 25.91, 22.22, 13.67. 19F NMR (376 MHz, CDCl3 with 
10% CD3OD, 300K) δ -114.25, -114.55, -114.76. ESI-TOF (m/z): Calcd. [C262H174F8N36Ru4Cl8O2-
8Cl]8+ for 551.88, found 551.88; Calcd. [C262H174F8N36Ru4Cl8O2-7Cl]7+ for 635.72, found 635.72; 
Calcd. [C262H174F8N36Ru4Cl8O2-6Cl]6+ for 747.50, found 747.50; Calcd. [C262H174F8N36Ru4Cl8O2-
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5Cl]5+ for 903.99, found 903.99; Calcd. [C262H174F8N36Ru4Cl8O2-4Cl]4+ for 1138.74, found 
1138.74.  
 
Compound 16 To a flask containing compound 4 (500 mg, 1.45 mmol), RuCl2(DMSO)4 
(336 mg, 0.7 mmol) was added. With the addition of 100 mL chloroform and 100 mL methanol, 
the mixture was stirred under reflux for 24h when it gradually become a uniform red solution. 
Afterwards the solvent was removed under vacuum, and the residue was purified via column 
chromatography on aluminum oxide (CHCl3/MeOH = 100/1) to give compound 16 as a red solid 
(399 mg, 58% yield). 1H NMR (500 MHz, DMSO-d6, 300K) δ 9.26 (s, 2H, tpy-H3’,5’), 8.93 (d, J = 
8.1 Hz, 2H, tpy-H3,3’’), 8.30 (dd, J = 6.9, 2.6 Hz, 1H, Ha), 8.01 (td, J = 7.8, 1.5 Hz, 2H, tpy-H4,4’’), 
7.86 (ddd, J = 8.8, 4.3, 2.5 Hz, 1H, Hb), 7.58 (dd, J = 10.4, 8.8 Hz, 1H, Hc), 7.51 (d, J = 5.7 Hz, 
1H, tpy-H6,6’’), 7.27 (ddd, J = 7.2, 5.5, 1.3 Hz, 1H, tpy-H5,5’’) 13C NMR (126 MHz, DMSO-d6, 
300K) δ 163.98, 161.99, 161.50, 159.12, 155.98, 146.57, 142.59, 139.06, 137.67, 137.56, 132.20, 
130.53, 130.42, 129.08, 127.50, 122.56, 122.37, 122.00. 19F NMR (376 MHz, DMSO-d6, 300K) δ 
-118.45. ESI-TOF (m/z): Calcd. [C42H26Br2Cl2F2N6Ru-2Cl]2+ for 455.98, found 455.98. 
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Compound 17 Compound 16 (200 mg, 0.19 mmol) and compound 6 (200 mg, 0.57 mmol) 
were mixed in a 100 mL Schlenk flask, Pd(PPh3)4 (21.9 mg, 0.019 mmol) and CuI (3.6 mg, 0.019 
mmol) were added. After degassing and backfill with nitrogen for three times, 30 mL of DMF, 30 
mL of DME and 30 mL of Et3N were added under nitrogen atmosphere. The mixture was stirred 
at 80 °C for 16h. After that the reaction was cooled down to room temperature and the solvent was 
evaporated under vacuum. The crude product was purified via column chromatography on 
aluminum oxide (CHCl3/MeOH = 100/1) to give compound 17 as a dark red solid (175 mg, 58.6% 
yield). 1H NMR (400 MHz, DMSO-d6, 300K) δ 9.41 (s, 2H, tpyA-H3’, 5’), 9.04 (d, J = 7.9 Hz, 2H, 
tpyA-H3, 3’’), 8.77 (ddd, J = 4.8, 1.8, 0.9 Hz, 2H, tpyB-H6’, 6’’), 8.71 (dt, J = 8.0, 1.1 Hz, 2H, tpyB-
H3, 3’’), 8.69 (d, J = 1.4 Hz, 1H, tpyB-H3’, 5’), 8.43 (dd, J = 7.5, 2.1 Hz, 1H, Ha), 8.08 (dt, J = 7.9, 
1.7 Hz, 2H, tpyA-H4, 4’’), 8.07 (dt, J = 7.7, 1.5 Hz, 2H, tpyB-H4, 4’’), 8.02 (m, 1H, Hd), 7.98 (ddd, 
J = 8.6, 4.8, 2.1 Hz, 1H, Hc), 7.85 (ddd, J = 8.6, 4.7, 2.2 Hz, 1H, He), 7.75 (dd, J = 10.6, 8.6 Hz, 
1H, Hb), 7.65 – 7.60 (m, 1H, Hf), 7.61 – 7.53 (m, 4H, tpyA-H6, 6’’ & tpyB-H5, 5’’), 7.32 (ddd, J = 
7.3, 5.6, 1.3 Hz, 2H, tpyB-H5, 5’’). 13C NMR (151 MHz, DMSO-d6, 300K) δ 158.99, 158.90, 158.06, 
155.95, 155.25, 154.95, 152.70, 149.85, 149.74, 144.31, 141.88, 140.55, 138.74, 138.58, 138.21, 
138.06, 135.38, 134.04, 133.87, 128.37, 128.24, 127.11, 126.25, 126.16, 125.32, 125.15, 124.34, 
123.94, 121.53, 121.45, 120.55, 119.79, 118.22, 118.07, 117.86, 88.94, 88.81. 19F NMR (376 MHz, 
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DMSO-d6, 300K) δ -114.97, -115.86. ESI-TOF (m/z): Calcd. [C88H52Cl2F4N12Ru-2Cl]2+ for 
727.17, found 727.18. 
 
Compound 18 Compound 18 was synthesized using the method similar to compound 7. To 
a flask containing compound 17 (100 mg, 0.06 mmol), RuCl3.xH2O (49.7 mg, 0.24 mmol) was 
added. With the addition of 100 mL chloroform and 100 mL methanol, the brown slurry was stirred 
under reflux for 24h. Afterwards the solvent was removed under vacuum, and the residue was 
washed with methanol for three times. The solid was collected and dried under vacuum to give 
compound 18 as a brown solid (2.8g, 83.6% yield). Due to the extremely poor solubility, 
compound 18 was directly used for the following steps without further characterization. 
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Ligand L3’ To a flask containing compound 18 (60 mg, 0.031 mmol) and compound 14 
(80 mg, 0.06 mmol), 100 mL chloroform and 100 mL methanol was added. After the addition of 
N-ethylmorphline (500 uL), the mixture was stirred under reflux for 36h when it became a dark 
red solution. After cooling down to room temperature, the solvent was evaporated under vacuum, 
and the crude product was purified via column chromatography on aluminum oxide (DCM/MeOH 
= 100/1) to give L3’ as a dark red solid (26.5 mg, 27.3% yield). 1H NMR (500 MHz, DMSO-d6) δ 
9.54 (s, 4H, tpyB-H3’,5’), 9.51 (s, 8H, tpyC,D-H3’,5’), 9.21 – 9.08 (m, 12H, tpyB,C,D-H3,3’’), 8.95 
(s, 4H, tpyA-H3’,5’), 8.85 – 8.75 (m, 8H, tpyA-H3,3’’, tpyA-H6,6’’), 8.58 – 8.48 (m, 4H, Hc.f), 8.38 – 
8.33 (m, 2H, Hb), 8.28 (d, J = 2.1 Hz, 2H, Ha), 8.19 – 7.97 (m, 20H, tpyA,B,C,D-H4,4’’, Hd,g), 7.83 
– 7.77 (m, 4H, He,h), 7.67 – 7.51 (m, 16H, tpyB,C,D-H6,6’’, tpyA-H5,5’’), 7.28 – 7.38 (m, 12H, 
tpyB,C,D-H5,5’’), 3.74 (s, 4H, Hi), 1.38 (s, 4H, Hj), 1.26 – 1.08 (m, 4H, Hk), 0.93 – 0.74 (m, 4H, 
Hl), 0.62 (dq, J = 14.9, 7.5, 6.5 Hz, 4H, Hm), 0.26 (t, J = 7.3 Hz, 6H, Hn). 13C NMR (126 MHz, 
DMSO, 300K) δ 172.42, 160.98, 158.96, 158.31, 158.25, 158.18, 155.86, 155.82, 155.71, 155.40, 
155.38, 155.36, 155.15, 155.03, 152.81, 152.42, 149.85, 147.11, 144.97, 142.01, 141.94, 138.73, 
138.10, 135.59, 135.35, 135.07, 134.75, 134.61, 134.02, 128.35, 126.47, 126.38, 126.29, 125.49, 
125.19, 125.09, 124.28, 121.50, 121.32, 119.96, 119.68, 118.31, 118.12, 89.77, 89.18, 79.71, 77.05, 
75.04, 74.53, 56.13, 31.37, 29.61, 25.42, 13.86. 19F NMR (376 MHz, DMSO-d6) δ -112.87. ESI-
TOF (m/z): Calcd. [C174H122Cl6F4N24Ru3O2-6Cl]6+ for 493.45, found 493.45; Calcd. 
[C174H122Cl6F4N24Ru3O2-5Cl]5+ for 599.14, found 599.14; Calcd. [C174H122Cl6F4N24Ru3O2-4Cl]4+ 
for 757.67. found 757.67; Calcd. [C174H122Cl6F4N24Ru3O2-3Cl]3+ for 1021.87, found 1021.88. 
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Compound 19 To a flask containing compound 14 (650 mg, 0.5 mmol) and compound 7 
(152 mg, 0.25 mmol), 150 mL chloroform and 150 mL methanol was added. After the addition of 
N-ethylmorphline (500 uL), the mixture was stirred under reflux for 36h when it became a dark 
red solution. After cooling down to room temperature, the solvent was evaporated under vacuum, 
and the crude product was purified via column chromatography on aluminum oxide (DCM/MeOH 
= 100/1) to give compound 19 as a dark red solid (258 mg, 55.7% yield). 1H NMR (500 MHz, 
CDCl3, 300K) δ 9.08 (s, 2H, tpyB-H3’,5’), 9.03 (s, 2H, tpyC-H3’,5’), 8.84 (s, 2H, tpyA-H3’,5’), 8.77 
(d, J = 11.2 Hz, 2H, tpyB-H3,3’’), 8.75 (s, 4H, tpyD-H3’,5’), 8.73 – 8.63 (m, 18H, tpyA-H3,3’’, tpyC-
H3,3’’, tpyD-H3,3’’, tpyA-H6,6’’, tpyD-H6,6’’), 8.46 (dd, J = 7.0, 2.5 Hz, 1H, Hc), 8.20 (d, J = 2.1 Hz, 
1H, Hb), 8.03 – 7.93 (m, 5H, tpyB-H4,4’’, tpyC-H4,4’’, Ha), 7.92 – 7.81 (m, 8H, tpyA-H4,4’’, tpyD-
H4,4’’, Hf), 7.62 (ddd, J = 8.8, 4.4, 2.5 Hz, 1H, Hd), 7.55 (d, J = 5.5 Hz, 2H, tpyB-H6,6’’), 7.37-7.30 
(m, 10H, tpyA-H5,5’’, tpyB-H5,5’’, tpyD-H5,5’’, tpyC-H6,6’’), 7.24 – 7.15 (m, 3H, tpyC-H5,5’’ & He), 
3.61 (t, J = 6.0 Hz, 2H, Hg), 3.37 (t, J = 6.1 Hz, 2H, Hm), 1.30 (m, 2H, Hh), 1.21 (m, 2H, Hn), 1.03 
(p, J = 7.4 Hz, 2H, Hi), 0.93 – 0.61 (m, 10H, Hj, Hk, Ho, Hp, Hq), 0.47 – 0.42 (m, 3H, Hl), 0.39 (t, 
J = 7.1 Hz, 3H, Hr). 13C NMR (126 MHz, CDCl3, 300K) δ 160.02, 158.02, 157.74, 157.44, 155.92, 
155.73, 155.61, 155.53, 154.95, 154.83, 154.73, 152.39, 151.38, 149.11, 147.28, 146.95, 145.41, 
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142.45, 138.81, 138.56, 137.18, 137.00, 134.89, 134.63, 134.58, 134.34, 134.23, 131.56, 130.87, 
128.78, 128.54, 128.14, 126.33, 126.23, 126.03, 125.02, 124.13, 124.09, 123.97, 121.50, 121.42, 
121.34, 121.29, 120.57, 119.40, 118.31, 118.24, 118.21, 118.12, 90.16, 88.86, 75.28, 74.55, 31.32, 
31.27, 30.13, 29.67, 25.91, 25.39, 22.20, 13.76, 13.71. 19F NMR (376 MHz, CD3CN, 300K) δ -
118.92. ESI-TOF (m/z): Calcd. [C107H83BrCl2FN15RuO2-2Cl]2+ for 904.75, found 904.74. 
 
Ligand L3 Compound 19 (91.8 mg, 0.049 mmol) and compound 9 (80.7 mg, 0.064 mmol) 
were mixed in a 100 mL Schlenk flask, Pd(PPh3)4 (2.9 mg, 2.5 µmol) and CuI (0.38 mg, 2.0 µmol) 
were added. After degassing and backfill with nitrogen for three times, 15 mL of DMF, 10 mL of 
DME and 30 mL of Et3N were added under nitrogen atmosphere. Upon addition of TBAF (65 µL, 
0.065 mmol, 1.0 mol/L in THF), the mixture was stirred at 80 °C for 16h. After that the reaction 
was cooled down to room temperature and the solvent was evaporated under vacuum. The crude 
product was purified via column chromatography on aluminum oxide (CHCl3/MeOH = 100/1.8) 
to give compound L3 with Cl‾ as the counterion as a dark red solid. The solid was dissolved in a 
mixed solvent of 10 mL of chloroform and 80 mL of methanol, and 200 mg of NH4PF6 was added. 
The mixture was stirred at room temperature for 30 min, the red precipitate formed was collected 
via filtration, washed with methanol and dried in vacuum to give L3 with PF6‾ as the counterion 
(54.1 mg, 28.5% yield). 1H NMR (500 MHz, CD3CN, 300K) δ 9.08 (s, 2H, tpyB-H3’,5’), 9.02 (s, 
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2H, tpyE-H3’,5’), 9.01 (s, 4H, tpyC,D-H3’,5’), 8.93 (s, 4H, tpyA-H3’,5’), 8.80 (s, 2H, tpyH,G-H3’,5’), 
8.78 – 8.69 (m, 18H, tpyF-H3’,5’, tpyA,F,G,H-H3,3’’, tpyA,F,G,H-H6,6’’), 8.65 – 8.59  (m, 6H, 
tpyC,D,E-H3,3’’), 8.56 (d, J = 8.1 Hz, 2H, tpyB-H3,3’’), 8.38 – 8.30 (m, 2H, Hg,j), 8.27 (dd, J = 7.4, 
2.2 Hz, 1H, Hk), 8.23 – 8.21 (m, 1H, Hb), 8.10 – 7.88 (m, 23H, tpyA,B,C,D,E,F,G,H-H6,6’’, 
Ha,c,d,n,h,l,f), 7.78 (ddd, J = 8.6, 4.7, 2.2 Hz, 1H, Ho), 7.68 – 7.55 (m, 3H, He,i,m ), 7.54 – 7.39 (m, 
16H, tpyB,C,D,E-H6,6’’, tpyA,F,G,H-H5,5’’), 7.30 – 7.15 (m, 8H, tpyB,C,D,E-H5,5’’), 3.65 (t, J = 5.9 
Hz, 2H, alkyl chain 1- H-OCH2- ), 3.35 (t, J = 5.9 Hz, 2H, alkyl chain 2- H-OCH2-), 1.47 – 1.31 (m, 
2H, alkyl chain 1- H-CH2-), 1.23 – 1.12 (m, J = 7.3 Hz, 2H, alkyl chain 2- H-CH2-), 1.08 (q, J = 7.7 
Hz, 2H, alkyl chain 1- H-CH2-), 0.85 – 0.78 (m, 4H, alkyl chain 1,2- H-CH2- ), 0.75 – 0.61 (m, 6H, 
alkyl chain 1,2- H-CH2-), 0.43 (t, J = 6.7 Hz, 2H, alkyl chain 1- H-CH3), 0.37 (t, J = 7.2 Hz, 2H, alkyl 
chain 2- H-CH3). 13C NMR (101 MHz, CD3CN, 300K) δ 159.22, 158.68, 158.13, 158.03, 157.89, 
157.12, 156.46, 155.85, 155.85, 155.61, 155.41, 155.38, 155.20, 155.05, 155.04, 154.54, 153.43, 
152.62, 152.42, 151.67, 151.13, 150.81, 149.35, 148.58, 147.08, 144.38, 143.19, 142.80, 142.31, 
142.12, 140.54, 140.29, 138.25, 137.30, 135.32, 134.46, 134.07, 127.60, 124.40, 123.55, 121.21, 
121.11, 120.98, 120.46, 97.02, 94.96, 75.06, 74.47, 31.16, 30.93, 30.93, 29.80, 29.49, 29.49, 25.82, 
25.28, 25.27, 22.05, 21.90, 21.90, 13.04. 19F NMR (376 MHz, CD3CN, 300K) δ -115.18, -115.63, 
-115.92. ESI-TOF (m/z): Calcd. [C174H122P4F28N24Ru2O2-4PF6]4+ for 714.71, found 714.71; Calcd. 
[C174H122P4F28N24Ru2O2-3PF6]3+ for 1001.26, found 1001.26; Calcd. [C174H122P4F28N24Ru2O2-
2PF6]2+ for 1574.37, found 1574.37. 
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Ligand L4 Compound 19 (400 mg, 0.21 mmol) and compound 6 (149.3 mg, 0.42 mmol) 
were mixed in a 100 mL Schlenk flask, Pd(PPh3)4 (13 mg, 0.011 mmol) and CuI (5 mg, 0.011 
mmol) were added. After degassing and backfill with nitrogen for three times, 15 mL of DMF, 10 
mL of DME and 30 mL of Et3N were added under nitrogen atmosphere. The mixture was stirred 
at 80 °C for 16h. After that the reaction was cooled down to room temperature and the solvent was 
evaporated under vacuum. The crude product was purified via column chromatography on 
aluminum oxide (CHCl3/MeOH = 100/1) to give ligand L4 as a dark red solid (259 mg, 57.5 % 
yield). 1H NMR (500 MHz, CDCl3, 300K) δ 8.99 (s, 2H, tpyB-H3’,5’ ), 8.98 (s, 2H, tpyC-H3’,5’), 
8.87 (s, 2H, tpyD-H3’,5’), 8.80 – 8.74 (m, 2H, tpyB-H3,3’’), 8.77-8.73 (m, 4H, tpyD-H3,3’’ & tpyD-
H6,6’’), 8.72 (s, 4H, tpyE(F)-H3’,5’), 8.71 – 8.50 (m, 15H, , tpyE(F)-H6,6’’, tpyA-H3’,5’, tpyA, C, E(F)-
H3,3’’, tpyA-H6,6’’, Hg), 8.22 (d, J = 2.0 Hz, 1H, Hg), 8.04 – 7.79 (m, 17H, tpyA, B, C, D, E(F)-
H4,4’’, Hh, Ha, Hi, Hj), 7.76 – 7.69 (m, 2H, Hc, He), 7.58 (d, J = 5.5 Hz, 2H, tpyB-H6,6’’), 7.46 (m, 
4H, tpyB-H5,5’’ & tpyA-H5,5’’), 7.44 – 7.26 (m, 13H, tpyC-H6,6’’, tpyD-H5,5’’, tpyE(F)-H5,5’’, tpyC-
H5,5’’, Hf), 7.14 (dd, J = 10.1, 8.6 Hz, 1H, Hb), 3.55 (t, J = 5.9 Hz, 2H, Hq), 3.42 (t, J = 6.1 Hz, 2H, 
Hk), 1.24 (m, 4H, Hr & Hl), 0.95 (m, 2H, Hm & Hs), 0.80 – 0.59 (m, 8H, Ho, Hn, Hu & Ht), 0.52 – 
0.42 (t,  J = 7.2 Hz, 3H, Ht), 0.37 (t, J = 7.1 Hz, 1H, Hp). 13C NMR (126 MHz, CDCl3, 300K) δ 
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160.67, 158.64, 157.68, 157.30, 155.93, 155.75, 155.66, 155.52, 154.91, 154.80, 154.61, 152.60, 
151.52, 149.10, 147.37, 146.99, 145.11, 144.51, 142.58, 138.68, 138.41, 137.10, 137.03, 135.60, 
135.12, 134.85, 134.63, 134.44, 134.19, 133.28, 131.37, 128.63, 128.19, 126.87, 126.76, 125.86, 
124.87, 124.15, 123.98, 123.87, 123.73, 121.46, 121.35, 120.84, 120.58, 119.78, 119.44, 117.40, 
117.21, 116.90, 116.72, 90.22, 89.27, 88.89, 88.26, 75.29, 74.62, 31.31, 30.12, 29.68, 25.93, 25.42, 
22.19, 22.12, 13.78, 13.73. 19F NMR (376 MHz, CDCl3, 300K) δ -114.32, -114.41. ESI-TOF (m/z): 
Calcd. [C130H96F2N18RuCl2O2-2Cl]2+ for 1040.35, found 1040.35. 
 
Compound 20 To a flask containing compound 14 (300 mg, 0.23 mmol), RuCl2(DMSO)4 
(27.9 mg, 0.057 mmol) was added. With the addition of 150 mL chloroform and 150 mL methanol, 
the mixture was stirred under reflux for 24h when it gradually became a uniform red solution. 
Afterwards the solvent was removed under vacuum, and the residue was purified via column 
chromatography on aluminum oxide (CHCl3/MeOH = 100/1) to give compound 20 as a red solid 
(88.6 mg, 56% yield). 1H NMR (500 MHz, CDCl3) δ 9.13 (s, 4H, tpyC-H3’,5’), 8.83 (s, 4H, tpyB-
H3’,5’), 8.75 (s, 8H, tpyA-H3’,5’), 8.72 – 8.66 (m, 20H, tpyC, B-H3,3’’, , tpyA,B-H6,6’’), 8.63 (d, J = 
8.0 Hz, 8H, tpyA-H3,3’’). 8.19 (d, J = 2.0 Hz, 2H, Hb), 8.06 – 7.96 (m, 6H, Hc, tpyC-H4,4’’), 7.93 – 
7.83 (m, 16H, Ha, tpyA,B-H4,4’’), 7.42 (dd, J = 5.6, 1.4 Hz, 4H, tpyC-H6,6’’), 7.40 – 7.27 (m, 16H, 
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tpyC,B,A-H5,5’’), 3.62 (t, J = 6.0 Hz, 4H, alkyl chain 1-H-OCH2-), 3.37 (t, J = 6.0 Hz, 4H, alkyl chain 
2-H-OCH2-), 1.36 – 1.28 (m, 4H, , alkyl chain 1-H-CH2-), 1.19 – 1.11 (m, 4H, alkyl chain 2-H-CH2-), 
1.08 – 0.99 (m, 4H, alkyl chain 2-H-CH2-), 0.87 (t, J = 7.7 Hz, 4H, alkyl chain 1-H-CH2-), 0.78 (p, J 
= 7.1 Hz, 4H, alkyl chain 2-H-CH2-), 0.74 – 0.61 (m, J = 9.4, 7.5, 5.3 Hz, 12H, alkyl chain 1,2-H-
CH
2
-), 0.45 – 0.42 (m, 3H, alkyl chain 1-HCH3), 0.38 (t, J = 7.2 Hz, 3H, alkyl chain 2-HCH3). 13C 
NMR (126 MHz, CDCl3, 300K) δ 160.45, 157.91, 157.81, 157.64, 157.48, 156.09, 156.01, 155.84, 
155.56, 154.98, 154.88, 152.47, 151.73, 151.23, 148.30, 146.23, 145.52, 143.40, 138.91, 138.72, 
137.54, 137.31, 137.01, 136.55, 135.23, 134.80, 133.58, 131.21, 129.30, 128.53, 128.04, 127.43, 
125.70, 125.45, 125.03, 124.31, 123.54, 122.41, 121.23, 114.45, 93.45, 91.53, 89.02, 79.45, 72.55, 
31.30, 30.17, 30.02, 25.88, 25.41, 24.21, 23.94, 12.28. ESI-TOF (m/z): Calcd. 
[C172H140N24RuCl2O4-2Cl]2+ for 1353.53, found 1353.50. 
 
Compound 21-trans Compound 20 (400 mg, 0.144 mmol) and compound 7 (82 mg, 0.048 
mmol) were mixed in a 200 mL round bottom flask, 100 mL of methanol and 100 mL of 
chloroform was added. After the addition of N-ethylmorphline (500 uL), the mixture was stirred 
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under reflux for 24h. After that the reaction was cooled down to room temperature and the solvent 
was evaporated under vacuum. The crude product was purified via column chromatography on 
aluminum oxide (CHCl3/MeOH = 100/1.5) to give compound 20 as a dark red solid (83.7 mg, 52% 
yield). 1H NMR (400 MHz, CDCl3) δ 9.49 (s, 4H, tpyC-H3’,5’ & tpyD-H3’,5’), 9.16 (s, 2H, tpyG-
H3’,5’), 9.14 (s, 2H, tpyF-H3’,5’), 9.11 – 9.04 (m, 6H, tpyC-H3,3’’, tpyD-H3,3’’ & ), 8.93 – 8.88 (m, 
9H, tpyB-H3’,5’, tpyE-H3’,5’, tpyH-H3’,5’,tpyF-H3,3’’), 8.82 – 8.65 (m, 26H, tpyA-H3’,5’, 
tpyA,B,E,H,G-H3,3’’, tpyA,B,E,H-H6,6’’, ), 8.58 (dd, J = 7.0, 2.4 Hz, 1H, Hh), 8.31 (s, 1H, Hg), 7.80-
8.05 (m, 25H, tpyA,B,C,D,E,F,G,H-H4,4’’, Ha,b,c,d,e,f), 7.60 – 7.51 (m, 1H, Hi), 7.62 – 7.27 (m, 26H, 
tpyC,D,F,G-H6,6’’, tpyA,B,C,D,E,F,G,H-H5,5’’), 7.07 (t, J = 9.5 Hz, 1H, Hj ), 3.72 – 3.57 (m, 6H, 
alkyl chain 2,3,4 – H-OCH2-), 3.40 (t, J = 6.1 Hz, 2H, alkyl chain 1 – H-OCH2-), 1.40 – 1.29 (m, 6H, 
alkyl chain 2,3,4 – H-CH2-), 1.23 – 1.15 (m, 2H, alkyl chain 1 – H-CH2-), 1.14 – 1.10 (m, 6H, alkyl 
chain 2,3,4 – H-CH2-), 0.91 – 0.65 (m, 18H, alkyl chain 1,2,3,4 – H-CH2-), 0.51 – 0.40 (m, 9H, alkyl 
chain 2,3,4 – H-CH3)0.38 (t, J = 7.1 Hz, 3H, alkyl chain 1 – H-CH3). 13C NMR (126 MHz, CDCl3, 
300K) δ 160.45, 157.91, 157.81, 157.64, 157.48, 156.09, 156.01, 155.84, 155.56, 154.98, 154.88, 
152.47, 151.98, 151.73, 151.23, 149.23, 147.43, 147.28, 147.20, 145.73, 142.46, 138.83, 138.72, 
138.63, 137.23, 137.01, 136.88, 135.93, 134.81, 134.42, 134.25, 131.30, 128.71, 128.28, 128.02, 
125.98, 125.70, 125.53, 125.12, 124.28, 124.06, 123.87, 121.40, 121.09, 119.26, 118.23, 90.16, 
88.98, 75.32, 74.56, 31.32, 30.17, 29.69, 25.90, 25.41, 22.24, 22.12, 13.76. 19F NMR (376 MHz, 
CDCl3, 300K) δ -118.95. ESI-TOF (m/z): Calcd. [C193H153N27Ru2BrFCl4O4-2Cl]2+ for 1596.96, 
found 1596.92. Note that isomers do form during the reaction. flash column chromatography on 
aluminum oxide (DCM/MeOH = 100/2) gave a mixture of cis and trans isomers. 1H NMR 
indicated that the trans compound is the major product. By slowly adjusting the gradient from 
DCM/MeOH = 100/1 to DCM/MeOH = 100/1.5 we were able to isolate compound 21 as trans 
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compound. (Supplementary Figure 6, 104). Due to the small amount, we were unable to isolate 
21-cis.  
 
Ligand L5 Compound 21 (100 mg, 0.03 mmol) and compound 9 (82 mg, 0.064 mmol) 
were mixed in a 100 mL Schlenk flask, Pd(PPh3)4 (1.9 mg, 0.0016 mmol) and CuI (0.23 mg, 0.0012 
mmol) were added. After degassing and backfill with nitrogen for three times, 15 mL of DMF, 10 
mL of DME and 30 mL of Et3N were added under nitrogen atmosphere. With the addition of 
TBAF (70 uL, 0.07 mmol), the mixture was stirred at 80 °C for 16h. After that the reaction was 
cooled down to room temperature and the solvent was evaporated under vacuum. The crude 
product was purified via column chromatography on aluminum oxide (CHCl3/MeOH = 100/2) to 
give compound 17 as a dark red solid. The solid was dissolved in a mixed solvent of 10 mL of 
chloroform and 80 mL of methanol, and 200 mg of NH4PF6 was added. The mixture was stirred 
at room temperature for 30 min, the red precipitate formed was collected via filtration, washed 
with methanol and dried in vacuum to give L5 with PF6‾ as the counterion (103.2 mg, 67% yield). 
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1H NMR (600 MHz, CD3CN) δ 9.16 (s, 2H, tpyE-H3’,5’), 9.15 (s, 2H, tpyD-H3’,5’), 9.13 (s, 2H, 
tpyG-H3’,5’), 9.04 (s, 2H, tpyH-H3’,5’), 9.01 (s, 2H, tpyI-H3’,5’), 8.99 (s, 2H, tpyJ-H3’,5’), 8.98 (s, 4H, 
tpyC,L-H3’,5’), 8.94 (s, 2H, tpyF-H3’,5’), 8.82 (s, 4H, tpyA(B)-H3’,5’), 8.81– 8.79 (m, 10H, tpyC,L-
H6,6’’, , tpyC,L-H3,3’’, tpyK-H3’,5’), 8.79 – 8.70 (m, 12H, tpyK-H6,6’’, tpyJ-H6,6’’, tpyF-H6,6’’, tpyF-
H3,3’’, tpyA(B)-H3,3’’), 8.68 – 8.58 (m, 14H, tpyD,E,G,H,I,J,K-H3,3’’), 8.33 (ddd, J = 7.6, 5.8, 2.2 
Hz, 2H, Hk, Hn), 8.31 (dd, J = 5.0, 2.1 Hz, 2H, He, Hd), 8.25 (dd, J = 7.4, 2.2 Hz, 1H, Hq), 8.23 (d, 
J = 2.1 Hz, 1H, Hg), 8.15 (t, J = 2.3 Hz, 2H, Hc, Hh), 8.05 – 8.00 (m, 5H, tpyC,L-H4,4’’, Hf), 8.00 – 
7.91 (m, 25H, tpyA,B,D,E,F,G,H,I,J,K-H4,4’’, Ha,b,t,j,m), 7.89 (ddd, J = 8.6, 4.7, 2.1 Hz, 1H, Hp), 
7.75 (ddd, J = 8.6, 4.8, 2.2 Hz, 1H, Hs), 7.63 (ddd, J = 10.2, 8.7, 1.3 Hz, 2H, Hi, j), 7.57 (dd, J = 
10.5, 8.6 Hz, 1H, Ho), 7.54 – 7.43 (m, 22H, tpyA,B,C,F,K-H5,5’’, tpyD,E,G,H,I,J-H6,6’’), 7.41 (dd, 
J = 10.7, 8.6 Hz, 1H, Hr), 7.29 – 7.19 (m, 12H, tpyD,E,G,H,I,J-H5,5’’), 3.72 (q, J = 5.5 Hz, 4H, 
alkyl chain 2,3,– H-OCH2-), 3.68 (t, J = 5.8 Hz, 2H, alkyl chain 4 – H-OCH2-), 3.38 (t, J = 5.8 Hz, 2H, 
alkyl chain 1 – H-OCH2-), 1.55 – 1.32 (m, 8H, alkyl chain 1,2,3,4 – H-CH2-), 1.23 – 1.03 (m, 10H, 
alkyl chain 1,2,3,4 – H-CH2-), 0.93 – 0.80 (m, 10H, alkyl chain 1,2,3,4 – H-CH2-), 0.79 – 0.64 (m, 
14H, alkyl chain 1,2,3,4 – H-CH2-), 0.44 (t, J = 6.8 Hz, 3H, alkyl chain 1 – H-CH3), 0.42 – 0.36 (m, 
9H, alkyl chain 2,3,4 – H-CH3). 13C NMR (101 MHz, CD3CN, 300K) δ 159.34, 158.68, 158.55, 
158.13, 157.89, 155.99, 155.85, 155.61, 155.38, 155.05, 153.71, 153.43, 152.62, 152.42, 151.13, 
149.35, 147.21, 147.08, 145.75, 145.13, 144.38, 142.22, 142.12, 138.23, 137.30, 135.31, 134.88, 
134.46, 134.07, 133.25, 132.95, 127.60, 124.44, 124.39, 123.54, 121.21, 121.11, 120.98, 120.46, 
96.50, 75.07, 74.47, 31.16, 29.80, 25.82, 25.28, 22.05, 13.04. 19F NMR (376 MHz, CD3CN, 300K) 
δ -115.20, -115.55, -115.91. ESI-TOF (m/z): Calcd. [C260H192N36Ru3F40P6O4-3PF6]3+ for 1566.06, 
found 1566.06, Calcd. [C260H192N36Ru3F40P6O4-4PF6]4+ for 1138.31, found 1138.31, Calcd. 
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[C260H192N36Ru3F40P6O4-5PF6]5+ for 881.65, found 881.65, Calcd. [C260H192N36Ru3F40P6O4-
6PF6]6+ for 710.55, found 710.55.  
3.2.2. Synthesis of Supramolecules C1-C5. 
 
C1 To a flask containing L1 (80 mg, 0.095 mmol) and FeSO4•7H2O (26.5 mg, 0.095 mmol), 
30 mL of chloroform and 30 mL of methanol was added. The mixture was stirred at 80 °C for 36h, 
then solvent was evaporated under vacuum. The crude product was purified via column 
chromatography on silica gel with acetonitrile/saturated aqueous KNO3 (100/5, v/v) as the eluent 
to afford N1, which was dried and further washed with water to remove extra KNO3. Afterwards 
3 mL of acetonitrile was added to dissolve the precipitate, and the solution was added dropwise to 
saturated NH4PF6 solution in methanol to afford purple precipitate. The precipitate was isolated 
via centrifugation and further washed with methanol, dried in vacuum to give C1 with PF6- as the 
counterion for further characterizations (34.4 mg, 30.5% yield). 1H NMR (500 MHz, CD3CN) δ 
9.22 (s, 12H, 12H, tpy-H3’,5’), 8.53 (dd, J = 8.0, 1.2 Hz, 12H, 12H, tpy-H3,3’’), 8.26 (d, J = 2.0 Hz, 
6H, Ha), 7.98 – 7.82 (m, 18H, Hc &  tpy-H4,4’’), 7.45 (d, J = 8.6 Hz, 6H, Hb), 7.23 – 7.16 (m, 12H, 
tpy-H6,6’’), 7.09 (t, J = 6.0, 0.9 Hz, 12H, H5,5’’), 4.38 (t, J = 5.9 Hz, 12H, Hd), 1.96 – 2.05 (m, 12H, 
He)1.58 (p, J = 7.8 Hz, 12H, Hf), 1.25 (p, J = 7.5 Hz, 12H, Hg), 1.00 (h, J = 7.4 Hz, 12H, Hh), 0.52 
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(t, J = 7.3 Hz, 18H, Hi). 13C NMR (151 MHz, CD3CN, 300K) δ 159.66, 158.01, 156.76, 152.95, 
147.53, 138.80, 134.94, 133.77, 127.30, 126.41, 124.20, 123.62, 115.96, 113.47, 88.22, 69.10, 
31.34, 29.01, 25.91, 22.24, 13.14. DOSY-NMR (600 MHz, CD3CN, 300K): log D = -9.25. ESI-
TOF (m/z): 448.2 [M-6PF6‾]6+ (calcd. m/z 448.2), 566.8 [M-5PF6‾]5+ (calcd. m/z 566.8), 744.7 [M-
4PF6‾]4+ (calcd. m/z 744.7), 1041.3 [M-3PF6‾]3+ (calcd. m/z 1041.3). 
 
C2 L2 (5.2 mg, 1.1 µmol) was dissolved in a mixed solvent of 1.0 mL of chloroform and 
1.0 mL of methanol, and Zn(NO3)2•6H2O (0.65 mg, 2.2 µmol) was dissolved in 2.0 mL of 
methanol. The two solutions were mixed together and heated under 50 °C for 8h. After that the 
solution was poured into 15 mL of saturated solution of NH4PF6 in methanol and the precipitate 
formed was collected via centrifugation and washed with methanol, dried in vacuum to afford C2 
with PF6‾ as the counterion for further characterizations (6.5 mg, 95% yield). 1H NMR (500 MHz, 
CD3CN, 300K) δ 9.27 (s, 2H, tpyF-H3’,5’), 9.25 (s, 2H, tpyA-H3’,5’), 9.04 (s, 2H, tpyE-H3’,5’), 9.03 
(s, 2H, tpyC-H3’,5’), 9.01 (s, 2H, tpyD-H3’,5’), 8.97 (s, 2H, tpyB-H3’,5’), 8.85 (d, J = 8.2 Hz, 2H, 
tpyA-H3,3’’), 8.73 (dd, J = 8.2, 2.0 Hz, 4H, tpyF,B-H3,3’’), 8.68 – 8.60 (m, 6H, tpyC,D,E-H3,3’’), 
8.52 (d, J = 2.1 Hz, 1H, Hb), 8.41 (d, J = 2.0 Hz, 1H, Ha), 8.36 – 8.13 (m, 8H, Hn,h,i,c, tpyF,A-H4,4’’, 
Hm,g,k,d), 8.07 – 7.88 (m, 8H, tpyB,C,D,E-H4,4’’), 7.71 – 7.42 (m, 14H, He,f,j,l, tpyF,A-H5,5’’, 
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tpyB,C,D,E-H6,6’’ ), 7.31 – 7.15 (m, 12H, tpyB-H5,5’’, tpyA,F-H6,6’’, tpyC,D,E-H5,5’’), 3.83 (t, J = 
5.7 Hz, 2H, Ho), 1.47 (dt, J = 11.2, 5.8 Hz, 2H, Hp), 1.38 – 1.18 (m, 2H, Hq), 0.94 (dq, J = 15.5, 
7.5 Hz, 2H, Hr), 0.74 (h, J = 7.4 Hz, 2H, Hs), 0.36 (t, J = 7.3 Hz, 3H, Ht). 13C NMR (151 MHz, 
CD3CN, 300K) δ 161.09, 160.74, 159.05, 157.88, 155.37, 153.38, 152.58, 152.32, 149.67, 148.78, 
148.59, 147.90, 145.74, 142.23, 141.46, 138.18, 135.28, 134.40, 130.88, 127.60, 125.86, 124.61, 
124.20, 123.55, 123.53, 122.60, 120.18, 88.27, 75.60, 31.26, 30.14, 26.04, 22.12, 12.99. 19F NMR 
(376 MHz, CD3CN, 300K) δ -115.30. DOSY-NMR (600 MHz, CD3CN, 300K): log D = -9.40. 
ESI-TOF (m/z): 483.3 [M-10PF6‾]10+ (calcd. m/z 483.3), 553.3 [M-9PF6‾]9+ (calcd. m/z 553.3), 
640.3 [M-8PF6‾]8+ (calcd. m/z 640.3), 752.5 [M-7PF6‾]7+ (calcd. m/z 752.5), 902.2 [M-6PF6‾]6+ 
(calcd. m/z 902.2), 1111.5 [M-5PF6‾]5+ (calcd. m/z 1111.5), 1425.7 [M-4PF6‾]4+ (calcd. m/z 1425.7). 
 
 
&
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C3 L3 (3.5 mg, 1.0 µmol) was dissolved in 2.0 mL of acetonitrile while Zn(NO3)2•6H2O 
(0.6 mg, 2.0 µmol) was dissolved in 0.5 mL of methanol. The two solutions were mixed together 
and heated under 50 °C for 8h. After that the solution was poured into 15 mL of saturated solution 
of NH4PF6 in methanol and the precipitate formed was collected via centrifugation and washed 
with methanol, dried in vacuum to afford C3 with PF6‾ as the counterion (3.8 mg, 93% yield). Due 
to the existing of isomers and overlap between the two species, only the major (taller) peaks were 
signed in NMR spectrum.  1H NMR (600 MHz, CD3CN, 300K) δ 9.34 (s, 2H, tpyB-H3’,5’), 9.32 (s, 
2H, tpyC-H3’,5’), 9.30 (s, 2H, tpyA-H3’,5’), 9.29 (s, 2H, tpyD-H3’,5’), 9.09 – 8.98 (m, 8H, 
tpyH,E,F,G-H3’,5’), 8.87 (t, J = 6.7 Hz, 4H, tpyB,C-H3,3’’), 8.81 (d, J = 8.1 Hz, 2H, tpyA-H3,3’’), 
8.77 – 8.72 (m, 2H, tpyD-H3,3’’), 8.72 – 8.63 (m, 2H, tpyH-H3,3’’), 8.61 – 8.58 (m, 6H, tpyE,F,G-
H3,3’’), 8.55 (s, 1H, Ha), 8.52 (s, 1H, Hc), 8.50 (s, 2H, Hb,d), 8.38 – 8.18 (m, 12H, tpyA,B,C,H-H4,4’’, 
Hg,j,k,o), 8.05 – 7.87 (m, 20H, tpyD,E,F,G-H4,4’’, tpyA,B,C,H-H6,6’’, Hf,h,l,p), 7.68 – 7.59 (m, 4H, 
Hg,m,i,e), 7.57 – 7.38 (m, 12H, tpyD,E,F,G-H6,6’’, tpyA,B,C,H-H5,5’’), 7.23 (m, 8H, tpyD,E,F,G-
H5,5’’), 3.94 – 3.72 (m, 4H, alkyl-H-OCH2-), 1.53 – 1.45 (m, 4H, alkyl-H-CH2-), 1.34 – 1.25  (m, 4H, 
alkyl-H-CH2-), 1.00 – 0.92  (m, 4H, alkyl-H-CH2-), 0.34 (dt, J = 13.8, 7.2 Hz, 6H, alkyl-H-CH3). 13C 
NMR (151 MHz, CD3CN, 300K) δ 159.06, 157.89, 155.58, 155.37, 152.94, 152.57, 152.33, 149.62, 
147.99, 147.68, 145.10, 143.07, 141.54, 141.43, 139.62, 138.18, 135.27, 134.41, 130.08, 128.55, 
127.60, 124.62, 124.21, 123.52, 88.29, 75.72, 31.27, 30.24, 26.11, 22.09, 15.14, 12.96. 19F NMR 
(376 MHz, CD3CN, 300K) δ -114.95, -115.07, -115.27. DOSY-NMR (600 MHz, CD3CN, 300K): 
log D = -9.56. ESI-TOF (m/z): 891.6 [M-12PF6‾]12+ (calcd. m/z 891.6), 985.9 [M-11PF6‾]11+ (calcd. 
m/z 985.9), 1099.0 [M-10PF6‾]10+ (calcd. m/z 1099.0), 1237.2 [M-9PF6‾]9+ (calcd. m/z 1237.2), 
1409.9 [M-8PF6‾]8+ (calcd. m/z 1409.9), 1632.1 [M-7PF6‾]7+ (calcd. m/z 1632.1), 1928.2 [M-
6PF6‾]6+ (calcd. m/z 1928.2), 2342.9 [M-5PF6‾]5+ (calcd. m/z 2342.9). 
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C3’ L3’ (3.0 mg, 0.95 µmol) was dissolved in a mixed solvent of 1.0 mL of chloroform 
and 1.0 mL of methanol, while Zn(NO3)2•6H2O (0.28 mg, 0.95 µmol) was dissolved in 2.0 mL of 
methanol. The two solutions were mixed together and heated under 50 °C for 8h. After that the 
solution was poured into 15 mL of saturated solution of NH4PF6 in methanol and the precipitate 
formed was collected via centrifugation and washed with methanol, dried in vacuum to afford C3’ 
with PF6‾ as the counterion (3.7 mg, 94% yield). 1H NMR (500 MHz, CD3CN, 300K) δ 9.37 (s, 
2H, tpyA-H3’,5’), 9.33 (s, 2H, tpyB-H3’,5’), 9.05 (s, 2H, tpyC-H3’,5’), 9.03 (s, 2H, tpyD-H3’,5’), 8.90 
(d, J = 8.1 Hz, 2H, tpyA-H3,3’’), 8.77 (d, J = 8.1 Hz, 2H, tpyB-H3,3’’), 8.70 – 8.62  (m, 4H, tpyC,D-
H3,3’’), 8.58 (s, 1H, Hb), 8.53 (s, 1H, Ha), 8.48 – 8.20 (m, 4H,  Hc,f, tpyA-H4,4’’), 8.20 – 7.80  (m, 
8H, He,h, tpyB,C,D-H4,4’’), 7.70 – 7.60 (m, 2H, Hd,g), 7.59 – 7.40 (m, 8H, tpyA-H5,5’’tpyB,C,D-
H6,6’’), 7.35 – 7.17 (m, 8H, tpyA-H6,6’’, tpyB,C,D-H5,5’’), 3.91 (s, 2H, alkyl-H-OCH2-), 1.65 – 1.16 
(m, 4H, alkyl-H-CH2-), 1.08 – 0.93 (m, 2H, alkyl- H-CH2-), 0.78 – 0.75  (m, 2H, alkyl-H-CH2-), 0.34 
(t, J = 7.2 Hz, 3H, alkyl-H-CH3). 13C NMR (151 MHz, CD3CN) δ 160.75, 159.06, 158.02, 157.89, 
155.37, 155.21, 153.34, 152.58, 149.60, 147.89, 144.67, 144.35, 142.23, 141.56, 138.23, 135.30, 
134.41, 133.55, 133.10, 129.89, 127.92, 127.62, 125.96, 124.62, 124.20, 123.52, 120.21, 88.27, 
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75.73, 31.29, 30.25, 26.14, 22.11, 12.96. 19F NMR (376 MHz, CD3CN, 300K) δ -115.30. DOSY-
NMR (600 MHz, CD3CN, 300K): log D = -9.57. ESI-TOF (m/z): 639.6 [M-16PF6‾]16+ (calcd. m/z 
639.6), 691.9 [M-15PF6‾]15+ (calcd. m/z 691.9), 751.6 [M-14PF6‾]14+ (calcd. m/z 751.6), 820.6 [M-
13PF6‾]13+ (calcd. m/z 820.6), 901.1 [M-12PF6‾]12+ (calcd. m/z 901.1), 996.2 [M-11PF6‾]11+ (calcd. 
m/z 996.2), 1426.2 [M-10PF6‾]10+ (calcd. m/z 1110.3), 1249.8 [M-9PF6‾]9+ (calcd. m/z 1249.8), 
1424.1 [M-8PF6‾]8+ (calcd. m/z 1424.1), 1648.2 [M-7PF6‾]7+ (calcd. m/z 1648.2). 
 
C4 L4 (4.0 mg, 1.82 µmol) was dissolved in a mixed solvent of 1.0 mL of chloroform and 
1.0 mL of methanol, while Zn(NO3)2•6H2O (1.1 mg, 3.63 µmol) was dissolved in 2.0 mL of 
methanol. The two solutions were mixed together and heated under 50 °C for 8h. After that the 
solution was poured into 15 mL of saturated solution of NH4PF6 in methanol and the precipitate 
formed was collected via centrifugation and washed with methanol, dried in vacuum to afford C4 
with PF6‾ as the counterion. (5.2 mg, 93% yield). 1H NMR (600 MHz, CD3CN, 300K) δ 9.35 (s, 
4H, tpyE,F-H3’,5’), 9.33 (s, 2H, tpyD-H3’,5’), 9.32 (s, 2H, tpyA-H3’,5’), 9.06 (s, 2H, tpyC-H3’,5’), 9.04 
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(s, 2H, tpyB-H3’,5’), 8.92 – 8.83  (m, 6H, tpyE,F,D-H3,3’’), 8.77 (d, J = 8.2 Hz, 2H, tpyA-H3,3’’), 
8.73 (d, J = 8.1 Hz, 2H, tpyB-H3,3’’), 8.67 (d, J = 8.2 Hz, 2H, tpyC-H3,3’’), 8.58 (d, J = 1.9 Hz, 1H, 
Hh), 8.53 (s, 2H, Hi,j), 8.50 (d, J = 1.8 Hz, 1H, Ha), 8.36 – 8.32 (m, 1H, Hg), 8.31 – 8.16 (m, 9H, 
Hd, tpyD,E,F,B-H4,4’’), 8.07 – 7.90 (m, 14H, tpyA,C-H4,4’’, tpyD,E,F,B-H6,6’’, Hc,e), 7.65 (ddd, J = 
10.0, 8.0, 5.4 Hz, 2H, Hf,b), 7.57 – 7.51 (m, 4H, tpyA,C-H6,6’’), 7.50 – 7.42 (m, 8H, tpyB,D,E,F-
H5,5’’), 7.34 – 7.22 (m, 4H, tpyA,C-H5,5’’), 3.88 (s, 2H, alkyl-H-OCH2-), 3.77 (s, 2H, alkyl-H-OCH2-), 
1.55 – 1.38 (m, 4H, alkyl-H-CH2-), 1.36 – 1.19 (m, 4H, alkyl-H-CH2-), 1.06 – 0.56 (m, 8H, alkyl-H-
CH
2
-), 0.34 (t, J = 7.3 Hz, 3H, alkyl-H-CH3), 0.27 (t, J = 7.3 Hz, 3H, alkyl-H-CH3). 13C NMR (126 
MHz, CD3CN, 300K) δ 158.95, 158.82, 158.07, 155.75, 155.66, 155.43, 155.26, 153.13, 152.88, 
152.76, 152.39, 150.80, 149.80, 149.62, 148.35, 148.08, 147.87, 147.80, 147.72, 144.41, 142.32, 
141.51, 140.67, 138.30, 136.84, 136.09, 135.50, 134.19, 133.62, 133.19, 133.11, 129.42, 127.72, 
127.23, 125.91, 125.49, 125.38, 124.78, 124.51, 124.32, 123.71, 123.35, 120.65, 120.41, 91.62, 
89.44, 89.16, 88.47, 88.17, 75.80, 31.30, 31.25, 30.24, 26.12, 22.49, 22.14, 22.00, 12.98, 12.90. 
19F NMR (376 MHz, CD3CN, 300K) δ -115.19. DOSY-NMR (600 MHz, CD3CN, 300K): log D 
= -9.63. ESI-TOF (m/z): 694.6 [M-22PF6‾]22+ (calcd. m/z 694.6), 734.6 [M-21PF6‾]21+ (calcd. m/z 
734.6), 778.5 [M-20PF6‾]20+ (calcd. m/z 778.5), 827.1 [M-19PF6‾]19+ (calcd. m/z 827.1), 881.1 [M-
18PF6‾]18+ (calcd. m/z 881.1), 941.5 [M-17PF6‾]17+ (calcd. m/z 941.5), 1009.4 [M-16PF6‾]16+ (calcd. 
m/z 1009.4), 1086.4 [M-15PF6‾]15+ (calcd. m/z 1086.4), 1174.3 [M-14PF6‾]14+ (calcd. m/z 1174.3), 
1275.8 [M-13PF6‾]13+ (calcd. m/z 1275.8), 1394.2 [M-12PF6‾]12+ (calcd. m/z 1394.2), 1534.1 [M-
11PF6‾]11+ (calcd. m/z 1534.1), 1702.0 [M-10PF6‾]10+ (calcd. m/z 1702.0), 1907.3 [M-9PF6‾]9+ 
(calcd. m/z 1907.3), 2163.8 [M-8PF6‾]8+ (calcd. m/z 2163.8). 
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C5 L5 (3.5 mg, 0.68 µmol) was dissolved in 2.0 mL of acetonitrile, while Cd(NO3)2•4H2O 
(0.63 mg, 2.05 µmol) was dissolved in 0.3 mL of methanol. The two solutions were mixed together 
and heated under 50 °C for 8h. After that the solution was poured into 15 mL of saturated solution 
of NH4PF6 in methanol and the precipitate formed was collected via centrifugation and washed 
with methanol, dried in vacuum to afford C5 with PF6‾ as the counterion (4.1 mg, 95% yield). 1H 
NMR (600 MHz, CD3CN, 300K) δ 9.24 – 9.39 (m, 16H, tpyC,D,L,A,B,K,F,E,G-H3’,5’), 9.10 (s, 
2H, tpyH-H3’,5’), 9.05 (s, 2H, tpyI-H3’,5’), 9.02 (s, 2H, tpyJ-H3’,5’), 8.97 (m, 2H, tpyK-H3,3’’), 8.91 
(m, 4H, tpyA,B-H3,3’’), 8.85 (m, 4H, tpyD,E-H3,3’’), 8.80 (m, 4H, tpyC,L-H3,3’’), 8.73 (m, 4H, 
tpyF,G-H3,3’’), 8.65 – 8.60 (m, 6H, tpyH,I,J-H3,3’’), 8.58 (s, 2H, Ha & Hb), 8.49 (s, 1H, Hc), 8.46 (s, 
1H, Hf), 8.40– 8.30 (m, 7H, Hk,n,q, tpyA,B-H4,4’’), 8.30 – 8.25 (m, 8H, tpyE,D-H4,4’’, Hd,e,h,s), 8.25 
– 8.13 (m, 4H, tpyK,F-H4,4’’), 8.10 – 8.05 (m, 6H, Ht,g, tpyC,L-H4,4’’), 8.05 – 7.85 (m, 15H, 
tpyD,E,G,H,I,J-H4,4’’, Hj,m,p), 7.70 – 7.57 (m, 15H, Ho,r,i,l, tpyK,F-H6,6’’, tpyA,B-H5,5’’, tpyC,L-
H6,6’’), 7.57 – 7.45 (m, 8H, tpyD,E,G,H,-H6,6’’), 7.45 – 7.40 (m, 4H, tpyI,J-H6,6’’), 7.40 – 7.37 (m, 
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4H, tpyA,B-H6,6’’), 7.37 – 7.18 (m, 12H, tpyD,E,G,H,I,J-H5,5’’) 3.85 – 3.73 (m, 8H, alkyl- H-OCH2-), 
1.70 – 1.24 (m, 16H, alkyl- H-CH2-), 1.12 – 0.80 (m, 8H, alkyl- H-CH2-), 0.80 – 0.60 (m, 8H, alkyl- 
H-CH2-), 0.41– 0.25 (m, 12H, alkyl- H-CH3). 13C NMR (151 MHz, CD3CN) δ 160.65, 159.07, 157.89, 
155.37, 152.58, 148.71, 147.02, 145.30, 142.22, 141.53, 138.18, 137.43, 134.40, 133.19, 127.60, 
125.95, 124.62, 123.53, 120.19, 88.09, 75.62, 31.30, 30.22, 26.12, 22.12, 13.02. 19F NMR (376 
MHz, CD3CN, 300K) δ -115.31. DOSY-NMR (600 MHz, CD3CN, 300K): log D = -9.81. ESI-
TOF (m/z):1008.6 [M-33PF6‾]33+ (calcd. m/z 1008.6), 1044.6 [M-32PF6‾]32+ (calcd. m/z 1044.6), 
1083.0 [M-31PF6‾]31+ (calcd. m/z 1083.0), 1124.0 [M-30PF6‾]30+ (calcd. m/z 1124.0), 1167.7 [M-
29PF6‾]29+ (calcd. m/z 1167.7), 1214.6 [M-28PF6‾]28+ (calcd. m/z 1214.6), 1264.9 [M-27PF6‾]27+ 
(calcd. m/z 1264.9), 1319.2 [M-26PF6‾]26+ (calcd. m/z 1319.2), 1377.7 [M-25PF6‾]25+ (calcd. m/z 
1377.7), 1441.2 [M-24PF6‾]24+ (calcd. m/z 1441.2), 1510.1 [M-23PF6‾]23+ (calcd. m/z 1510.1), 
1585.4 [M-22PF6‾]22+ (calcd. m/z 1585.4), 1667.8 [M-21PF6‾]21+ (calcd. m/z 1667.8), 1758.4 [M-
20PF6‾]20+ (calcd. m/z 1758.4), 1858.6 [M-19PF6‾]19+ (calcd. m/z 1858.6), 1969.9 [M-18PF6‾]18+ 
(calcd. m/z 1969.9), 2094.3 [M-17PF6‾]17+ (calcd. m/z 2094.3), 2234.3 [M-16PF6‾]16+ (calcd. m/z 
2234.3), 2392.9 [M-15PF6‾]15+ (calcd. m/z 2392.9), 2574.1 [M-14PF6‾]14+ (calcd. m/z 2574.1).  
3.3. Results and Discussion 
As can be seen from Figures 3.2-3.7, a series of linear metal-organic building blocks were 
first designed through the connections of two basic residues A and B with Ru(II). In this system, 
‘A’ provided an expansion of the structure, while ‘B’ served as end-cap which led to the formation 
of discrete architectures. For example, the terminator ‘B’ could be solely used as a ligand to 
construct the smallest structure C1; while L4, which has the sequence ‘AB’ would self-assemble 
to C4 with weak coordination metal ions. Meanwhile, elongation of the ‘AB’ sequence to either 
side gave different ligands, and thus changed the shape and complexity of the final supramolecules.  
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Figure 3.8. Three approaches to terpyridine-Ru(II) metal-organic ligands. End-capping approach 
based on the coordination with Ru(III) complex followed by reduction (1)17; Suzuki coupling 
reaction on terpyridine Ru(II) complex (2); Sonogashira coupling reaction on terpyridine Ru(II) 
complex (This work) (3). Cardinal ball = Ru.  
The sequence ‘ABB’ would assemble C3 with C3 symmetry, but the ‘BBABB’ sequence, which 
was created via elongation with B on both sides, would only construct a smaller structure C2 with 
C2 symmetry. On the contrary, by introducing ‘A’ on the left and ‘B’ on the right to form the 
‘AABB’ sequence, the ligand for a high generation of supramolecule C5 could be created. 
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However, it should be noted that the actual synthesis of ligands was not approached by linking ‘A’ 
and ‘B’ with Ru(II) directly. In chapter 1, we have summarized the two types of approaches for 
the preparation of terpyridine-Ru(II) metal-organic ligands (Figures 3.8-1 & 3.8-2), including 1) 
end-capping approach based on the coordination with Ru(III) complex followed by reduction; 2) 
Suzuki coupling reaction on terpyridine-Ru(II) complex. End-capping approach was first 
developed to prepare symmetric metal-organic ligand. With the introduction of Suzuki coupling 
reaction, short linear metal-organic ligand could be obtained for single point or multiple points 
with the same -B(OH)2 reactant. Without appropriate protection and deprotection groups, however, 
it is very challenging to use Suzuki coupling reaction for longer asymmetric metal-organic ligand 
synthesis. Subsequently, Sonogashira coupling reaction on the terpyridine-Ru(II) complexes, 
which include -TMS protection and deprotection was used to define the linear sequence of metal-
organic building blocks with rigid linkages (Figure 3.8-3). This synthetic approach is reminiscent 
of the protection and deprotection in peptide synthesis. 
 
Figure 3.9. ESI-MS for self-assembly of L1 with Zn(II)  
Our study was initiated from the construction of C1. Alkyl chains were used as substituent 
groups to improve solubility. Not surprisingly, treatment of pure organic ligand L1 with Zn(II) in 
1:1 ratio led to the formation of multiple species (Figure 3.9), due to the flexibility of single-
layered ligands18.  
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Figure 3.10. ESI-MS (a) and TWIM-MS (b) for C1 
 
Figure 3.11.  (a) 1H NMR (500 MHz, CDCl3, 300K) for L1 (aromatic region). (b) 1H NMR (500 
MHz, CD3CN, 300K) for C1 (aromatic region). 
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Figure 3.12. Electrospray ionization mass spectrometry (ESI-MS) (a) and travelling wave ion-
mobility mass spectrometry (TWIM-MS) (b) for C4  
Following the same route of previous study19, Fe(II) was used instead, which has a stronger 
binding with terpyridine17c. After column chromatography, C1 was obtained in 39% yield, and the 
structure was further characterized by electrospray ionization mass spectrometry (ESI-MS) and 
traveling wave ion-mobility mass spectrometry (TWIM-MS)18 (Figure 3.10). Also, proton NMR 
with clearly splitting showed that terpyridine have coordinated with Fe(II) forming a symmetric 
architecture (Figure 3.11). 
Next, L4 with sequence ‘AB’ was synthesized to construct C4.  As has been depicted 
before, a stepwise strategy of coordinating Ru(III) complex with ‘A’ first, followed by Sonogashira 
coupling with alkyne-terpyridine was applied to give L4. Then C4 was assembled by mixing L4 
and Zn(II) in 1:2 ratio in CHCl3/MeOH for 8h. For the supramolecule C4, ESI-MS and TWIM-
MS were both used for characterization. A series of peaks with continuous charge states ranging 
from 8+ to 21+ were recorded on ESI-MS (Figure 3.12a). Each charge stateshowed well resolved 
isotope patterns, which were consistent with theoretical isotope distribution (Appendix B). After 
deconvolution, the molecular weight was 18470.47 Da, in well agreement with chemical 
composition of C780H576F120P18N108O12Ru6Zn12. TWIM-MS showed one set of peaks from 12+ to 
21+ with narrow drift time distribution, excluding the formation of other isomeric structures 
(Figure 3.12b). Also, NMR was also applied for the characterization. All 3’,5’ protons 
(a) (b)
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Figure 3.13. (a) 1H NMR (600 MHz, CDCl3, 300K) for L4 (aromatic region). (b) 1H NMR (600 
MHz, CD3CN, 300K) for C4 (aromatic region). 
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Figure 3.14. 19F NMR spectrum (376 MHz, CD3CN, 300K) for supramolecule C4. 
showed down field shift on 1H NMR, while the 6,6’’ protons shifted upfield (Figure 3.13). The 
aliphatic region displayed two sets of peaks from 0.2 ppm – 4.0 ppm, corresponding to the alkyl 
chain on the inner and outer of the ring (Figure 3.13). 19F NMR showed two sets of peaks at -
114.64 ppm, -114.81 ppm, respectively, showing a highly symmetric assembly (Figure 3.14).  
 
Figure 3.15. Electrospray ionization mass spectrometry (ESI-MS) (a) and travelling wave ion-
mobility mass spectrometry (TWIM-MS) (b) for C3  
The journey proceeded to C3 with the construction of ‘ABB’ sequence. Being similar to 
L4, L3 was also synthesized by direct coupling reaction between two Ru complexes (Figure 3.6). 
Note that the inner part of L3 was similar to that of L1 in terms of size and angle. However, after 
mixing L3 and Zn(II) in 1:2 ratio at 50 °C for 8h, a single species with only one set of peaks from 
(a) (b)
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5+ to 12+ was observed on ESI-MS, and the molecular weight after deconvolution was consistent 
with [L33Zn6(PF6)12]. TWIM-MS also showed only one series of peaks (Figure 3.15), suggesting 
the success formation of the desired product with rigid structure. In contrast to the mixture obtained 
in C1, the success of C3 implied that the longer sequence increased specificity and rigidity of the 
ligand backbone, which led to the successful self-assembly. Interestingly, 1H NMR showed two 
sets of peaks for -OCH2- groups (Figure 3.16a), giving strong evidence for the formation of 
isomers, C3-1 and C3-2. Meanwhile, 19F NMR spectra also showed complicated results (Figure 
3.16b). This is because the ligand can flip over with different orientation and form the self-
assembly with the same shape, but different arrangements of Ru(II) and Zn(II) on the outer layer.  
 
Figure 3.16.  (a). 1H NMR for mixture of isomers C3-1 and C3-2. (b). 19F NMR for mixture of 
isomers C3-1 and C3-2. 
(a)
(b)
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Figure 3.17. Electrospray ionization mass spectrometry (ESI-MS) (a) and travelling wave ion-
mobility mass spectrometry (TWIM-MS) (b) for C3’. 
 
Figure 3.18.  (a) 1H NMR (600 MHz, CDCl3, 300K) for L4 (aromatic region). (b) 1H NMR (600 
MHz, CD3CN, 300K) for C3’ (aromatic region). 
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Figure 3.19. 1H NMR (400 MHz, CDCl3, 300K) for mixture of isomers (upper) and compound 15 
as trans product after fine column separation (lower). 
 
Figure 3.20. Electrospray ionization mass spectrometry (ESI-MS) (a) and travelling wave ion-
mobility mass spectrometry (TWIM-MS) (b) for C2. 
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In order to get a single structure, another ligand L3’ with three Ru(II) on the outer layer 
was synthesized. By introducing an extra Ru(II) ion into the system, which connected the start and 
end terminals of ‘ABB’ sequence, a symmetrical ligand L3’ was obtained with higher rigidity, 
which ensured the exact geometry of the final self-assembly. Both ESI-MS and TWIM-MS 
showed the molecular information of desired structures (Figure 3.17), and 1H NMR also further 
supported the formation of a single product C3’ (Figure 3.18). 
Following the same design principle, introducing ‘B’ on both sides would lead to a closed 
structure. Elongation of the sequence from ‘ABB’ to ‘BBABB’ gave a linear ligand L2. Similar to 
L3, the synthesis was initiated with coordination between ‘A’ and two equivalents of ‘B’, followed 
by Sonogashira coupling with two equivalents of Ru complex. During the first step of coordination, 
both cis and trans isomers were formed (Figure 3.4). The trans one as the major product was 
eventually isolated via column chromatography on aluminum oxide, while the cis product was 
unable to be isolated due to the negligible fraction (Figure 3.19). The successful isolation of 
configurational isomers enabled the synthesis of L2 as ‘BBABB’ sequence without isomerization. 
Afterwards, mixing Zn(II) and L2 in 1:2 ratio in CHCl3/MeOH at 50 °C for 8h, a set of peaks with 
clear isotope patterns was observed on ESI-MS, and was consistent with theoretical calculations. 
TWIM-MS clearly showed a set of peaks with continuous charges from 5+ to 10+, indicating the 
uniqueness of the assembly (Figure 3.20). According to 1H NMR, the 6, 6’’ proton on the metal-
free terpyridines in ligand showed diagnostic upfield shifts after the coordination with Zn(II) due 
to the electron shielding effect. Only one set of peaks was observed at 3.70 ppm for C2, indicating 
the single conformation of self-assembly (Figure 3.21). 19F spectrum for the supramolecule 
showed three sets of peaks with 1:1:2 ratio (Figure 3.22), suggesting the symmetry of the structure 
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after coordination. If we were able to isolate precursor 15-cis for further coupling reaction to obtain 
cis L2, the self-assembly of cis L2 with Zn(II) would give similar C2-like structure (Figure 3.23). 
 
 
Figure 3.21.  (a) 1H NMR (400 MHz, CDCl3, 300K) for L2 (aromatic region). (b) 1H NMR (600 
MHz, CD3CN, 300K) for C2 (aromatic region). 
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Figure 3.22. 19F NMR spectrum (376 MHz, CD3CN, 300K) for supramolecule C2. 
 
 
Figure 3.23. Self-assembly of cis L2 for C2-like supramolecule 
Based on the success of previous generations, C5 with giant size and high complexity was 
finally achieved. L5 has a sequence of ‘AABB’, which was synthesized via two steps of 
coordination and one step of Sonogashira coupling (Figure 3.7). Similar to L2, isomeric 
compounds during the second step coordination was finally successfully isolated via column 
chromatography (Figure 3.24).  
Zn (II)
 152 
 
 
Figure 3.24. 1H NMR (400 MHz, CDCl3, 300K) for mixture of isomers (upper) and compound 
21 as trans product after fine column separation (lower). 
Note that we attempted to synthesize L5’ using a direct ‘end-capping’ strategy similar to 
L3’. However, undesired products were generated along with L5’ due to the flexibility and 
multiple coordination sites. We were unable to isolate L5’ for further self-assembly (Figure 3.25). 
19F NMR of the ligand showed three sets of peaks with integration ratio of 2:1:1 (Figure 
3.26), which indicated the formation of a pure ligand L5 without isomerization. In the structure of 
C5, ‘A’ located in the center and formed a structure similar to C4, while ‘B’ was left on the outside 
for end-capping. Using L5 with linear structure to assemble, 
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Figure 3.25. Synthesis of L5’ using end-cap strategy and possible products. 
 
Figure 3.26. 19F NMR NMR spectrum (376 MHz, CD3CN, 300K) for ligand L5. 
the self-assembly can be controlled by intramolecular and intermolecular complexation processes: 
The intramolecular complexation resulted in C1-like cycle, followed by intermolecular 
complexation to further form C5. This process is reminiscent of the folding and self-assembly of 
proteins. Considering the large molecular weight and increasing number of coordination sites, we 
Desired
Undesired
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chose Cd(II) as the self-assembly metal ion, which has higher reversibility and self-correction 
ability than Zn(II) for assembling of large and complex architectures20.  
 
Figure 3.27. Electrospray ionization mass spectrometry (ESI-MS) (a) and travelling wave ion-
mobility mass spectrometry (TWIM-MS) (b) for C5. 
After mixing L5 and Cd(II) in 1:3 ratio at 50 °C for 8h, mass spectrometry was first applied to 
characterize the assembly. ESI-MS displayed a series of peaks with continuous charges from 14+ 
to 32+, corresponding to molecular weight 38,066 Da, which is among one of the largest 2D 
metallo-supramolecules ever reported17b, 21. These signals were consistent with theoretical values 
of the mass to charge ratio of each charge state (Figure 3.27a). Only one set of peaks on TWIM-
MS excluded the formation of other isomers or conformers (Figure 3.27b). Isotope patterns of each 
charge state, however, was not obtained after numerous attempts, possibly due to the high weight 
beyond resolution of our ESI-TOF mass spectrometer. 1H NMR showed broad peaks, owning to 
the giant structure as well as similar chemical environments for some terpyridines after 
coordination. Despite that, we were still able to observe a well-resolved down-field shift of the 
free terpyridinyl-3’, 5’ and upfield shift of the free terpyridinyl-6,6’’ protons in the coordination 
with Cd(II) (Figure 3.28).  
 
(a) (b)
 155 
 
  
Figure 3.28. 1H NMR spectra (aromatic region). (a) L5 (600 MHz, CD3CN, 300K); (b) C5 (600 
MHz, CD3CN, 300K). 
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Figure 3.29. DOSY NMR spectra of supramolecules C1-C5. 
DOSY-NMR was applied to provide size information of the five structures. As shown in 
Figure 3-29, C1-C5 exhibit a single narrow diffusion band, respectively, indicating the discrete 
species were assembled. Diffusion coefficient decreased gradually from C1 to C5, suggesting the 
increase in size. Moreover, the experimental collision-cross section deduced from TWIM-MS16 
for the supramolecules C2-C5were consistent with theoretical value calculated via MOBCAL13 
(Table 3.1).  
TEM and AFM characterization also provided more evidence of the complexes regarding 
the size. Uniform dots were observed on TEM images for C3-C5 with the measured size in 
accordance with theoretical modeling (Figure 3.30).  
The AFM image also showed uniform dots for C4 and C5 with height around 0.75 nm, 
which is in good in agreement with the actual height of all the supramolecules (Figure 3.31). The 
diameter for the single dots on AFM was inaccurate due to investable tip broadening effect22.  
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Table 3.1. Experimental collision cross section and theoretical collision cross section of 
supramolecules C2-C5. 
 Drift Time 
(ms) 
CCS 
[Å2] 
CCS average 
[Å2] 
CCS (calcd. avg) 
[Å2] 
C2 
5.15 (5+) 887.5  
 
901.7 (9.8) 
 
 
920.1 ± 16.5 
3.96 (6+) 897.1 
3.15 (7+) 907.6 
2.62 (8+) 912.5 
2.22 (9+) 904.0 
 
C3 
6.89 (8+) 1723.4  
 
1753.4 (28.7) 
 
 
1759.4 ± 40.3 
5.68 (9+) 1736.9 
4.81 (10+) 1741.7 
4.19 (11+) 1739.3 
3.68 (12+) 1787.3 
3.32 (13+) 1791.6 
 
C3’ 
5.73 (9+) 1721.7  
 
1726.9 (17.6) 
 
 
1763.5 ± 35.1 
4.82 (10+) 1717.7 
4.13 (11+) 1724.8 
3.58 (12+) 1720.7 
3.13 (13+) 1714.6 
2.87 (14+) 1762.2 
 
C4 
7.28 (11+) 2454.9  
 
 
 
 
2442.2 (30.0) 
 
 
 
 
 
2470.6 ± 33.0 
6.28 (12+) 2461.1 
5.40 (13+) 2441.9 
4.74 (14+) 2436.3 
4.19 (15+) 2426.7 
3.75 (16+) 2422.8 
3.31 (17+) 2387.5 
3.09 (18+) 2424.9 
2.87 (19+) 2446.9 
2.65 (20+) 2452.2 
2.54 (21+) 2508.6 
 
C5 
6.84 (23+) 4896.2  
 
 
 
 
 
4821.1 (41) 
 
 
 
 
 
 
  4880.2 ± 169.2 
6.28 (24+) 4851.2 
5.84 (25+) 4831.1 
5.51 (26+) 4846.3 
5.07 (27+) 4777.9 
4.85 (28+) 4819.6 
4.52 (29+) 4775.3 
4.30 (30+) 4787.1 
4.08 (31+) 4785.0 
3.86 (32+) 4768.3 
3.75 (33+) 4828.2 
3.68 (34+) 4881.3 
3.62 (35+) 4827.4 
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Figure 3.30. TEM image for C3, C4 and C5. a C3 (scale bar, 100 nm); b C3 (scale bar, 20 nm); 
c C4 (scale bar, 100 nm); d C4 (scale bar, 20 nm); e C5 (scale bar, 100 nm); f C5 (scale bar, 20 
nm). 
 
Figure 3.31. AFM image for C4 and C5. 2D AFM image of a C4 (scale bar, 500 nm); b C5 (scale 
bar, 250 nm). 3D AFM images of c C4 and d C5. 
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Figure 3.32. TEM image and zoom-in images for nanotubes of C4 and C5. a C4 (scale bar, 100 
nm); b C4 (scale bar, 40 nm); c C5 (scale bar, 40 nm); d C5 (scale bar, 40 nm). 
On the other hand, considering previous studies that the pre-assembled supramolecules 
may undergo hierarchical self-assembly based on either intermolecular or molecular-substrate 
interactions to form ordered nanostructures,23 we investigated the hierarchical self-assembly 
behavior of the supramolecules in hand. Since the rigid backbones contain multiple aromatic rings 
which possibly have π- π interactions with each other, the supramolecules are prone to stack with 
each other to form hierarchical self-assembled nano-tubes.24  We chose C4 and C5 as the 
representatives to verify our speculation. After a slow vapor diffusion of diethyl ether into the 
solution of C4 and C5 in DMF, regular stacked nanotubes were obtained and clearly observed 
under TEM (Figure 3.32). The diameters of the tubes measured were comparable with single 
molecular width on theoretical modeling. Instead of just forming single tubular nanostructures, 
some of the nanotubes observed for C4 were further stacked together, which possibly came from 
the self-assembly among the nanotubes with the ABAB pattern.24  
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Figure 3.33. STM image for C4 and C5. a C4 (scale bar, 20 nm); b C4 (scale bar, 20 nm); c C4 
(scale bar, 5 nm); d C5 (scale bar, 10 nm); e C5 (scale bar, 20 nm); f C5 (scale bar, 10 nm). 
Besides the formation of supramolecular nanotubes in solution, the behavior of 
supramolecules self-assemble on liquid-solid interfaces was even more attractive.25 Previous 
researches suggested that this type of supramolecules with alkyl chains have at least two kinds of 
interactions with highly oriented pyrolytic graphite (HOPG) surface: 1) The π- π interactions 
between the aromatic rings and HOPG surface;26 2) The alkyl chains which could further induce 
self-assemblies on HOPG surfaces.27 With these interactions in hand, we might be able to observe 
self-assembly behavior of C4 and C5 on solid-liquid interfaces. After dropcasting of a solution of 
C4 and C5 on freshly cleaved HOPG surface and washed with water, single strand supramolecular 
metal-organic nanoribbons (SMONs) were obtained and further visualized under STM. The width 
of the SMONs was equal to physical diameter of a single molecule as simulated. Some of the 
SMONs bounded together and formed aggregates (Figure 3.33). 
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Figure 3.34. 2D STM images of self-assembled nanosheets on HOPG surface of a C4 (scale bar, 
25 nm) and c C5 (scale bar, 25 nm); 3D STM images from the highlighted area of b C4 (scale bar, 
10 nm) and d C5 (scale bar, 10 nm); proposed patterns of e C4 and f C5 on HOPG surfaces (dark 
gray spots represent dark region observed on STM). 
With longer deposition time of supramolecule solution on HOPG, we even observed the 
formation of monolayer supramolecular nanosheets through the neat arranged supramolecules 
(Figure3.34). The outline of C4 was imaged as bright part, while the big hole in the center of the 
molecule was clearly observed (as shown in dark). The gaps between each supramolecule could 
not be clearly observed, perhaps because the supramolecules were very closely packed with each 
other (Figure 3.34e). Being similar to the nanosheets in C4, a large area was observed with C5 
well assembled on the HOPG surface, giving uniform molecular pattern (Figure 3.34c). In contrast 
to C4, the gaps between individual C5 were also clearly observed (Figure 3.34d). Considering the 
geometry, the ordered nanostructure was proposed to be a ‘head-by-head’ style based on C5 
molecules (Figure 3.34f).  
In summary, using linear metal-organic ligands, we have successfully generated a series of 
2D discrete polycyclic structures C1-C5 with increasing complexity based on the coordination 
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driven self-assembly. The order of the residues enhanced the specificity of metal-organic building 
blocks, and thus in turn giving self-assemblies with different complexity as well as structural 
uniformity. In principle, the self-assembly can be divided into intramolecular and intermolecular 
complexation processes. C1 was assembled by intermolecular complexation and C2 was 
assembled by intramolecular complexation. In contrast, C3, C4 and C5 were constructed by 
intramolecular complexation to form C1-like rings on the outside along with intermolecular 
complexation to form the rest rings in the center. With the improvement of synthesis and separation, 
design and utilizing linear metal-organic ligand with more types of residues and longer chain will 
open another avenue toward the construction of more complicated architectures. The pre-
assembled supramolecules with precisely-controlled shapes and sizes may find more promising 
application as 2D materials based on their hierarchical self-assembly behaviors both in solution 
and on the liquid-solid surface. 
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APPENDIX A. NMR & ESI-MS (ISOTOPE PATTERNS) IN CHAPTER 2 
 
Figure A1. 1H NMR (500 MHz, CDCl3, 300 K) spectrum of ligand LA. 
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Figure A2. 13C NMR (125 MHz, CDCl3, 300 K) spectrum of ligand LA. 
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Figure A3. 2D COSY NMR (500 MHz, CDCl3, 300 K) spectrum of ligand LA. 
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Figure A4. 1H NMR (500 MHz, CDCl3, 300 K) spectrum of ligand LB. 
 
Figure A5. 13C NMR (125 MHz, CDCl3, 300 K) spectrum of ligand LB. 
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Figure A6. 2D COSY NMR (500 MHz, CDCl3, 300 K) spectrum of ligand LB. 
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Figure A7. 2D COSY NMR (500 MHz, CDCl3, 300 K) spectrum of ligand LB (aliphatic 
region). 
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Figure A8. 2D COSY NMR (500 MHz, CDCl3, 300 K) spectrum of ligand LB (aromatic region). 
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Figure A9. 1H NMR (500 MHz, DMSO-d6, 300 K) spectrum of 2D Star of David A1 with NO3¯ 
as the counterion. 
 
Figure A10. 13C NMR (125 MHz, DMSO-d6, 300 K) spectrum of 2D Star of David A1 with NO3¯ 
as the counterion 
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Figure A11. 31P NMR spectra of 180° diplatinum (II) acceptor with NO3¯ as the counterion (202.5 
MHz, CDCl3, 300 K) and 2D Star of David A1 with NO3¯ as the counterion (202.5 MHz, DMSO-
d6, 300 K). 
 
Figure A12. 31P NMR spectra of 180° diplatinum (II) acceptor with NO3¯ as the counterion (202.5 
MHz, CDCl3, 300 K) and 2D Star of David B1 with NO3¯ as the counterion (202.5 MHz, DMSO-
d6, 300 K). 
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Figure A13. 2D NOESY (500 MHz, DMSO-d6, 300 K) spectrum of 2D Star of David A1 with 
NO3¯ as the counterion. 
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Figure A14. 2D NOESY (500 MHz, DMSO-d6, 300 K) spectrum of 2D Star of David A1 with 
NO3¯ as the counterion (aromatic region). 
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Figure A15. 1H NMR (500 MHz, DMSO-d6, 300 K) spectrum of 2D Star of David B1 with NO3¯ 
as the counterion 
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Figure A16. 13C NMR (150 MHz, DMSO-d6, 300 K) spectrum of 2D Star of David B1 with NO3¯ 
as the counterion. 
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Figure A17. 1H NMR (500 MHz, DMSO-d6, 300 K) spectrum of 2D Star of David B1 with NO3¯ 
as the counterion. 
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Figure A18. 1H NMR (500 MHz, DMSO-d6, 300 K) spectrum of 2D Star of David B1 with NO3¯ 
as the counterion (aromatic region). 
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Figure A19. 1H NMR (500 MHz, DMSO-d6, 300 K) spectrum of 3D Star of David B2 with NO3¯ 
as the counterion 
 
Figure A20. 13C NMR (150 MHz, DMSO-d6, 300 K) spectrum of 3D Star of David B2 with NO3¯ 
as the counterion. 
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Figure A21. 2D NOESY NMR (500 MHz, DMSO-d6, 300 K) spectrum of 3D Star of David B2 
with NO3¯ as the counterion. 
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Figure A22. 2D NOESY NMR (500 MHz, DMSO-d6, 300 K) spectrum of 3D Star of David B2 
with NO3¯ as the counterion (aromatic region). 
1,7
9 3
8
2,4
5,6
 194 
 
 
 
Figure A23. 2D NOESY NMR (500 MHz, DMSO-d6, 300 K) spectrum of 3D Star of David B2 
with NO3¯ as the counterion (alphilic region). 
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Figure A24. Variant temperature 1H NMR (600 MHz, DMSO-d6, 300 K to 340 K) for 2D Star of 
David A1 with NO3¯ as the counterion. Pre-saturation at 0 dB power was applied to suppress water 
peak. 
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Figure A25. Variant temperature 1H NMR (600 MHz, DMSO-d6, 300 K to 340 K) for 2D Star of 
David B1 with NO3¯ as the counterion. Pre-saturation at 0 dB power was applied to suppress water 
peak. 
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Figure A26. Variant temperature NMR (600 MHz, DMSO-d6, 300 K to 340 K) for 3D Star of 
David B2 with NO3¯ as the counterion. Pre-saturation at 0 dB power was applied to suppress 
water peak. 
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Figure A27. (a) 1H NMR (500 MHz, CDCl3, 300 K) spectrum for ligand LB. (b) 1H NMR (600 
MHz, DMSO-d6, 340 K) spectrum for ligand LB. (c) 1H NMR (600 MHz, DMSO-d6, 300 K) for 
2D Star of David B1 with NO3¯ as the counterion. Due to the extremely poor solubility of LA in 
DMSO-d6, we were unable to get satisfactory 1H NMR spectrum for LA using DMSO-d6 even at 
340 K. Attempts to get 1H NMR spectrum for LB in DMSO-d6 at 300 K also failed because of the 
poor solubility, and we were only able to get satisfactory 1H NMR spectrum for LB in DMSO-d6 
at 340 K. 
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Figure A28. (a) 1H NMR (500 MHz, CDCl3, 300 K) spectrum for ligand LB. (b) 1H NMR (600 
MHz, DMSO-d6, 340 K) spectrum for ligand LB. (c) 1H NMR (600 MHz, DMSO-d6, 300 K) for 
3D Star of David B2 with NO3¯ as the counterion. Note that solubility of LB in DMSO-d6 at 300K 
was poor, and we were only able to get satisfactory 1H NMR spectrum for LB in DMSO-d6 at 340 
K. 
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Figure A29. Measured (bottom) and calculated (top) isotope distributions for the different charge 
states observed from 2D Star of David A1 with OTf¯ as the counterion. Note that two sets of peaks 
were observed at m/z 1429.3 (12+) and m/z 1203.8 (14+), respectively, which is due to the overlap 
with fragments [(C50H26N4)(C30H64P4Pt2)2(CF3SO3-)2¯]2+,  and 
[(C50H26N4)3(C30H64P4Pt2)6(CF3SO3-)5¯]7+, respectively. 
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Figure A30. Measured (bottom) and calculated (top) isotope distributions for the different charge 
states observed from 2D Star of David B1 with OTf¯ as the counterion. Note that two sets of peaks 
were observed at m/z 1587.4 (12+) and m/z 1240.2 (15+), m/z 1153.3 (16+), respectively, which is 
due to the overlap with fragments [(C68H62N4O4)(C30H64P4Pt2)2(CF3SO3¯)2]2+,  
[(C68H62N4O4)2(C30H64P4Pt2)4(CF3SO3)3¯]5+, and [(C68H62N4O4)3(C30H64P4Pt2)6(CF3SO3-)4¯]8+, 
respectively. 
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APPENDIX B. NMR & ESI-MS (ISOTOPE PATTERNS) IN CHAPTER 3 
 
Figure A31. 1H NMR spectrum (500 MHz, CDCl3, 300K) for ligand L1 
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Figure A32. 13C NMR spectrum (126 MHz, CDCl3, 300K) for ligand L1 
 
Figure A33. 1H NMR spectrum (400 MHz, CDCl3+10% CD3OD, 300K) for ligand L2 
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Figure A34. 13C NMR spectrum (125 MHz, CDCl3+10% CD3OD, 300K) for ligand L2 
 
Figure A35. 19F NMR spectrum (376 MHz, CD3CN, 300K) for ligand L2 
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Figure A36. 2D COSY NMR spectrum (400 MHz, CDCl3+10% CD3OD, 300K) for ligand L2 
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Figure A37. 2D COSY NMR spectrum (400 MHz, CDCl3+10% CD3OD, 300K) for ligand L2 
(aromatic region). 
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Figure A38. 2D NOESY NMR spectrum (400 MHz, CDCl3+10% CD3OD, 300K) for ligand L2. 
* represent residual solvent.  
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Figure A39. 2D NOESY NMR spectrum (400 MHz, CDCl3+10% CD3OD, 300K) for ligand L2 
(aromatic region). 
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Figure A40. 1H NMR NMR spectrum (500 MHz, CD3CN, 300K) for ligand L3. 
 
Figure A41. 13C NMR NMR spectrum (100 MHz, CD3CN, 300K) for ligand L3. 
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Figure A42. 19F NMR NMR spectrum (376 MHz, CD3CN, 300K) for ligand L3. 
 
Figure A43. 2D COSY NMR spectrum (500 MHz, CD3CN, 300K) for ligand L3 
 213 
 
 
Figure A44. 2D COSY NMR spectrum (500 MHz, CD3CN, 300K) for ligand L3 (aromatic region) 
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Figure A45. 2D ROESY NMR spectrum (500 MHz, CD3CN, 300K) for ligand L3  
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Figure A46. 2D ROESY NMR spectrum (500 MHz, CD3CN, 300K) for ligand L3 (aromatic 
region) 
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Figure A47. 1H NMR NMR spectrum (500 MHz, DMSO-d6, 300K) for ligand L3’. * represent 
residue solvent. 
 
Figure A48. 13C NMR NMR spectrum (125 MHz, DMSO-d6, 300K) for ligand L3’. 
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Figure A49. 19F NMR NMR spectrum (376 MHz, DMSO-d6, 300K) for ligand L3’ 
 
Figure A50. 2D COSY NMR NMR spectrum (500 MHz, DMSO-d6, 300K) for ligand L3’ 
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Figure A51. 2D COSY NMR NMR spectrum (500 MHz, DMSO-d6, 300K) for ligand L3’ 
(aromatic region) 
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Figure A52. 2D NOESY NMR spectrum (500 MHz, DMSO-d6, 300K) for ligand L3’  
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Figure A53. 2D NOESY NMR NMR spectrum (500 MHz, DMSO-d6, 300K) for ligand L3’ 
(aromatic region) 
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Figure A54. 1H NMR NMR spectrum (500 MHz, CDCl3, 300K) for ligand L4. 
 
Figure A55. 13C NMR NMR spectrum (125 MHz, CDCl3, 300K) for ligand L4. 
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Figure A56. 19F NMR NMR spectrum (376 MHz, CDCl3, 300K) for ligand L4 
 
Figure A57. 2D COSY NMR NMR spectrum (500 MHz, CDCl3, 300K) for ligand L4 
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Figure A58. 2D COSY NMR NMR spectrum (500 MHz, CDCl3, 300K) for ligand L4 (aromatic 
region). 
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Figure A59. 2D ROESY NMR NMR spectrum (500 MHz, CDCl3, 300K) for ligand L4. 
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Figure A60. 2D ROESY NMR NMR spectrum (500 MHz, CDCl3, 300K) for ligand L4 (aromatic 
region). 
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Figure A61. 1H NMR NMR spectrum (600 MHz, CD3CN, 300K) for ligand L5. 
 
Figure A62. 13C NMR NMR spectrum (100 MHz, CD3CN, 300K) for ligand L5. 
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Figure A63. 19F NMR NMR spectrum (376 MHz, CD3CN, 300K) for ligand L5. 
 
Figure A64. 2D COSY NMR NMR spectrum (600 MHz, CD3CN, 300K) for ligand L5. 
 228 
 
 
Figure A65. 2D COSY NMR NMR spectrum (600 MHz, CD3CN, 300K) for ligand L5 (aromatic 
region). 
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Figure A66. 2D ROESY NMR spectrum (600 MHz, CD3CN, 300K) for ligand L5. 
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Figure A67. 2D ROESY NMR spectrum (600 MHz, CD3CN, 300K) for ligand L5 (aromatic 
region). 
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Figure A68. 1H NMR spectrum (600 MHz, CD3CN, 300K) for supramolecule C1  
  
Figure A69. DEPT Q NMR spectrum (600 MHz, CD3CN, 300K) for supramolecule C1. 
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Figure A70. 2D COSY NMR spectrum (600 MHz, CD3CN, 300K) for supramolecule C1. 
 
 
 
 
 
 
 
 233 
 
 
Figure A71. 2D COSY NMR spectrum (600 MHz, CD3CN, 300K) for supramolecule C1. 
(aromatic region) 
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Figure A72. 2D ROESY NMR spectrum (600 MHz, CD3CN, 300K) for supramolecule C1.  
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Figure A73. 2D ROESY NMR spectrum (600 MHz, CD3CN, 300K) for supramolecule C1. 
(aromatic region) 
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Figure A74. 1H NMR spectrum (500 MHz, CD3CN, 300K) for supramolecule C2.  
 
Figure A75. DEPT Q NMR spectrum (600 MHz, CD3CN, 300K) for supramolecule C2. 
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Figure A76. 19F NMR spectrum (376 MHz, CD3CN, 300K) for supramolecule C2. 
 
Figure A77. 2D COSY NMR spectrum (600 MHz, CD3CN, 300K) for supramolecule C2. 
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Figure A78. 2D COSY NMR spectrum (600 MHz, CD3CN, 300K) for supramolecule C2 
(aromatic region). 
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Figure A79. 2D ROESY NMR spectrum (600 MHz, CD3CN, 300K) for supramolecule C2. 
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Figure A80. 2D ROESY NMR spectrum (600 MHz, CD3CN, 300K) for supramolecule C2 
(aromatic region). 
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Figure A81. 1H NMR spectrum (600 MHz, CD3CN, 300K) for supramolecule C3. 
 
Figure A82. DEPT Q NMR spectrum (125 MHz, CD3CN, 300K) for supramolecule C3. 
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Figure A83. 19F NMR spectrum (376 MHz, CD3CN, 300K) for supramolecule C3. 
 
Figure A84. 2D COSY NMR spectrum (600 MHz, CD3CN, 300K) for supramolecule C3. 
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Figure A85. 2D COSY NMR spectrum (600 MHz, CD3CN, 300K) for supramolecule C3 
(aromatic region). Due to existing of isomers, only major peaks were signed. 
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Figure A86. 2D ROESY NMR spectrum (600 MHz, CD3CN, 300K) for supramolecule C3. 
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Figure A87. 2D ROESY NMR spectrum (600 MHz, CD3CN, 300K) for supramolecule C3 
(aromatic region). Due to existing of isomers, only major peaks were signed. 
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Figure A88. 1H NMR spectrum (500 MHz, CD3CN, 300K) for supramolecule C3’. 
 
Figure A89. DEPT Q NMR spectrum (150 MHz, CD3CN, 300K) for supramolecule C3’. 
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Figure A90. 19F NMR spectrum (376 MHz, CD3CN, 300K) for supramolecule C3’. 
 
Figure A91. 2D COSY NMR spectrum (500 MHz, CD3CN, 300K) for supramolecule C3’. 
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Figure A92. 2D COSY NMR spectrum (500 MHz, CD3CN, 300K) for supramolecule C3’ 
(aromatic region). 
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Figure A93. 2D NOESY NMR spectrum (500 MHz, CD3CN, 300K) for supramolecule C3’. 
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Figure A94. 2D NOESY NMR spectrum (500 MHz, CD3CN, 300K) for supramolecule C3’ 
(aromatic region). 
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Figure A95. 1H NMR spectrum (600 MHz, CD3CN, 300K) for supramolecule C4. 
 
 
 
Figure A96. 13C NMR spectrum (125 MHz, CD3CN, 300K) for supramolecule C4. 
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Figure A97. 19F NMR spectrum (376 MHz, CD3CN, 300K) for supramolecule C4. 
 
Figure A98. 2D COSY NMR spectrum (600 MHz, CD3CN, 300K) for supramolecule C4. 
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Figure A99. 2D COSY NMR spectrum (600 MHz, CD3CN, 300K) for supramolecule C4 
(aromatic region). 
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Figure A100. 2D NOESY NMR spectrum (600 MHz, CD3CN, 300K) for supramolecule C4. 
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Figure A101. 2D NOESY NMR spectrum (600 MHz, CD3CN, 300K) for supramolecule C4 
(aromatic region). 
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Figure A102. 1H NMR spectrum (600 MHz, CD3CN, 300K) for supramolecule C5. 
 
 
 
Figure A103. DEPT Q NMR spectrum (150 MHz, CD3CN, 300K) for supramolecule C5. 
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Figure A104. 19F NMR spectrum (376 MHz, CD3CN, 300K) for supramolecule C5. 
 
Figure A105. 2D COSY NMR spectrum (600 MHz, CD3CN, 300K) for supramolecule C5. 
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Figure A106. 2D COSY NMR spectrum (600 MHz, CD3CN, 300K) for supramolecule C5 
(aromatic region). 
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Figure A107. 2D NOESY NMR spectrum (600 MHz, CD3CN, 300K) for supramolecule C5. 
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Figure A108. 2D NOESY NMR spectrum (600 MHz, CD3CN, 300K) for supramolecule C5 
(aromatic region). 
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Figure A109. Theoretical isotope (red) and experimental isotope (blue) for C1 
 
 
 
 
 
 
5+
566.6 567.6
567 m/z
566.6 567.6
448 449 m/z
448.0 449.0
6+
448.0 449.0
4+ 3+
745 746 m/z
744.7 745.7
744.7 745.7
1041 1043 m/z
1041.3 1042.3
1042
1041.3 1042.3
 262 
 
 
Figure A110. Theoretical isotope (red) and experimental isotope (blue) for C3’ 
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Figure A111. Theoretical isotope (red) and experimental isotope (blue) for C2 
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Figure A112. Theoretical isotope (red) and experimental isotope (blue) for C3 
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Figure A113. Theoretical isotope (red) and experimental isotope (blue) for C4 
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APPENDIX C. REPRODUCTION PERMISSION 
 
 
 
 
 267 
 
 
 
 
 
 
 
 
 
 
 268 
 
 
 
 
 
 
 
 
 269 
 
 
 
 
 
 
 
 
 
 270 
 
 
 
 271 
 
 
 
 
 
 272 
 
 
 273 
 
 
 
 
 274 
 
 
 
 
 
 
 275 
 
 
 
 276 
 
 
 
 
 
 
 
 277 
 
 
 
 
 
 
 
 
 
 278 
 
 
 
 
 
 
 
 
 279 
 
 
 
 
 
 
 
 
 280 
 
 
 
 
 
 
 
 
 
 
 281 
 
 
 
 
 
 
 
 
 
 
 282 
 
 
 
 
 
 
 283 
 
 
 
 
 
 
 
 
 
 
 284 
 
 
 
 
 
 285 
 
 
 
 
 
 
 
 286 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
ABOUT THE AUTHOR 
Bo Song was born in Lanzhou, Gansu province in China. He obtained his bachelor’s degree 
from Zhejiang University majoring in biomedical engineering. Afterwards he went to Lanzhou 
University for a systematic training in synthetic organic chemistry and got a master’s degree. At 
the year of 2015 he went to the United States under the supervision of Dr. Xiaopeng Li and thus 
started his journey in the field of supramolecular chemistry and mass spectrometry. During the 
four years’ PhD studies he has more than 20 publications in peer-reviewed journals including 
Journal of the American Chemical Society, Angewande Chemie International Edition, Nature 
Communications, etc. He also got several awards, including Theodore and Venette Askounes 
Ashford doctoral fellowship in chemistry, and Martin travel award.  
